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 Abstract  
 
Background: Current malaria vector control programmes rely on insecticides with rapid 
contact toxicity. However, spatial repellents can also be applied to reduce man-vector 
contact, with the ultimate goal of reducing malaria transmission.  
Objectives and methods: The overall goal of my PhD thesis was to evaluate existing 
spatial repellents as potential tools for malaria control. This thesis focused on 
characterizing the effect of pyrethroid spatial repellents on mosquito behaviour indoors 
and outdoors. Emphasis was placed on the effect on entomological parameters that 
influence malaria transmission. Experiments were conducted in experimental huts in a 
malaria endemic village in rural south eastern Tanzania and in a semi-field system against 
laboratory reared Anopheles gambiae sensu stricto mosquitoes.  
Results and conclusions: Transfluthrin and Metofluthrin coils and DDT reduced human 
vector contact through deterrence, irritancy/excito-repellency and blood-feeding 
inhibition. Pyrethroid coils were shown to cause excitation and increased activity of 
mosquitoes in the presence of humans. Transfluthrin coils did not hinder attraction of 
mosquitoes to humans but prevented mosquitoes from biting and blood feeding. This way 
coils provided area wide protection for up to 15m and prolonged anti-feeding for 12 
hours. There was no evidence of Transfluthrin induced repellency (directional movement 
of mosquitoes away from humans) under outdoor conditions. Locally developed 
Transfluthrin hessian strips also prevented mosquitoes from biting. This thesis elucidates 
the mode of action of spatial repellents: spatial repellents reduce human – vector contact 
 4 
and induce mortality, hence directly affect ma: human biting rate, m: mosquito density 
and p: mosquito survival which are among the most important parameters of the vectorial 
capacity of a mosquito population. This information is critical for the development of 
target product profiles for spatial repellent products. This study shows that spatial 
repellents may be a suitable complementary option where mosquitoes feed in the early 
evening and rest outdoors.  
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CHAPTER ONE 
1     General introduction 
1.1. Public health importance of malaria in Africa 
 
Malaria burden is generally falling albeit to varying degrees across most regions of the 
world [1]. From 2000 to 2013 estimated malaria mortality rates dropped by 47% 
worldwide and by 54% in the World Health Organization Africa region [1]. The success 
in malaria control is attributed to high coverage of long lasting insecticidal nets (LLINs) 
and indoor residual spraying (IRS) programmes [2, 3] as well as use of effective 
diagnostic testing, malaria treatment and chemoprevention [1].  
Massive scale up of interventions in sub Saharan Africa is attributed to tremendous 
financing. International financial disbursements to malaria-endemic countries totalled 
US$ 2.7 Billion in 2013. [1]. Despite increased funding, the amount available remains 
below that required to achieve universal access to malaria interventions that would 
control and eliminate malaria. These are among challenges facing malaria control in sub-
Saharan Africa. The development of artemisinin resistance in the Greater Mekong sub-
region [4], insecticide resistance in parts of Africa [5], lack of tools that sufficiently 
reduce vectorial capacity, and the presence of mosquitoes that rest and feed outdoors are 
factors that may hinder malaria elimination and eradication [6].  
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1.2. Distribution and bionomics of malaria vectors in Africa 
 
The most important vector of malaria in Africa is Anopheles gambiae species complex 
[7]. It comprises at least six sibling species including: An. gambiae sensu stricto, An. 
arabiensis, An. quadrianulatus, An. melas, An. merus and An. bwambae [8, 9]. The 
distribution of these vectors in Africa is shown in Figure 1.1 [10]. Within this complex, 
An. gambiae sensu stricto, An. arabiensis and An. funestus are the most dominant vector 
species [11, 12] and are responsible for most of malaria transmission throughout Africa 
[13]. Anopheles gambiae s.s. and An. funestus mosquitoes are shown to exhibit 
anthropophilic (feed on humans) [14-16], endophagic (feed indoors) and endophilic (rest 
indoors) behaviour [17, 18] and typically feed late at night [19] hence the ability to 
sustain high malaria transmission in Sub Saharan Africa. .Unfortunately, close proximity 
to humans and indoor insecticides, is believed to have led to selective pressure and 
development of resistance to pyrethroids followed by resurgence of malaria in Kwa Zulu- 
Natal, South Africa. An. arabiensis mosquitoes exhibit behavioural plasticity that allows 
them to survive in a range of geographical locations [12]. These mosquitoes are 
considered to be mainly zoophilic (feed on animals), exophagic (feed outdoors) and 
exophilic (rest outdoors) [20] but have also been shown to exhibit a range of feeding and 
resting behaviour showing both anthropophilic and zoophilic behaviour [21]. The plastic 
behaviour is believed to enhance their adaptability to avoid contact with LLINs and IRS 
[20]. Studies indicate that An. gambiae s.s. mosquitoes that previously predominated in 
western Kenya [22] and northeastern Tanzania [23] have tremendously decreased in 
relation to An. arabiensis. This change is attributed to the plastic behaviour of An. 
arabiensis that makes them less responsive to intra-domiciliary vector control tools such 
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as LLINs and IRS. A recent illustration of the distribution of malaria vectors shows 
predominant distribution of An. arabiensis and An. funestus mosquitoes in East Africa 
[24] (Figure 1.2.) compared to Figure 1.1 where An. gambiae s.s. were predominant.  
1.3. Mosquito control and malaria transmission 
 
The main objective of malaria vector control is reduction of the vectorial capacity. 
Vectorial capacity refers to the expected number of new human malaria infections 
disseminated per human per day, by a mosquito population from a single case, presuming 
that all vector females feeding on the case become infective [25]. It relates to 
entomological parameters relevant for malaria transmission including: the density of 
mosquitoes in relation to man, human biting rate and the daily probability of the survival 
of vectors [26, 27]. A decrease in the vectorial capacity of mosquitoes leads to a 
reduction in malaria transmission [25]. The main mosquito control tools include larval 
source management, use of LLINs and IRS. The distribution of LLINs and high coverage 
of IRS have led to massive reduction of malaria [28-30]. The main aim of larviciding is to 
reduce vector density in order to reduce malaria transmission [31]. Efficacy of larviciding 
depends on location and treatment of all larval habitats. This is challenging in rural areas 
where larval habitats are many and hard to identify and may be the reason why 
larviciding is not as effective as other tools [32]. However, larval source management is 
proven effective against malaria transmission as well as cost effective where mosquito 
larval habitats are accessible and well defined. IRS is particularly effective where female 
mosquitoes after feeding, rest inside houses to digest blood meals. Therefore, high 
coverage of spraying and ensuring that all surfaces are sprayed enhances efficacy of IRS 
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due to increased contact of mosquitoes with toxic insecticides hence a decrease in 
survival and population densities. In this respect IRS has successfully reduced malaria 
transmission where vectors are endophilic [30] but may be ineffective against exophilic 
mosquitoes. LLINs massively reduce malaria because they affect different stages of the 
mosquito life cycle hence lead to more gains [33, 34]. They reduce the mosquito lifespan, 
lengthen the cycle and prevent biting through the killing and repellent actions [33]. 
However, efficacy is highest where mosquitoes are zoophagic because mosquitoes that 
are prevented from feeding can be diverted to non-malaria hosts [35]. Other control 
measures such as improving housing have also been shown to reduce malaria 
transmission [36, 37] through reduction of indoor densities of mosquitoes and  human - 
vector contact [38, 39]. 
In order to achieve maximum benefits from vector control interventions, it is necessary to 
consider the distribution and behaviour of mosquitoes as well as the level endemicity of 
malaria before implementation. For instance, ntra-domiciliary tools are effective where 
mosquitoes are anthropophilic, endophagic and endophilic but less effective where 
mosquitoes are exophagic and exophilic [40]. These underscore the need for additional 
vector control tools that can protect people in the early evening and when they are 
outdoors. This thesis focuses on the use of spatial repellents as complementary tools for 
malaria control. Spatial repellents are chemicals that work at a distance in the vapour 
phase [61] causing mosquitoes to sit apart from the source of the chemical [62]. Spatial 
repellents render a specific area mosquito free by preventing landing or biting within that 
area [63]. 
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Figure.1.1: Map of Africa showing distribution of Anopheles gambiae species complex 
mosquitoes. (These maps were produced in 2000). Source: [10]. 
 
 
 
An. gambiae An. arabiensis 
An.quadrianulatus 
 
An. melas An. merus 
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Figure. 1.2. A regional map showing the distribution of the three most dominant malaria vectors 
in Africa. (This map was produced in 2012) Source: [24]. 
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1.4. Statement of problem 
 
The World Health Organization recommends full coverage of Long Lasting Insecticidal 
Nets (LLINs) for all people at risk of malaria [41], and Indoor Residual Spraying (IRS) 
for low and moderate transmission areas in order to reduce seasonal annual malaria 
transmission [42]. Recent massive scale up of LLINs and IRS has successfully reduced 
malaria throughout sub Saharan Africa including Tanzania [2, 3]. Despite these 
successes, elimination and eradication remain challenging for most countries in Africa 
[6]. The main goal for vector control is to reduce vectorial capacity to levels that prevent 
transmission of parasites. Existing vector control tools are failing to elicit complete 
malaria control due to factors including: development of insecticide resistance and the 
presence of mosquitoes that rest and feed outdoors [6].  
Use of LLINs and IRS targets night biting, indoor feeding (endophagic) and indoor 
resting mosquitoes (endophilic), which are primarily anthropophilic (feed on man). High 
coverage of LLINs and IRS has successfully reduced these mosquitoes in most areas in 
Africa [22, 43, 44]. Unfortunately, success of indoor mosquito control means that there is 
a competitive advantage for those species and sub-species that feed when hosts are still 
active outdoors and they are able to maintain transmission, albeit at lower levels [40]. 
LLINs prevent blood feeding and therefore disrupt the feeding process of mosquitoes, 
increasing the length of the oviposition cycle of the overall population. This mechanism 
might explain the immediate change in biting cycles of several species such as has been 
reported for An. farauti and An. koliensis in Papua New Guinea [45]. Other studies also 
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report complete species shift to those that are able to feed and rest outdoors [22, 43, 44] 
and the appearance of cryptic species that have increased outdoor activity [46]. In 
addition, reduced malaria transmission is accompanied by heterogeneous transmission 
that has created transmission hot spots that remain highly malaria endemic, despite 
existing control programmes [47]. This indicates that apart from new control tools there 
is need to identify and target hot spots that continue to maintain transmission [47]. 
So far, there has been no deliberate control strategy geared towards early evening or 
outdoor biting and resting mosquitoes in sub-Saharan Africa, although in Greater 
Mekong sub region outdoor malaria transmission is well recognized [48, 49]. In order to 
eliminate and eventually eradicate malaria, efforts should be put into developing tools 
that target outdoor biting mosquitoes. Tools that protect people when they are not 
protected by LLINs and IRS are topical repellents. Topical repellents protect people from 
early – biting mosquitoes and the effect on reduced malaria transmission has been 
reported [50-52]. However, most topical repellents provide an average of 4 -10 hours 
protection [53] hence the development of long lasting formulations that confer maximum 
protection is necessary. Furthermore, efficacy of topical repellents is highly dependent on 
regular compliance by users. Studies indicate that when there is inconsistent compliance, 
mosquitoes are likely to be diverted between users and non-users. This might undermine 
control efforts due to increased diversion of infectious mosquitoes to unprotected people, 
who are potentially the poorest members of a population (unable to afford repellents), 
hence most vulnerable to the effects of malaria [54]. Efficacy of other interventions such 
as LLINs is also attenuated by lack of compliance by the community [55, 56]. 
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Behavioural, change is needed to make compliance a daily occurrence. It is widely 
recognized that interventions requiring minimal compliance by users are needed.  
 
One such method, to protect people at times when they are near to the home but not yet 
under their bednets are Spatial Repellents (SR) [57-60]. Spatial repellents are chemicals 
that work at a distance in the vapour phase [61] causing mosquitoes to either fly away 
from the source of the chemical [62] or mask human odours and prevent attraction. 
Spatial repellents render a specific area mosquito free by preventing landing or biting 
within that area [63]. They are also referred to as area repellents. Examples of SR include 
vaporizing mats, candles, mosquito coils and passive emanators [64].  
There is need to develop passive means of dispensing SR that provide area wide 
protection especially outdoors and extend protection to the whole household rather than 
to one person. Mosquito coils are commonly used in sub-Saharan Africa and their 
efficacy is well documented [64]. However, coils burn out after 6-8 hours, hence 
requiring replacement and therefore may end up being expensive and unaffordable. In 
addition, coils produce smoke that may be undesirable. To solve this problem, paper 
strips and plastic impregnated with the volatile pyrethroid Metofluthrin have been 
developed [59, 65-67]. The active ingredient evaporates at ambient temperature without 
the need for electricity or heating. This suggests that they can be used anywhere and 
makes them suitable for developing regions where there is no electricity. Like coils, 
emanators reduce landing and biting mosquitoes and have been shown to be effective 
against indoor and outdoor biting mosquitoes [59, 68, 69]. Efficacy of these emanators 
lasts a few weeks, and thus there is a need to develop novel passive ways of dispensing 
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volatile chemicals that last longer: preferably as long as a malaria transmission season. 
There is need to generate more data on the entomological mode of action i.e. the way a 
vector control intervention works preventing disease transmission by killing, repelling or 
inhibiting reproduction of target insects [70] of spatial repellents that can be linked with 
the epidemiological modes of action in order to understand the impact of SR on malaria 
transmission. 
The overall goal of this thesis is to determine the range of mosquito behaviours elicited 
by SR that minimize human - vector contact and consequently reduce malaria 
transmission. The SR selected for evaluation in this thesis are: Transfluthrin and 
Metofluthrin mosquito coils and DDT used as IRS.  
Metofluthrin and Transfluthrin compounds are highly volatile at ambient temperature; 
and hence are good candidates for passive emanators. However, the mode of action is not 
fully understood. This study focuses on determining the mode of action during indoor and 
outdoor use. 
Firstly, coils were selected because they have been extensively studied. [64]. Secondly, 
coils burn uniformly for 6-8 hours thus the release rate of the active ingredient is likely to 
be constant over time. Thirdly, coils are widely used for protection against mosquito bites 
and have high user acceptability [71]. This makes them suitable for use in experimental 
studies involving humans who are easily convinced to use them unlike when the product 
being tested is new. The mosquito coils used in the study have undergone rigorous safety 
testing and were donated by a reputable Personal Products supplier: SC Johnson. We 
were therefore sure that they were of the correct concentration and free of contaminants 
that could cause respiratory complications. 
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Mosquito coils were compared to DDT used as IRS because its mode of action as SR and 
the effect on malaria transmission are well documented [72, 73]. DDT was sprayed on 
palm woven mats. This enabled rotation between huts alongside other treatments and 
reduced locational bias that could have arisen from experimental huts.  
 
1.5. Hypotheses 
 
It is hypothesized that airborne pyrethroids 1) induce mosquitoes to move away from the 
highest concentration of the molecule to an area of lower concentration [74], 2) interfere 
with host detection [72] and blood feeding behaviour of mosquitoes [65, 69, 75] and also 
3) prevent mosquitoes from flying through sub-lethal incapacitation [76-78]. This study 
aims at characterizing the effect of pyrethroid based spatial repellents on mosquito 
behavior that reduces their vectorial capacity. The effect of DDT, Metofluthrin coils and 
Transfluthrin coils on house entry and exiting, host seeking, blood feeding, mosquito 
fertility and survival of the Afro Tropical malaria vectors An. gambiae s.s. and An. 
arabiensis were measured in experimental huts and the semi-field system.  
 
1.6. Specific objectives 
1. To perform an in-depth literature review, on existing studies of spatial repellents 
with emphasis on mosquito coils and passive emanators that are suitable for use in 
rural areas 
 30 
2. To develop and standardize an assay for evaluation of the modes of action of 
volatile pyrethroids: Metofluthrin and Transfluthrin against outdoor biting 
mosquitoes 
3. To measure the effect of airborne pyrethroids: Metofluthrin and Transfluthrin 
released by mosquito coils on mosquito behaviours that influence entomological 
parameters of malaria transmission indoors and outdoors 
4. To determine the effect of volatile Transfluthrin in coils on the host seeking and 
blood-feeding behaviour of mosquitoes 
5. To evaluate an appropriate alternative low-cost, passive format of dispensing 
volatile Transfluthrin to protect humans against outdoor biting mosquitoes suitable 
for use by the poor people in rural sub-Saharan Africa 
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CHAPTER TWO 
2     Literature review 
A systematic review of mosquito coils and passive emanators: 
defining recommendations for spatial repellent testing 
methodologies of spatially acting pyrethroids 
2.1. Abstract 
 
Mosquito coils, vaporizer mats and emanators confer protection against mosquito bites 
through the spatial action of emanated vapour or airborne pyrethroid particles. These 
products dominate the pest control market; therefore, it is vital to characterize mosquito 
responses elicited by the chemical actives and their potential for disease prevention. The 
aim of this review was to determine effects of mosquito coils and emanators on mosquito 
responses that reduce human-vector contact and to propose scientific consensus on 
terminologies and methodologies used for evaluation of product formats that could 
contain spatial chemical actives, including indoor residual spraying (IRS), long lasting 
insecticide treated nets (LLINs) and insecticide treated materials (ITMs). PubMed, 
(National Centre for Biotechnology Information (NCBI), U.S. National Library of 
Medicine, NIH), MEDLINE, LILAC, Cochrane library, IBECS and Armed Forces Pest 
Management Board Literature Retrieval System search engines were used to identify 
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studies of pyrethroid based coils and emanators with key-words “Mosquito coils” 
“Mosquito emanators” and “Spatial repellents”. It was concluded that there is need to 
improve statistical reporting of studies, and reach consensus in the methodologies and 
terminologies used through standardized testing guidelines. Despite differing evaluation 
methodologies, data showed that coils and emanators induce mortality, deterrence, 
repellency as well as reduce the ability of mosquitoes to feed on humans. Available data 
on efficacy outdoors, dose–response relationships and effective distance of coils and 
emanators is inadequate for developing a target product profile (TPP), which will be 
required for such chemicals before optimized implementation can occur for maximum 
benefits in disease control. 
Keywords: Spatial repellents, Pyrethroids, Coils, Passive emanators, Mosquito responses 
 
2.2. Review 
 
Currently, control of malaria vectors relies almost entirely on indoor residual-spraying 
(IRS) and Long Lasting Insecticidal Nets (LLINs) [1]. These vector control tools have 
successfully reduced mosquito population densities and malaria by targeting indoor-
feeding (endophagic) and indoor-resting (endophilic) mosquitoes [2]. The most 
successful IRS chemical active used to date is DDT, which, in addition to killing 
mosquitoes, also reduces indoor mosquito densities consequently reducing malaria 
transmission [3-6]. 
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Literature shows that much of the success of DDT is due to excito-repellency [4, 5]. An 
excito-repellent is defined as a chemical that causes insects to make undirected 
movements that set them apart from insecticides [7]. Excito-repellency results from 
insect‟s physical contact with chemicals on treated surfaces or with vapour particles at a 
distance [8, 9]. It has been demonstrated that volatile DDT can induce neural excitement 
in insects [10] and importantly, it was observed that insects exposed to sub-lethal 
concentrations of DDT move towards the light explaining why mosquitoes are likely to 
quickly leave a sprayed dwelling [11]. Excito-repellency was also originally seen as a 
beneficial feature of pyrethroid treated bednets to reduce the probability of mosquitoes 
developing resistance to insecticides through lower contact with insecticides [12]. It is 
known that DDT and pyrethroids act on the voltage-gated sodium channel proteins found 
in insect nerve cell membranes, disrupting transmission of nerve impulses thereby 
causing mortality [13]. Cross resistance between DDT and pyrethroids is conferred by 
point mutations on the voltage gated sodium channel in mosquitoes indicating a common 
mode of toxic action for these insecticides on mosquitoes [14]. Mechanisms underlying 
host-seeking and feeding behaviours of mosquitoes are largely unknown and have been 
the topic of current investigations. It is known that sublethal exposure to both pyrethroids 
and DDT has a differing effect on insect feeding responses: pyrethroids inhibit responses 
to attractants while DDT increases neural sensitivity to attractive sources [15, 16]. New 
advancements in the field of neurobiology have demonstrated that perception of 
chemicals in the environment by insects begins when compounds activate ionotropic 
receptors, gustatory receptors and olfactory receptors (ORs) located on the dendritic 
surface of chemosensory neurons of the olfactory receptor cells (ORCs) housed in a head 
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appendage (e.g. antenna or palp) [17]. ORs recognize biologically meaningful chemical 
ligands, and shape responses of olfactory sensory neurons (OSNs), thus regulating many 
behaviours including repellency. 
Repellents either activate or inhibit action of ORs interfering with the host-seeking 
behaviour of mosquitoes, resulting in repellency or anti-feeding [18]. A repellent 
pyrethroid has been shown to disrupt insect behaviour not through targeting the voltage 
gated sodium channel but instead inhibits the response of odorant receptors (ORs) to 
attractants in a similar way to para-menthane 3,8 diol and nepetalactone [18]. Repellency 
is a characteristic of personal protection tools such as mosquito coils, liquid vaporizers, 
vaporizer mats and ambient emanators [19]. These tools have been extensively studied 
yet they have not been promoted as formal methods for mosquito control. In 2006 the 
consumer market for pesticides was about $8.4 billion, with expected double-digit annual 
growth mainly due to rising income levels in several developing-world markets, notably 
China [20]. By far the most popular segment was aerosols, at $3.6 billion, followed by 
topical repellents, powders, and gels at $2 billion. The smaller segments of mats and 
vaporizers accounted for $1.6 billion and coils for $1 billion [20]. These products are 
already widely used and would therefore be expected to have community uptake if they 
were introduced as a formal means of disease control in an integrated vector management 
(IVM) strategy. 
In addition, due to increased need for effective vector control tools, to combat residual 
outdoor-biting and resting mosquitoes [21], it is timely to review studies of mosquito 
coils and emanators. This will enable better understanding of their mode of action and 
hence gain useful knowledge for development of effective spatially acting chemical 
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products that can be used outdoors hence complement LLINs and IRS for integration into 
a malaria elimination strategy [22]. 
The main active ingredients recommended by the World Health Organization (WHO) for 
use in the vapour phase all belong to the pyrethroid chemical class. The most commonly 
used format; mosquito coils are cheap and effective but produce smoke [23] which is 
undesirable. Vaporizer mats are an alternative to coils. The mats contain embedded 
repellent active ingredients that are volatilised using an electric heating element. The 
need for electricity can increase product costs making them inappropriate for some rural 
and urban settings in low or middle-income countries. 
Recently, other delivery formats that do not require heating or combustion have been 
developed. These are commonly known as emanators and are composed of insecticides 
impregnated on substrates such as paper, plastic or agarose-based gels [24, 25]. Unlike 
coils and mats, emanators function through passive evaporation of chemical actives. 
These chemicals are less polar and have lower vapour pressure than conventional 
pyrethroids hence evaporate at ambient temperature without the need for an external 
source of energy. Examples of these insecticides include metofluthrin and transfluthrin. 
The aim of this review was to determine effects of mosquito coils and emanators on 
mosquito responses that reduce human-vector contact and to propose scientific consensus 
on terminologies and methodologies used for evaluation of product formats that could 
contain spatial repellents including IRS, LLINs and insecticide treated materials (ITMs). 
 
This review was conducted in accordance with PRISMA (Preferred Reporting Items for 
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Systematic Reviews and Meta-Analyses) guidelines [26]. PubMed, (National Centre for 
Biotechnology Information (NCBI), National Library of Medicine, NIH), MEDLINE, 
LILACS, Cochrane library, IBECS and Armed Forces Pest Management Board Literature 
Retrieval System were searched systematically for both field and laboratory studies that 
included pyrethroid based coils and/or emanators using the English key-words “Mosquito 
coils”, “Mosquito emanators” and “Spatial repellents”, between January and November 
2011. In addition to journal articles, we searched reference lists of identified papers. We 
also checked the System for Information on Grey Literature in Europe (SIGLE) for 
unpublished data from sources such as conference proceedings and abstracts in an 
attempt to avoid the so called top drawer effect where only positive findings are 
published. The last search was conducted on 21
st
 September 2012. We were confident 
that the search engines we used provided almost all relevant studies of interest. Data were 
extracted from selected articles that met all study criteria using a standardized 
spreadsheet. The information collected included first author, year of publication, methods 
and design, active ingredient, dose, mosquito species, sample size, description of the 
control, testing conditions (experimental huts, rooms, chambers or cylinders) and the 
outcome measures reported with any available statistical information. 
 
2.3. Inclusion and exclusion criteria 
 
All publications evaluating coils and/or emanators were reviewed. However, to facilitate 
comparison of bioefficacy of different active ingredients across studies, the following 
selection scheme was employed (Figure 2.1): (i) laboratory and field studies were 
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reviewed separately; (ii) only laboratory and field studies that quantified mosquito 
responses including biting/feeding inhibition of mosquitoes, knock-down time and 
percentage mortality 24 hours post-exposure to insecticides, deterrence, repellency or 
irritancy of insecticides were included; (iii) studies where the dose of active ingredient 
was not indicated were excluded, (iv) all studies where coils contained a mixture of 
insecticides or additives were excluded. 
 
 49 
877 articles were identified
through database searching
54 duplicates were removed
824 articles were screened for
eligibility
806 studies were excluded:
Studies that did not report mosquito behavioral outcomes - 800
Studies that did not report the dose of active ingredient used - 4
Studies where the active ingredients included additives - 2
17 full-text articles were
included in qualitative analysis
Meta-analysis was not
conducted
 
Figure 2.1: A flow diagram of the selection procedure of articles included in the systematic review 
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2.4. Summaries of reported mosquito responses to coils and 
emanators, and suggestions for harmonization of terminologies 
 
Several investigators report a number of mosquito responses to airborne 
insecticide particles. These responses are classified into measurable indicators 
namely: deterrence, repellency and irritancy, biting/feeding inhibition, knock-
down and mortality. Scientific discussions differentiate between mechanisms in 
mosquitoes leading to responses elicited in the presence of chemical actives and 
the outcomes quantified [4, 7, 8, 11], this review is restricted to measured 
behavioural endpoints or consequences and not possible mechanisms causing 
them. 
All studies identified and included in the review evaluated formulated/optimized 
emanators and coils. It should be noted that comparison of pyrethrins to 
metofluthrin emanators is only appropriate if both actives were formulated or 
both were neat material (unoptimized) as effects on volatization and longevity 
(among other chemical properties) will be different and bias analyses. This holds 
true even for comparing results of the same active ingredient. 
2.4.1. Deterrence 
 
Airborne insecticide particles present inside and around houses create a chemical 
barrier that prevents mosquitoes from entering [27]. Deterrence has been 
measured in the field by comparing the number of mosquitoes entering houses 
with insecticides and those without. Coils containing pyrethrins deter between 
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45% and 80% mosquitoes (Table 2.1) and 200mg optimized metofluthrin 
emanators reduce mosquitoes by > 80% within the first 4 weeks of treatment 
[28]. However, results from these studies cannot be generalized for other spatial 
repellent compounds due to potential differences in product formulation i.e., 
optimized components for release and retention. Only one study measured dose-
dependent effects of pyrethrum coils [29] and showed no correlation between the 
proportion of mosquitoes deterred and the dose of pyrethrum (Table 2.1). 
Reduced indoor density of mosquitoes in insecticide treated houses could be due 
to the spatial action of chemical actives that interfere with the host seeking 
process of mosquitoes making the houses less attractive even when humans are 
present. In addition, mosquitoes entering treated houses are prevented from 
feeding. Such observations warrant further investigations of spatially acting 
chemicals. 
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Table 2.1.: Mosquito behavioural reactions induced by burning pyrethrum coils in experimental huts 
Dose of pyrethrum (w/w %)  Vector  Feeding inhibition (%)  Non-Contact irritancy (%)  Deterrence (%)  Mortality (%) 
0.10  Anopheles gambiae Gillies
a 
 54  82  51  16 
0.10  Culex fatigans  26  58  64  4 
0.10  Mansonia uniformis  24  93  45  3 
0.50  Anopheles gambiae Gillies  60  87  58  15 
0.50  Culex fatigans  46  67  51  7 
0.50  Mansonia uniformis  69  87  58  15 
a 
The sub species of Anopheles gambiae Gillies was not specified. These data is  from Smith et al 1972 [29]. 
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2.4.2. Repellency and irritancy 
 
Repellency was originally defined to refer to the distribution of insects/mosquitoes on 
chemically treated surfaces compared to untreated surfaces [11]. This description considers 
the end result of the effect of chemicals and does not account for a series of preceding 
behaviours exhibited by mosquitoes that lead to the final outcome. Therefore, this definition 
was refined to refer to movement of mosquitoes away from a source to which they would 
otherwise be attracted [30]. Dethier described two kinds of behaviour causing insects to sit 
apart from insecticide treated surfaces: [7] “taxis”: - immediate directional reaction, 
resulting in movement away from a treated surface and; 2) “orthokinesis”: - increased 
undirected activity after contact with insecticides. Both reactions reduce mosquitoes on 
treated surfaces [7, 8]. These terms have been developed further to include "contact 
irritancy” where mosquitoes make oriented movement away from a chemical source after 
physical contact with insecticide treated surfaces [3, 4] and “non-contact irritancy”, where 
mosquitoes move away when exposed to vapour insecticide particles usually operating at a 
distance. This has also been described as “spatial repellency” [4, 31], or “area repellency” 
[32] or “non-contact disengagement” [8]. Non-contact irritancy, spatial repellency and non-
contact disengagement all describe behavioural endpoints resulting from exposure to 
chemical emanations from coils and emanators. For purposes of clarity we propose that 
spatial repellency should be used as a general term to refer to the sum of mosquito 
behaviours produced by airborne chemicals that result in mosquitoes sitting apart from a 
source of stimulation [8]. 
“Non-contact irritancy” was measured in the field using local houses or experimental huts 
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fitted with exit- and entry-traps [29, 33-35] by comparing the proportion of mosquitoes 
exiting untreated and treated structures. Using this approach, studies have demonstrated an 
increased proportion of mosquitoes that exit earlier from huts with burning coils compared 
to huts that do not have coils [29]. There was a positive correlation between the proportion 
of mosquitoes exiting huts and the concentration of the active ingredient [29]. This indicates 
that the magnitude of irritancy might be dose-dependent [31]. An effective way of 
measuring “non-contact irritancy” is by releasing laboratory-reared mosquitoes inside 
experimental huts [4] and observing how fast they leave treated huts compared to control 
huts. This field data demonstrated good correlation with laboratory data from a high-
throughput screening system (HiTSS) developed for evaluating behavioural mode of action 
of active ingredients [4]. 
 
2.4.3. Biting/feeding inhibition 
 
Feeding or biting inhibition is where mosquitoes are prevented from biting or feeding on 
humans. Coils reduce the biting rate of mosquitoes (Table 2.1). Small amounts of 
insecticides [36] or repellents have been shown to interfere with the host-seeking process of 
disease vectors [37, 38]. Sometimes mosquitoes land on the host but do not feed in the 
presence of repellent actives [39]. Therefore, the act of feeding (probing) should be 
quantified rather than landing rate. Only one study displayed an increase in the proportion 
of mosquitoes inhibited from feeding when the dose was increased [29]. In some cases even 
the smoke which does not contain chemicals reduces biting rate significantly compared to 
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controls where coils are not used [40]. This warrants the need to conduct more studies with 
different doses of spatial chemical actives and to generate dose–response curves which will 
enhance better understanding of the mode of action. 
The most accurate and representative method to measure feeding inhibition is through 
human landing catch (HLC) [41]. Some studies use guinea-pigs as bait [42], which are not 
proxy indicators for man. A study comparing biting inhibition on guinea pigs and man 
indicated that guinea pigs underestimated reduction in biting inhibition [42]. This is because 
guinea pigs do not produce sufficient heat, moisture and carbon dioxide and have a different 
composition of head space kairomones hence do not attract anthropophilic mosquitoes as 
much as humans. We propose conducting HLC evaluations inside semi-field systems (SFS) 
using laboratory reared disease-free mosquitoes to reflect the end use of spatial repellents, 
while protecting participants from potential exposure to disease carrying mosquitoes. 
 
2.4.4. Knock-down and mortality 
 
Knocked-down (KD) is the incapacitation of mosquitoes after contact with a sub-lethal dose 
of insecticide [43] resulting in the inability of the insect to maintain normal posture or fly. 
High concentrations of pyrethrins induce faster KD50 (within 3–5 minutes of exposure) 
followed by high mortality rate while low concentrations induce slower KD50 (more than 
10 minutes after exposure) indicating a dose–response relationship (Table 2.2). It is also 
important to note that coils induce up to 95% mortality in laboratory-assays compared to 
very low levels observed in field-assays (3%–16%) (Table 2.2). This is attributed to volume 
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and/or ventilation limitations that may occur in some laboratory subsequently assay spaces, 
which reduce insecticide dispersion consequently increasing relative insecticide 
concentration.  
The relationship between KD50 and mortality of mosquitoes exposed to different pyrethroid 
mosquito coils is presented in Figure 2.2; 2.3 and 2.4. 
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Table 2.2. Knock-down time and mortality of mosquitoes after exposure to smoke from mosquito coils impregnated with different 
doses of Allethrin, d- allethrin, d,d-T-plarethrin, dl,d-T80 allethrin, d-trans allethrin, Esbiothrin, Pyrethrin, S-d- t –allethrin, and 
Terallethrin pyrethroids. 
Dose 
(w/w %) 
Vector Mortality (%) Knock-down (KT50 
minutes) 
Method  
0.60 Culex pipiens pallens 0.12 5.10 70 cm³ Chamber 
0.60 Stegomyia (Aedes) aegypti 0.72 3.10 70 cm³ Chamber 
0.60 Anopheles stephensi 0.81 3.20 70 cm³ Chamber 
0.50 Anopheles stephensi 33.00 9.50 25m³ room 
0.25 Anopheles stephensi 38.00 11.10 25m³ room 
0.20 Anopheles stephensi 25.00 11.30 25m³ room 
0.15 Anopheles stephensi 32.00 14.50 25m³ room 
0.50 Stegomyia (Aedes) aegypti 88.00 14.90 25m³ room 
0.25 Stegomyia (Aedes) aegypti 70.00 24.80 25m³ room 
0.20 Stegomyia (Aedes) aegypti 54.00 29.00 25m³ room 
0.20 Anopheles stephensi 49.00 4.50 500 mm by 300 mm cylinder 
0.15 Anopheles stephensi 49.00 4.90 500 mm by 300 mm cylinder 
0.10 Anopheles stephensi 42.00 5.50 500 mm by 300 mm cylinder 
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0.05 Anopheles stephensi 32.00 6.80 500 mm by 300 mm cylinder 
0.20 Stegomyia (Aedes) aegypti 95.00 6.20 500 mm by 300 mm cylinder 
0.15 Stegomyia (Aedes) aegypti 73.00 7.50 500 mm by 300 mm cylinder 
0.10 Stegomyia (Aedes) aegypti 54.00 10.00 500 mm by 300 mm cylinder 
0.05 Stegomyia (Aedes) aegypti 26.00 16.00 500 mm by 300 mm cylinder 
0.30 Culex pipiens pallens 0.15 3.80 70 cm³ Chamber 
2.00 Stegomyia (Aedes) aegypti 0.32 1.57 2m³ Peet-Grady chamber 
2.00 Culex quinquefasciatus 0.49 0.98 2m³ Peet-Grady chamber 
2.00 Anopheles stephensi 0.67 1.94 2m³ Peet-Grady chamber 
0.30 Anopheles stephensi 0.81 2.40 70 cm³ Chamber 
0.30 Stegomyia (Aedes) aegypti 0.84 2.40 70 cm³ Chamber 
0.10 Stegomyia (Aedes) aegypti 0.22 171.00 25m³ room 
0.10 Stegomyia (Aedes) aegypti 0.24 120.00 25m³ room 
0.10 Culex pipiens quinquefasciatus 0.25 108.00 25m³ room 
0.15 Stegomyia (Aedes) aegypti 0.25 140.00 25m³ room 
0.20 Stegomyia (Aedes) aegypti 0.28 130.00 25m³ room 
0.10 Culex pipiens quinquefasciatus 0.30 55.00 25m³ room 
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0.15 Stegomyia (Aedes) aegypti 0.30 100.00 25m³ room 
0.20 Stegomyia (Aedes) aegypti 0.30 85.00 25m³ room 
0.10 Culex pipiens pallens 0.36 20.60 25m³ room 
0.15 Culex pipiens pallens 0.39 14.00 25m³ room 
0.15 Culex pipiens quinquefasciatus 0.47 100.00 25m³ room 
0.20 Culex pipiens quinquefasciatus 0.50 63.00 25m³ room 
0.10 Culex pipiens pallens 0.51 14.50 25m³ room 
0.15 Culex pipiens pallens 0.53 11.40 25m³ room 
0.15 Culex pipiens quinquefasciatus 0.55 42.00 25m³ room 
0.20 Culex pipiens pallens 0.67 13.10 25m³ room 
0.20 Culex pipiens quinquefasciatus 0.71 24.00 25m³ room 
0.10 Anopheles dirus 0.91 8.00 25m³ room 
0.10 Anopheles dirus 0.91 8.00 25m³ room 
0.20 Culex pipiens pallens 0.92 10.30 25m³ room 
0.20 Anopheles dirus 1.00 8.10 25m³ room 
0.27 Culex pipiens quinquefasciatus 0.04 196.00 25m³ room 
0.27 Stegomyia (Aedes) aegypti 0.15 361.00 25m³ room 
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0.27 Culex pipiens pallens 0.20 28.30 25m³ room 
0.27 Stegomyia (Aedes) aegypti 0.21 174.00 25m³ room 
0.27 Culex pipiens pallens 0.27 18.60 25m³ room 
0.50 Culex pipiens pallens 0.28 20.80 25m³ room 
0.50 Stegomyia (Aedes) aegypti 0.29 170.00 25m³ room 
0.27 Culex pipiens quinquefasciatus 0.35 41.00 25m³ room 
0.50 Culex pipiens quinquefasciatus 0.55 72.00 25m³ room 
0.27 Anopheles dirus 1.00 11.10 25m³ room 
0.50 Anopheles dirus 1.00 8.00 25m³ room 
0.30 Culex pipiens pallens 0.18 3.90 70 cm³ Chamber 
0.30 Stegomyia (Aedes) aegypti 0.80 2.50 70 cm³ Chamber 
0.30 Anopheles stephensi 1.00 2.50 70 cm³ Chamber 
1.00 Stegomyia (Aedes) aegypti 0.30 1.14 2m³ Peet-Grady chamber 
1.00 Culex quinquefasciatus 0.76 0.81 2m³ Peet-Grady chamber 
1.00 Anopheles stephensi 0.90 1.68 2m³ Peet-Grady chamber 
0.30 Culex pipiens pallens 0.12 8.80 70 cm³ Chamber 
0.30 Anopheles stephensi 0.31 5.20 70 cm³ Chamber 
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These data is courtesy of Chadwick 1975, Yamaguchi et al 1981, Amalraj et al 1996 and Katsuda et al 2008 [42, 44, 45, 46] 
 
 
0.30 Stegomyia (Aedes) aegypti 0.46 5.50 70 cm³ Chamber 
0.15 Culex pipiens pallens 0.22 3.60 70 cm³ Chamber 
0.15 Stegomyia (Aedes) aegypti 0.87 2.50 70 cm³ Chamber 
0.15 Anopheles stephensi 0.88 2.70 70 cm³ Chamber 
0.15 Culex pipiens pallens 0.38 2.80 70 cm³ Chamber 
0.15 Stegomyia (Aedes) aegypti 0.59 1.80 70 cm³ Chamber 
0.15 Anopheles stephensi 0.73 1.70 70 cm³ Chamber 
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Figure 2.2: Mosquito species response of the relationship between KT50 and mortality. 
These data was extracted from Katsuda et al 2008 (Part 1) 
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Figure2.3: The relationship between knock down time (KT50) and mortality of mosquitoes 
after exposure to mosquito coils impregnated with different doses of mosquito coils. These 
data was extracted from Katsuda et al 2008 (Part 1) 
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Figure 2.4: The relationship between knock down time (KT50) and 24 hour mortality in 
laboratory assays. These data was extracted from Chadwick et al 1975 
 
Optimized metofluthrin emanators induce 100% KD of mosquitoes within 30 
minutes of exposure followed by 100% mortality within 24 hours in the laboratory 
[28]. We did not find any studies that demonstrated correlation between dose and 
response of mosquitoes to emanators. However, Kawada et al. reported that caged 
mosquitoes placed immediately near metofluthrin-treated paper strips showed 100% 
KD within 30 minutes and 100% mortality 24-hours post-exposure, while 
mosquitoes placed 1.5m away from the strip had slower KD and 70% mortality and 
mosquitoes placed 5m away were unaffected [28]. This could be attributed to 
decreasing concentration of airborne active ingredients as one moved away from the 
source. It is noteworthy that these results may not be representative of natural 
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conditions because mosquitoes are confined within the cage thus are likely to take up 
a high concentration of the active ingredient compared to when they are free flying. 
The intensity of KD and mortality of mosquitoes is largely dependent on release and 
degradation rates of active ingredients, initial loading dose on substrate and 
environmental conditions. 
 
2.5. Harmonization in methodologies for testing spatial mosquito 
repellents 
 
To characterize behavioural endpoints of mosquitoes exposed to chemical 
emanations of coils and emanators through rigorous independent and repeatable tests, 
it is essential to harmonize methodologies used. 
2.5.1. Mosquito species 
 
The mosquito species selected for bioefficacy studies is dependent on the objective 
and medical importance of a particular species in a given study area. The World 
Health Organization (WHO) recommends use of Stegomyia (Aedes) aegypti and 
Culex quinquefasciatus for testing household-insecticides [19]. Evaluations should 
be conducted on both susceptible and resistant strains of different mosquito species. 
Different mosquito genera, species, and population strains of the same species, vary 
in their susceptibility to insecticides due to specific selection pressures at site of 
origin and this can bias the intensity of outcome measures (Table 2.1.). 
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Consequently, we recommend that, when available, mosquito test populations should 
be acquired from disease endemic areas for which the chemical active ingredients are 
intended to be used. 
 
2.5.2. Size of the laboratory test chambers or rooms 
 
Field and laboratory studies are usually conducted in chambers, cylinders, rooms or 
huts of different sizes (Table 2.2.). Mosquitoes are knocked-down faster in cylinders 
or small chambers compared to large rooms (25m
3
) [42]. This is attributed to low 
aerial concentration of chemical actives in large ventilated rooms. Peet-Grady 
chambers [19] are good alternatives to air-tight cylinders. These chambers have 
improved ventilation provided by built-in fans and a larger volume (180cm by 
180cm by 180cm) [19]. Tests carried out in Peet-Grady chambers and large rooms 
demonstrated that KD time was relatively shorter in the chambers than in the rooms 
[42]. Despite these limitations, cylinders, chambers and small rooms enable precise 
measurement of mosquito responses to various doses of chemical actives and 
generation of dose response curves. This might not be possible in field settings where 
external environmental factors such as wind speed and direction are likely to 
influence efficacy of the spatially acting actives. Cylinders or small chambers should 
be used primarily during initial screening for actives. Subsequent studies should then 
be conducted in more natural environments such as experimental huts and semi-field 
systems. 
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2.5.3. Environmental factors 
 
The spatial activity of airborne insecticide is dependent on airflow (i.e., air 
exchange), wind speed, temperature and humidity within the treated space [47]. The 
greater the air current, the greater the insecticidal dispersion over a specified area 
followed by reduced insecticide concentration accompanied by dilution of chemical 
attractants from the human, leading to reduced host attack by mosquitoes [48]. A 
study carried out in Tanzania demonstrated reduced efficacy of emanators when used 
in houses with open eaves [25] compared to houses that did not have eaves in 
Vietnam [47]. It is necessary to consider the degree of ventilation of the test structure 
and average environmental conditions during peak disease transmission seasons 
within the test area where the spatial repellent will be used. High temperature 
increases evaporation rate of active ingredient [47] that may improve efficacy but 
can also lead to faster loss of actives followed by reduced efficacy over time. 
Therefore, it is necessary to determine the rate at which chemical actives are released 
from coils and emanators under different environmental conditions in order to 
determine how much repellent active ingredient will be required for efficacy over 
time. 
 
2.5.4. Experimental design 
 
Other factors affecting experimental outcomes include sample size, which may refer 
to the number of people used in the trial or number of mosquitoes used and the 
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number of replicates performed during evaluations. It is necessary to determine the 
number of mosquitoes required for a representative sample. This also applies to the 
number of human subjects required to account for differences in individual 
attractiveness to mosquitoes [49-51]. Wherever possible, a balanced Latin Square or 
William‟s Square design with rotation of volunteers and or treatments is desirable. 
We recommend analysis with generalised linear mixed models [52] which account 
for over-dispersed nature of repellent mosquito data when variance is greater than 
mean due to variability caused by the great variability among experimental days [53]. 
Few of the studies reviewed used appropriate study design or analyses. We propose 
that future studies should report means with standard errors or confidence intervals, 
or medians with the inter-quartile range in addition to test statistics. This information 
was not given by most of the studies reviewed, thus, we were unable to conduct a 
meta-analysis. 
 
2.6. Conclusion 
 
Spatial repellents is the general term used to describe delivery formats such as coils, 
mats and passive emanators which release vaporised chemical actives capable of 
affecting mosquito behaviour at a distance. Most vapour chemical actives also knock 
down, kill or inhibit feeding of mosquitoes. General use of this term causes 
confusion especially where oriented movement away from the chemical source is not 
demonstrated. For purposes of clarity we propose that spatial repellency should be 
used as a general term to refer to sum of mosquito behaviours induced by airborne 
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chemicals that cause mosquitoes to sit apart from a source of stimulation. Despite 
differences in evaluation methodologies, coils and emanators clearly reduce human-
mosquito contact. They induce mortality, deterrence, repellency and reduce feeding 
of mosquitoes on humans. Mortality was the least observed effect where tests were 
conducted in experimental huts. This shows that these products do not kill 
mosquitoes in natural settings with free air movements and therefore may not affect 
overall mosquito densities or contribute to “community effect” as other toxic 
insecticides would. 
Mosquito coils increased the proportion of mosquitoes exiting huts. It is not clear 
whether mosquitoes leave treated houses because they are unable to locate hosts for 
blood meals and therefore continue searching for other blood sources or whether they 
leave because they are irritated by chemicals in the smoke/vapour and are forced to 
escape. This needs more investigation. 
Reduction in human-vector contact through feeding inhibition is likely to have an 
epidemiologically significant effect because of reduced risk of getting infectious 
mosquito bites. Any reduction in human-biting rate of mosquitoes is likely to lower 
vectorial competence of vectors and affect the lifetime fecundity of vectors which 
will in turn influence the basic reproductive rate of any parasites that they transmit. 
In addition to the measure of chemically induced feeding inhibition, it is necessary to 
conduct studies that quantify fecundity in order to see whether reduced blood feeding 
consequently reduces fertility of mosquitoes and leads to an overall reduction of 
mosquito population. 
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There is minimal data available on dose–response relationships, effective distance 
and residual efficacy of treated materials. However, the data reviewed here indicate 
that feeding inhibition, knockdown and mortality are positively influenced by high 
doses of active ingredient while deterrence does not change with change in dose. 
However, other studies indicate that deterrence resulting from DDT residues inside 
huts diminishes with time as the active ingredient degrades [3], indicating a dose 
dependent-response relationship. Unfortunately, there was no evidence from testing 
coils and emanators, hence there is need to conduct studies to ascertain this for 
different doses of coils and emanators under outdoor conditions. 
It is hypothesized that since spatial repellents do not kill mosquitoes, there is 
increased risk of unprotected people being infected with pathogens transmitted by 
mosquitoes diverted from repellent users [54]. Therefore it is necessary to determine 
the distance at which non-users are at increased risk of receiving more mosquito bites 
for repellent-specific actives. On the other hand, non-users may in fact be protected 
due to airborne dispersion of volatized chemicals. In addition, it is also worthwhile to 
understand whether feeding inhibition of mosquitoes can be prolonged over several 
hours or days through product optimization, as this is an epidemiologically 
significant endpoint for arthropod-borne diseases. 
A meta-analysis could not be conducted as a result of the differences in evaluation 
methodologies as well as minimal statistical parameters reported by various studies. 
Hence, we strongly underline the need to reach consensus in spatial repellent testing 
methodologies and data reporting facilitated through the development of 
standardized assay guidelines. It is important to note that it is highly likely that 
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additional data on spatial repellents has been gathered but not made available to the 
scientific community. Publication bias due to industry-associated research may 
contribute to missing data sets, which if shared could greatly contribute to better 
characterization of spatial repellents. This information is vital for the development of 
standardized testing methodologies as well as target product profiles. Therefore 
scientists in industry are encouraged to share their data which will aid this process. 
Spatial repellents have the potential to become an important component of vector 
control since outdoor biting vectors are gaining importance as malaria vectors [55]. 
In order to understand the dynamics of these products and their potential for vector 
control programs it is necessary to comprehensively characterize their mode of action 
(i.e., physiological pathways/receptors and behavioural modification involved in 
insect response) using standardized methodologies to facilitate the development of a 
target product profile (TPP) and testing of candidate products so that the required 
information on their efficacy in disease prevention can be more rapidly collected and 
policy makers better informed for maximum effective benefit in disease control. 
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CHAPTER THREE 
3     Screening Mosquito House Entry Points as a Potential 
Method for Integrated Control of Endophagic Filariasis, 
Arbovirus and Malaria Vectors 
3.1. Abstract 
 
Background: Partial mosquito-proofing of houses with screens and ceilings has the 
potential to reduce indoor densities of malaria mosquitoes. We wish to measure 
whether it will also reduce indoor densities of vectors of neglected tropical diseases. 
Methodology: The main house entry points preferred by anopheline and culicine 
vectors were determined through controlled experiments using specially designed 
experimental huts and village houses in Lupiro village, southern Tanzania. The benefit 
of screening different entry points (eaves, windows and doors) using PVC-coated fibre 
glass netting material in terms of reduced indoor densities of mosquitoes was 
evaluated compared to the control. 
Findings: 23,027 mosquitoes were caught with CDC light traps; 77.9% (17,929) were 
Anopheles gambiae sensu lato, of which 66.2% were An. arabiensis and 33.8% An. 
gambiae sensu stricto. The remainder comprised 0.2% (50) An. funestus, 10.2% (2359) 
Culex spp. and 11.6% (2664) Mansonia spp. Screening eaves reduced densities of 
Anopheles gambiae s. l. (Relative ratio (RR) = 0.91; 95% CI = 0.84, 0.98; P = 0.01); 
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Mansonia africana (RR = 0.43; 95% CI = 0.26, 0.76; P,0.001) and Mansonia 
uniformis (RR = 0.37; 95% CI = 0.25, 0.56; P,0.001) but not Culex quinquefasciatus, 
Cx. univittatus or Cx. theileri. Numbers of these species were reduced by screening 
windows and doors but this was not significant. 
Significance: This study confirms that across Africa, screening eaves protects 
households against important mosquito vectors of filariasis, Rift Valley Fever and 
O‟Nyong nyong as well as malaria. While full house screening is required to exclude 
Culex species mosquitoes, screening of eaves alone or fitting ceilings has considerable 
potential for integrated control of other vectors of filariasis, arbovirus and malaria. 
 
3.2. Author Summary 
 
Mosquito vectors that transmit filariasis and several arboviruses such as Rift Valley 
Fever, Chikungunya and O‟Nyong nyong as well as malaria co-occur across tropical 
Africa. These diseases are co-endemic in most rural African countries where they are 
transmitted by the same mosquito vectors. The only control measure currently in 
widespread use is mass drug administration for filariasis. In this study, we used 
controlled experiments to evaluate the benefit of screening the main mosquito entry 
points into houses, namely, eaves, windows and doors. This study aims to illustrate the 
potential of screening specific house openings with the intention of preventing 
endophagic mosquitoes from entering houses and thus reducing contact between 
humans and vectors of neglected tropical diseases. This study confirms that while full 
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house screening is effective for reducing indoor densities of Culex spp. mosquitoes, 
screening of eaves alone has a great potential for integrated control of neglected 
tropical diseases and malaria. 
3.3. Introduction 
 
Houses are the main site for contact between humans and night biting mosquito 
vectors [1, 2]. The impact of improved housing on indoor malaria vector densities [3-
7] and transmission [4] is well established. In Africa, the primary malaria vectors are 
nocturnal, endophilic and endophagic mosquitoes of the Anopheles gambiae species 
complex [8, 9]. These vectors prefer to enter houses via open eaves [2]. Therefore, 
houses with open eaves or those lacking ceilings have higher numbers of mosquitoes 
and a greater malaria burden compared to those with closed eaves or with ceilings [4-
6, 10]. 
Regardless of evidence that improved housing provides protection from Anopheles 
malaria vectors, its potential to reduce indoor biting densities of other mosquito genera 
has received little attention, despite the fact that several of these species are known 
vectors of diseases which cause significant morbidity and mortality. These diseases 
include lymphatic filariasis, several arboviruses such as Chikungunya, O‟Nyong 
nyong, Rift Valley Fever (RVF) and West Nile Virus (WNV) (Table 3.1). 
An. gambiae sensu stricto and An. arabiensis are the most abundant malaria vectors in 
rural tropical African countries and are also the main vectors of filariasis [11] as well 
as O‟Nyong nyong [12]. Mansonia africana and Ma. uniformis are vectors of RVF 
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and filariasis, although the latter predominantly transmits Brugian filariasis in Asia. 
Integrated control of filariasis and malaria is feasible [13, 14] due to their co-
occurrence in rural areas, where they are often co-endemic and transmitted by the 
same vectors [15]. Though the main control measure against filariasis is 
chemotherapy, achieved through mass drug administration, a more holistic approach 
that integrates other proven interventions may be feasible in many endemic areas [16]. 
Culex quinquefasciatus is a vector of Wuchereria bancrofti causing lymphatic 
filariasis in Africa. It is the main vector in urban areas [17] but also contributes to rural 
transmission. Cx quinquefasciatus is also a vector of other arboviruses such as 
Chikungunya and West Nile Virus (Table 3.1.). Several other Culex species transmit 
other arboviruses in East Africa; these are shown in Table 3.1. 
Crucially, culicines are also the major cause of nuisance biting in rural and especially 
urban areas [18]. Several studies have shown that the community is sensitive to 
changes in biting nuisance related to changes in mosquito densities. Uptake of several 
control measures such as use of house screens [19] and mosquito coils [20] is 
dependent upon the desire to prevent mosquito bites in addition to preventing diseases. 
Similarly, use of insecticide treated nets (ITNs) is motivated by the desire to prevent 
nuisance bites [21, 22], as shown by reduction in the use of ITNs when mosquito 
densities are lower due to seasonal decline [23, 24] even when mosquito numbers are 
sufficient for disease transmission to continue. 
Unfortunately, efficacy of insecticide based interventions declines when resistance 
develops, as has already been seen in Tanzania [25, 26]. If people continue to be bitten 
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by nuisance mosquitoes due to development of insecticide resistance, it undermines 
public acceptance of ITNs as an intervention [27, 28]. Therefore, there is need to 
develop supplementary tools for control of nuisance mosquitoes. Reduction in 
nuisance mosquitoes will increase users‟ confidence in the available mosquito control 
measures and therefore also encourage use of other measures. 
The aim of the study was to evaluate preferential points of entry of different mosquito 
species into houses. This was determined by indoor densities of different species of 
mosquitoes when a specific entry point was screened, precisely, eaves, windows and 
doors compared to an unscreened control. Our overall goal was to evaluate the optimal 
method needed for house screening in order to provide integrated control of filariasis, 
arboviruses and malaria vectors. 
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Table 3.1: Mosquitoes naturally infected with arboviruses or Bancroftian filariasis in 
southern and eastern Africa. 
Species Disease carried  Country References 
Anopheles gambiae s.l. O‟Nyong nyong Uganda, Kenya, Mozambique [12] 
Bancroftian filariasis Tanzania [11] 
Anopheles funestus  O‟Nyong nyong Uganda, Kenya, Mozambique [12] 
Bancroftian filariasis Tanzania [11] 
Mansonia africana Rift Valley Fever Kenya [29] 
 Uganda [30, 31] 
Chikungunya Uganda [12] 
Culex pipiens quinquefasciatus West Nile Virus Madagascar [32] 
Chikungunya Tanzania [33] 
Bancroftian filariasis Tanzania [11] 
Culex univittatus complex Sindbis Virus South Africa [34, 35] 
West Nile Virus South Africa [34, 36] 
 Madagascar [32] 
 Kenya [32, 37] 
Culex theileri West Nile Virus South Africa [12, 32] 
Rift Valley Fever South Africa [38, 39] 
Culex rubinotus Witswatersrand Uganda, Mozambique, South 
Africa 
[12, 30, 40] 
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3.4. Methods 
3.4.1. Study site 
The experimental hut study was carried out at Lupiro village (8.01 °S and 36.63 °E) 
located in Ulanga district, in the south eastern part of Tanzania. The village lies 300 
meters above sea level on the flood plain of Kilombero River, approximately 26 km 
south of Ifakara town. The climate is hot and humid, experiencing annual rainfall 
ranging between 1200–1800 mm and annual mean temperature between 20–32 °C. 
This climate and the clearance of a perennial swamp for rice farming create ideal 
conditions for perennially abundant populations of both An. gambiae s. s. and An. 
arabiensis and many species of culicine mosquitoes [41]. Malaria transmission 
intensity in this village is exceptionally high, averaging between 474 and 851 
infectious bites per person per year, despite mosquito net coverage which consistently 
exceeds 75% [42]. In addition, there have been several cases of RVF and filariasis (E. 
Mossdorf pers comm).  
3.4.2. Local houses 
In Ulanga and Kilombero DSS (Demographic Surveillance System) areas, most of the 
local houses have mud walls (56%), while the remainder is made of baked mud bricks. 
The roofs are mostly thatched (70%) or made of corrugated iron. The houses chosen 
for these experiments therefore had mud walls and thatched roofs with open eaves and 
one or two windows (Figure 3.1.). Cooking was mainly done outside of the hut and 
each of the local houses selected had two or three people living in them. 
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Figure 3.1. A local house. The local houses are made of mud walls and thatched 
roofs. They have one door and two windows and open eaves (open spaces 
between the roof and the wall). 
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3.4.3. Experimental huts 
Several prototypes of new designs of experimental huts (Unpublished Moore et al) 
were built in Lupiro (Figure 3.2.)with the intention of representing, as closely as 
possible, the key structural features of local housing in southern Tanzania (i.e. brick or 
mud huts with corrugated iron or thatched roofing). These huts were designed in kit 
form for ease of portability, with a galvanized piping framework so that the entire hut 
could be flat packed. The roof is corrugated iron covered with grass thatch on the top, 
to simulate the temperature of local houses with thatched roofing. The outer walls are 
constructed from wooden planks or canvas. The inner walls are removable panels 
coated with mud, to simulate local mud walls. Two huts were constructed to mimic 
average local huts in the village. These were 6.5 m long, 3.5 m wide and 2 m high, 
(the size of these huts was determined by measuring 100 houses in Lupiro and 
calculating the average dimensions). The remaining two were smaller, at 3 m long, 3.5 
m wide and 2 m high. The height of each structure measured 2.5 m at the roof apex. 
Each experimental hut had one door and two window openings as this was the median 
number seen in local houses. 
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Figure 3.2. A wooden experimental hut. The experimental huts were designed to 
represent local housing in southern Tanzania An experimental hut had a corrugated roof 
and covered with grass thatch on the top, to simulate the temperature of local houses with 
thatched roofing. The outer walls were constructed from wooden planks or canvas. The 
inner walls were made of removable panels coated with mud. They had one door and two 
functional windows with open eaves (open spaces between the roof and the walls). 
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3.4.4. Experimental design 
 
Two blocks of four huts were used for these experiments: one block of four local 
houses and one block of four experimental huts. The selected houses were located 
nearest to the experimental huts and were selected to be approximately 50 m apart 
from each other. Two male volunteers slept in each experimental hut. The volunteers 
were not rotated between huts but remained in the same hut for the duration of the 
study. The bias created by variation in human attractiveness to mosquitoes and spatial 
variation between huts were therefore combined and treated as a single source of bias 
in the statistical analysis. For each of the two blocks of four houses, the following 
sequence of experimental treatments was completed. In each block, four repetitions of 
four experimental treatment arrangements were completed between 4th December and 
19th December 2007. This is the peak of short rains and therefore there is wide spread 
flooding leading to high densities of mosquitoes of all genera. Each repetition included 
three nights during which three of the four houses had the same one of the three 
potential entry points screened while the remaining fourth house was completely 
unscreened. On the first night of each repetition, all the four huts remained completely 
unscreened. For the subsequent three nights of each repetition, all the three treatments 
were changed each night from screening the eaves to windows and then doors, in that 
order. For each night, a different hut was chosen within each block to have no entry 
point screened, so that at the end of the four repetitions, all four huts had acted as these 
contemporaneous controls. The treatments were rotated across all the huts 
systematically. Rotation of treatments reduced the bias of mosquito collections 
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between the huts. 
 
3.4.5. Screening entry points 
 
PVC-coated fibre glass netting material (Elastic Manufacturing, Tanzania) was used to 
screen specific entry points each particular night. The netting was cut to fit each of the 
entry points (doors, windows and eaves). In the experimental huts, the size of the 
windows, eaves and doors was uniform for all the huts. Screens were fitted on the 
experimental huts by hook and loop fasteners. In the local houses, the screens were 
nailed onto the wall (mud wall). The nails could be removed easily each morning at 
the end of the experiments. Due to uneven wall surfaces of the local huts, small gaps 
were found between the netting and the wall. These gaps were blocked with cotton 
wool to create a complete barrier. 
3.4.6. Mosquito collection 
 
CDC light trap is an appropriate tool for sampling mosquito vectors that would 
otherwise bite humans, thus being comparable to human landing catches [43-46]. A 
CDC miniature light trap (model 512) was positioned approximately 1 m above the 
ground. It was placed next to the bed (at the foot end) occupied by an adult male 
volunteer, under an untreated bed net [45]. Volunteers operated light traps from 19:00 
to 07:00 hrs each night. 
Although no attempt was made to control times at which occupants slept, this period 
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typically approximated 19:00 hrs to 07:00 hrs. Traps were collected from each house 
every morning at 07.00. Collection bags were then placed in a plastic bucket, and 
mosquitoes were killed using cotton wool treated with chloroform. 
3.4.7. Mosquito identification 
 
The mosquitoes were morphologically identified to genus level each morning in the 
field while they were still fresh. Mosquitoes were stored in small centrifuge tubes 
which contained tissue paper with silica gel beneath, then transported to the laboratory 
where they were stored at 20°C, until further identification. Further identification was 
done to species level using polymerase chain reaction (PCR) for An. gambiae s. l. [47]. 
Mosquitoes allocated for PCR were sampled randomly from An. gambiae s. l., 
mosquitoes collected from different trap nights by placing labelled tubes in a box and 
picking them at random. Morphological identification of culicines was done using a 
key [47]. 
3.4.8. Ethics 
 
Volunteers were recruited only if they agreed to participate in the study and signed a 
written informed consent form. To minimize risk of infection of mosquito borne 
diseases, participants were provided with untreated nets. In addition, they were offered 
free malaria screening and treatment. Ethical approval was granted by Ifakara Health 
Institute (IHI) (IHRDC/IRB/No. A- 014-2007, IHRDC/IRB/No.A-019-2007) and the 
National Institute of Medical Research (NIMR/HQ/R.8a/Vol. W710). The Centre for 
Disease Control (CDC) ethical review deemed the work non- human subjects research. 
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3.4.9. Statistical analysis 
 
Generalized estimating equations were used with SPSS 15 to estimate the effect of 
screening specific entry points, which was treated as a categorical independent 
variable, on indoor mosquito densities relative to unscreened controls. House number 
was fitted as a subject effect and day as the within-subject variable, with an 
exchangeable working correlation matrix, to account for spatial and temporal 
heterogeneity in the dependent variable, namely number of mosquitoes of a given 
mosquito taxon caught in each house on each night. Note that, each species was 
analyzed separately using generalised estimating equation models (GEE). An. gambiae 
s. l. mosquito catch had a normal distribution and was fitted to an identity link. All the 
other species were negatively skewed and were therefore fitted with a negative 
binomial and a log link function. The model was used to derive the relative rates and 
their 95% confidence intervals. 
Binary logistic regression was used to test the strength of the influence of different 
treatments on the proportion of An. arabiensis and An. gambiae s. s caught that were 
identified to sibling species by PCR. The independent variables fitted in the model 
were treatment and house number. The outcome variable was binomial; An. arabiensis 
and An. gambiae s. s were coded as 1 and 0 respectively and the effect of treatment on 
the odds ratio of finding An. arabiensis relative to An. gambiae s. s. was calculated. 
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3.5. Results 
 
3.5.1. Mosquito collections 
During the cumulative 16 nights of sampling, with the CDC light traps, 77.9% 
(17,929) of the total catch were Anopheles gambiae s. l. This species complex 
comprised 66.2% (738) An. arabiensis and 33.8% (n = 377) An. gambiae s. s (n = 
1115 successful PCR amplifications). There were only 0.2% (n = 50) An. funestus 
species complex caught in the entire study. One tenth (10.2%, n = 2359) of all 
mosquitoes collected were various Culex spp. Three quarters (76.9%) of Culex spp. 
were identified as Cx. pipiens complex of which four fifths (80.3%, n = 875) were Cx. 
pipiens quinquefasciatus, while the remainder (19.7%, n = 214) were Cx. pipiens 
pipiens. Other culicines included Cx. univittatus and Cx. theileri (20.0% of the total 
Culex spp). Just over one tenth (11.6%) of all mosquitoes collected were Mansonia 
spp., of which more than half (58.3% n = 1038) were Ma. uniformis and the remaining 
41.6% (n = 742) were Ma. africana. Other species of culicines caught in smaller 
numbers were, Cx. horridis (n = 7), Cx. andersanius (n = 11), Cx. acrostichalis (n = 
43), Cx. rubinotus (n = 30), Cx. sitiens (n = 5), Cx. simpsoni (n = 18), and Cx. aureus 
(n = 69). 
3.5.2. Effect of screening different entry points on indoor densities 
 
A summary of the median indoor density species collections when each entry point 
was screened is presented in Table 3.2 and a statistical estimate of the impact of 
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screening is presented in Table 3.3. 
An. gambiae s. l. mosquitoes were less likely to be found in houses with screened 
eaves (Table 3.3.). Binary logistic regression revealed that both treatment (screening 
of various entry points) and house did not affect the proportion of An. gambiae s. s. 
versus that of An. arabiensis mosquitoes, (Treatment, Odds Ratio [95% confidence 
interval] = 1.06 [0.94, 1.20]; Wald Chi square = 0.87; P = 0.35), indicating that the 
effect of treatment on the two sibling species was similar. Screening eaves also 
reduced both Ma. africana and Ma. uniformis mosquito densities by almost half (Table 
3.3.). Screening windows and the door reduced indoor densities of Cx. 
quinquefasciatus, Cx. theileri and Cx. univittatus mosquito densities by a quarter or 
more although this was not significant (Table 3.3.). The relative densities of Cx. 
univittatus and Cx. theileri mosquitoes were increased when eaves were screened 
respectively (Table 3.3). 
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Table 3.2: Median indoor densities of different mosquito species caught in experimental huts and local houses when different entry 
points were screened. 
Screened entry points 
 
None
a
  Eaves  Windows  Doors 
Mosquito species 
n 
Median 
[IQR] 
n 
Median [IQR] n Median [IQR] n Median [IQR] 
An. gambiae sensu lato 
8341 80.0[4,630] 2708 59.0[9,415] 2946 80.0[15,370] 3934 96.0[17,700] 
Ma. africana 
336 3.0[0,31] 144 0.0[0,12] 138 3.0[0,24] 144 1.0[0,36] 
Ma. uniformis 
584 3.5[0,66] 93 1.5[0,21] 198 6.0[0,36] 163 1.5[0,37] 
Cx. quinquefasciatus 
sensu lato 544 2.0[0,79] 206 2.0[0,40] 171 2.0[0,46] 168 0.0[0,50] 
Cx. theileri 
27 0.0[0,5] 28 0.0[0,8] 4 0.0[0,2] 9 0.0[0,5] 
Cx. univittatus 
60 0.0[0,11] 49 0.5[0,10] 19 0.0[0,5] 16 0.0[0,4] 
n = number of mosquitoes. 
a
 =Reference group (No entry point was screened). IQR = Interquartile range. A total of 127 experimental hut nights were conducted. 
The number of experimental nights conducted for screened entry points are: None – 56, Eaves – 24, Windows – 23 and Doors – 24. A CDC Light trap on an eave 
night was attacked by ants, thus no data was recorded for that particular hut night. 
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Table 3.3: Impact of screening various entry points upon indoor densities of different mosquito species caught with reference to 
indoor densities when no entry point was screened. 
Screened entry points None
a 
Eaves  Windows  Doors  
Mosquito species 
 
RR [95%CI] P RR [95%CI] P RR [95%CI] P 
An. gambiae sensu lato 
1 0.91[0.84,0.98] 0.010 0.98[0.94,1.02] 0.340 1.03[0.97,1.09] 0.310 
Ma. africana 
1 0.43[0.26,0.76] <0.001 0.91[0.58,1.44] 0.700 1.03[0.63,1.70] 0.900 
Ma. uniformis 
1 0.37[0.25,0.56] <0.001 0.85[0.54,1.33] 0.470 0.65[0.38,1.13] 0.130 
Cx. quinquefasciatus sensu lato 
1 0.91[0.50,1.65] 0.740 0.77[0.42,1.39] 0.380 0.72[0.36,1.45] 0.360 
Cx. theileri 
1 2.42[1.13,5.18] 0.020 0.36[0.11,1.22] 0.100 0.78[0.25,2.46] 0.670 
Cx. univittatus 
1 1.91[1.05,3.47] 0.040 0.77[0.37,1.61] 0.490 0.62[0.31,1.25] 0.180 
The relative rates (RR), model estimated 95% confidence intervals (CI) and probability of equivalence (P) were all estimated by Generalized estimating 
equations as described in the Methods section.a = Reference group (No entry point was screened). 
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3.6. Discussion 
More than three quarters of the mosquitoes caught during the study were An. gambiae s. l. a 
major vector of both lymphatic filariasis as well as malaria in this area and across most of 
Africa [11]. An. funestus complex mosquitoes caught in this study were not identified to 
species level. However, other studies from Tanzania have shown that this species complex 
shows distinct behavioural differences. An. funestus s. s. mosquitoes are mainly endophagic 
while others like An. rivulorum are mainly exophagic [48]. Therefore, since mosquitoes 
were collected indoors we assume that most of the mosquitoes caught were An. funestus s. 
s. 
Culicine mosquitoes collected in this study contribute to the transmission of filariasis and 
arboviruses (Table 3.1). Cx. quinquefasciatus was the most abundant Culex spp. caught. 
Significant numbers of Cx. univittatus and Cx. theileri mosquitoes were also caught. Ma. 
africana has been incriminated as a vector of RVF [29-31], and was present in high 
densities during an outbreak of RVF among humans at the field site (E. Mossdorf pers 
comm). 
Most of the mosquitoes caught were unfed, and therefore considered to be in the act of host 
seeking [43, 44]. Studies carried out previously in the same experimental huts (unpublished 
data) indicated that there were very low densities of indoor resting mosquitoes. Only 0.35% 
of the mosquitoes caught in that particular study were caught resting. Therefore it may be 
assumed that indoor resting mosquitoes were present in insufficient numbers to bias the 
outcome of the screening experiments. 
Consistent with previous reports [5-7], Anopheles gambiae s. s. and An. arabiensis 
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mosquitoes were noted to prefer eaves as the main entry point, demonstrated by reduced 
indoor densities when this particular entry point was screened. Both Ma. africana and Ma. 
uniformis also preferred entry via eaves as exhibited by reduced indoor densities when 
eaves were screened. This data indicates that some mosquito borne diseases could be 
prevented by blocking eaves [2]. 
A study carried out in the Gambia showed a reduction in culicine indoor densities in houses 
with closed eaves but in association with horses tethered outside and with increased room 
height [49]. Indoor Cx. pipiens s. l. densities were reduced by 38% when eaves were closed 
[49]. On the contrary, a second study recently carried out in The Gambia measured the 
impact of closing eaves in addition to screening the doors in houses with no windows. The 
same study indicated that there was no additional reduction in culicine mosquito densities 
when eaves were blocked [50]. In the present study, we have shown that Cx. 
quinquefasciatus, Cx. univittatus and Cx. theileri mainly prefer windows and doors as their 
main point of entry. It is also important to note that when eaves were screened and windows 
and doors were left open, indoor densities of Cx. univittatus and Cx. theileri mosquitoes 
were increased in comparison to when all the three entry points were left unscreened. This 
indicated the importance of screening all the three entry points to achieve control of Culex 
spp. mosquitoes. 
Effectiveness of house proofing on mosquito vectors depends on the interaction between 
their feeding behaviour and human behaviour especially when and where people eat and 
sleep [51-53]. House screening will only reduce exposure to endophagic mosquito vectors. 
Several anophelines in Africa are endophagic; therefore, house screening would be highly 
effective. Since most Culex spp. mosquitoes are commonly thought to be predominantly 
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exophagic, then it raises concerns of whether house screening would be effective against 
them. However, varying levels of both endophagy and exophagy observed in different 
species; differ from one region to another. In East and West Africa Cx quinquefasciatus is 
more endophagic [54]. Cx. univittatus and Cx theileri exhibit both exophagy and endophagy 
in some areas [55-57]. 
Our findings suggest that screening eaves reduces indoor densities of An. gambiae s. l. as 
well as Mansonia spp. both of which are vectors of several neglected tropical diseases in 
rural areas of Africa and some parts of Asia. Blocking eaves and full house screening, as a 
control tool against mosquito vectors may reduce nuisance mosquitoes and thus encourage 
uptake of control interventions that rely on acceptance, participation and even investment 
by the community. 
Screening of eaves and/or installation of ceilings may prove to be practical and affordable 
where existing house designs prove amenable to such modifications. While most of the 
African population does not live in houses as uniform as our experimental huts, it is 
encouraging that mosquito proofing of houses by screening the eaves or installing ceilings 
has proven equally effective for anophelines and some culicines in rural settings in both 
East and West Africa. Blocking the eaves of the mud-walled, thatch-roofed village houses 
included in this Tanzanian study yielded results which are remarkably consistent with those 
observed when netting ceilings and screened eaves were installed into typical houses in The 
Gambia despite the wide geographical separation between them [5]. 
Recent evidence from urban Dar es Salaam [19] suggests that communities perceive closed 
ceilings and window screening as successful means to prevent house entry by mosquitoes. 
 100 
They demonstrate high levels of acceptance, uptake and even investment, despite the fact 
that this intervention has never been specifically promoted on this basis. We suggest that the 
true full potential of protecting houses against house entry by culicine and anopheline 
mosquitoes, could be better achieved through insecticide treated screening material for 
targeted killing by placing them on either eaves, windows and doors. 
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CHAPTER FOUR 
4     An experimental hut study to quantify the effect of DDT and 
airborne pyrethroids on entomological parameters of malaria 
transmission 
4.1. Abstract 
Background 
Current malaria vector control programmes rely on insecticides with rapid contact toxicity. 
However, spatial repellents can also be applied to reduce man-vector contact, which might 
ultimately impact malaria transmission. The aim of this study was to quantify effects of 
airborne pyrethroids from coils and DDT used as an indoor residual spray (IRS) on 
entomological parameters that influence malaria transmission. 
Methods 
The effect of Transfluthrin and Metofluthrin coils compared to DDT on house entry, exit 
and indoor feeding behaviour of Anopheles gambiae sensu lato were measured in 
experimental huts in the field and in the semi-field. Outcomes were deterrence - reduction 
in house entry of mosquitoes; irritancy or excito-repellency - induced premature exit of 
mosquitoes; blood feeding inhibition and effect on mosquito fecundity. 
Results 
Transfluthrin coils, Metofluthrin coils and DDT reduced human vector contact through 
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deterrence by 38%, 30% and 8%, respectively and induced half of the mosquitoes to leave 
huts before feeding (56%, 55% and 48%, respectively). Almost all mosquitoes inside huts 
with Metofluthrin and Transfluthrin coils and more than three quarters of mosquitoes in the 
DDT hut did not feed, almost none laid eggs and 67%, 72% and 70% of all mosquitoes 
collected from Transfluthrin, Metofluthrin and DDT huts, respectively had died after 24 
hours. 
Conclusion 
This study highlights that airborne pyrethroids and DDT affect a range of anopheline 
mosquito behaviours that are important parameters in malaria transmission, namely 
deterrence, irritancy/excito-repellency and blood-feeding inhibition. These effects are in 
addition to significant toxicity and reduced mosquito fecundity that affect mosquito 
densities and, therefore, provide community protection against diseases for both users and 
non-users. Airborne insecticides and freshly applied DDT had similar effects on deterrence, 
irritancy and feeding inhibition. Therefore, it is suggested that airborne pyrethroids, if 
delivered in suitable formats, may complement existing mainstream vector control tools. 
 
4.2. Background 
Currently, malaria vector control is focused on two interventions: Indoor Residual Spraying 
(IRS) and Long Lasting Insecticidal Nets (LLINs) that have successfully reduced malaria 
transmission throughout sub-Saharan Africa [1]. In public health vector control 
programmes, efficacy of insecticidal tools (LLINs and IRS) is measured by the 
epidemiological endpoints: malaria mortality and morbidity, related to reduced intensity of 
transmission in the mosquito vector population [2]. Mathematical models have been used to 
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explain dynamics of malaria transmission through entomological, immunological and 
parasitological parameters that influence malaria transmission [3] expressed as the basic 
reproductive rate (R0). The basic reproductive rate refers to the number of secondary disease 
infected persons arising from a single infected person in a completely susceptible 
population [2]. Therefore, the object of any control intervention is to reduce R0 to less than 
1. 
Garrett-Jones [4] described the relationship between entomological parameters that 
influence malaria transmission, termed the vectorial capacity of a mosquito population. . 
The parameters of the entomological equation include mosquito abundance (m), mosquito 
daily survival (p) (the vector must live long enough for parasites to develop to the infective 
stage inside the mosquito) and frequency of contact between mosquitoes and humans 
through the man biting rate (ma). Vectorial capacity is defined as the expected number of 
new human malaria infections disseminated per human per day, by a mosquito population 
from a single case, presuming that all vector females feeding on the case become infective 
[2]. 
 
4.2.1. Vectorial capacity equation 
 
The vectorial capacity equation as described by Garrett-Jones is as follows: C = ma
2
p
n
/-
logep. C = vectorial capacity, ma = density of mosquitoes per person per night, a
2
 = average 
frequency of biting on humans per day (a is squared because a mosquito must bite twice; 1
st
 
to receive parasites and 2
nd
 to transmit them), p = the probability of daily survival of the 
mosquito and n = the duration of sporogony i.e the time required for the parasites to develop 
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in the mosquito (extrinsic period). 
According to the vectorial capacity equation, changes to different aspects of the life cycle of 
mosquitoes will have differential impacts on malaria transmission [5]. For instance, a 
reduction in mosquito density (m) leads to an equal reduction in vectorial capacity because 
of their linear relationship, while a reduction in biting rate (ma) leads to a two-fold 
reduction in transmission due to the quadratic relationship (arising from the fact that 
mosquitoes need to feed twice to transmit malaria: once to become infected and once to 
infect) [5]. Importantly, interventions that affect the survival rate (p) of mosquitoes have the 
greatest impact on transmission due to their exponential relationship [5, 6]. Therefore, it 
becomes obvious why LLINs are such a successful vector control tool: they reduce man-
vector contact (ma) because they create a barrier between mosquitoes and humans, reduce 
mosquito average daily survival (p) through their insecticidal mode of action and therefore 
also affect mosquito density (m). 
Although the primary entomological modes of action (ENMoA) of insecticides used for 
LLINs and IRS are rapid knockdown and mortality, studies have shown other effects of 
insecticides that include 1) deterrence: when mosquitoes are prevented from entering human 
dwellings treated with insecticides [7, 8]; 2) irritancy: when mosquitoes contact insecticide 
surfaces inside houses and leave early [7]; 3) excito-repellency; when mosquitoes contact 
airborne insecticides and leave the house and 4) feeding inhibition; when mosquitoes are 
prevented from biting and getting blood meals [7]. The ENMoA of insecticides affect 
various aspects of the mosquito life cycle and this largely influence the success of any 
intervention. Despite emphasis placed on the importance of toxic insecticides, studies show 
that some highly effective insecticides, such as DDT (dichlorodiphenyltrichloroethane), are 
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primarily spatial repellents and feeding inhibitors [9] while toxicity is a lesser, but still 
important feature [9, 10]. In fact, the success of DDT is attributed to its deterrence and 
irritancy, and only to a lesser extent to its mortality [10, 11]. 
Mosquito coils, vaporizer mats and emanators also induce repellency, irritancy, feeding 
inhibition and toxicity [12, 13]. The impact of coils and emanators on vector borne diseases 
has been proven. These tools act over a distance by evaporating insecticides into a given 
space, hence are known as spatial repellents. This mode of action has parallels with the 
deterrent, feeding inhibition and excito-repellent modes of action of DDT. For this reason, it 
is worthwhile to compare their effects on entomological components that pertain to 
vectorial capacity. It is hypothesized that insecticides that have more than one mode of 
action affect different parameters of the vectorial capacity (m, a, ma, p,) and are likely to 
bring forth greater changes in transmission than anticipated if only toxicity is considered. 
The purpose of this study was to quantify the effect of airborne pyrethroids released by 
mosquito coils on mosquito behaviour. Emphasis was placed on outcome measures that 
influence entomological parameters of malaria transmission (Table 4.1) and to compare the 
mode of action of Transfluthrin and Metofluthrin coils against DDT, representing a gold 
standard insecticide with known impact on malaria transmission [11]. 
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Table 4.1: Entomological parameters of the vectorial capacity targeted by effects of 
airborne insecticides on mosquito behaviour 
Effect of airborne insecticides Parameter of the vectorial 
capacity 
System of 
study 
Deterrence ma
 
Field 
Excito-repellency and irritancy ma Semi-field 
Toxicity 
m, p
 
Field and semi-
field 
Reduced fecundity (ability of mosquitoes 
to lay eggs) 
m Semi-field 
Feeding inhibition 
(mosquitoes prevented from blood 
feeding) 
ma
 
Semi-field 
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4.3. Methods 
Studies were conducted in experimental huts in the field with wild Anopheles arabiensis 
mosquitoes and in a semi-field system [14] with laboratory reared Anopheles gambiae sensu 
stricto (s.s.) as a standard test organism for repellents [15]. The overall objective was to 
determine the effect of DDT, Metofluthrin and Transfluthrin coils on parameters of 
vectorial capacity using experimental huts. 
 
4.3.1. Outcomes measured in the field 
Deterrence 
Deterrence refers to reduced house entry of mosquitoes resulting to reduced indoor 
densities. It was determined by comparing the total number of mosquitoes in huts with 
insecticides to control huts. The total number of mosquitoes inside huts included: live and 
dead mosquitoes in exit traps, dead mosquitoes found on the floor as well as mosquitoes 
found resting inside the hut. 
Toxicity 
Toxicity of coils and DDT was determined by comparing the proportion of dead versus live 
mosquitoes in insecticide huts to the control huts. Mosquitoes collected from huts were kept 
for 24 hours in an insectary after which mortality was recorded. 
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4.3.2. Outcomes measured in the semi-field 
Contact irritancy and excito-repellency 
Contact irritancy and excito-repellency refer to the rate at which mosquitoes exit huts after 
physical contact with insecticide treated surfaces or airborne insecticides, respectively. The 
exit rate is the proportion of female mosquitoes found in the exit traps at the top of every 
hour compared with the total number found inside huts (resting or dead on the floor) 
relative to the control hut. The increased or premature exit of mosquitoes is the estimated 
irritancy or excito-repellency [16] of insecticides used in the house. 
Toxicity 
The number of dead versus live mosquitoes out of those recaptured was compared between 
huts. Mortality was recorded after 24 hours. The difference in mortality between a control 
hut (natural mortality) and a treated hut allows assessment of the insecticide-induced 
mortality [16]. 
Blood feeding inhibition 
Feeding inhibition was determined by comparing the number of blood fed versus unfed 
mosquitoes of total mosquitoes recaptured from huts. 
Reduced fecundity of mosquitoes 
Fecundity was determined by comparing the proportion of blood fed mosquitoes that laid 
eggs after exposure to different treatments compared to the control. In addition, the total 
number of eggs laid by each mosquito was determined. 
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4.3.3. Experiment 1: field 
Study area 
The study was conducted in Lupiro village in the Kilombero valley in the South East of 
Tanzania. Annual rainfall ranges between 1200 and 1800 mm with two rainy seasons per 
year: November to December and January to April. Annual mean temperature ranges 
between 20-32°C. Communities in Lupiro practice irrigated rice farming that provides 
suitable mosquito breeding conditions. Anopheles arabiensis is the dominant species (>95% 
of the malaria vector population) with the remainder comprising Anopheles funestus sensu 
lato (s.l.) mosquitoes. There is a high density of culicines comprised of Culex and Mansonia 
species [17]. A study conducted at the same time and site indicated 100% susceptibility of 
An. arabiensis mosquitoes to World Health Organization recommended doses of DDT and 
between 95.8% and 90.2% for Permethrin, Lambda cyhalothrin and Deltamethrin [18]. 
 
Treatments 
 
Mosquito coils were used at a standard dose recommended and approved by the World 
Health Organization for Pesticides (WHOPES). They included Transfluthrin (0.03%) and 
Metofluthrin coils (0.00625%). Seventy-five percent pure DDT wettable powder (AVIMA, 
South Africa) was applied to woven palm leaf mats using Hudson sprayers at 2 g/m
2
 
concentration of the active ingredient. DDT was sprayed on mats that could be rotated 
between huts during experiments. Rotation of treatments between huts is a crucial part of 
experimental hut study design because it minimizes the spatial bias between huts that often 
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affects relative mosquito density and behaviour. 
Palm woven mats were measured and cut out to fit the entire surface of the inside wall of an 
experimental hut. The reverse side of the mats was covered with plastic sheets (Figure 1) to 
prevent contamination of experimental hut surfaces with DDT during rotation of mats 
between huts. Two sets of mats were prepared, the control was sprayed with water and the 
other set was sprayed with DDT at a dose of 2 g/m
2
 as recommended by WHOPES [16] 
using a separate Hudson sprayer for each treatment. The quantity of DDT required to cover 
walls of one hut was determined by measuring the surface area of walls. The amount of 
DDT required in g/m
2
 was calculated and weighed. The volume of water required for 
mixing DDT was determined by pouring a known amount of water in a Hudson sprayer. 
The sprayers were calibrated to 55 psi and control mats were sprayed with water. The 
volume of water used in the control was measured and an equal volume of water was used 
for mixing DDT in a plastic bucket. Spraying was conducted in a disposable tent located 50 
meters from experimental huts (Figure 4.1). The mats were air dried for 15 minutes then 
fixed to respective walls using removable staples so that they could be detached easily 
during rotation (Figure 4.1). 
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Figure 4.1. Spraying palm woven mats with DDT. Palm woven mats previously cut out to 
fit on the walls of experimental huts were sprayed with 2 g/m
2
 DDT. Spraying was conducted 
in a temporary structure that was later burnt. Spraying the mats instead of the walls ensured 
that mats could be moved easily from one hut to another without contaminating the walls. 
This allowed rotation of treatments between huts. 
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Experimental huts 
Studies were conducted in Ifakara experimental huts [19] (Figure 3.2). Initially, information 
about the size, design of the houses and the materials required for constructing the roofs and 
walls was collected through a house hold survey conducted in Kilombero valley. The local 
houses (Figure 3.1) in this region are constructed with corrugated iron sheets or thatched 
roofing and walls are constructed with bricks or mud. This information was used in the 
construction of experimental huts to ensure a good representation of local houses in 
Kilombero valley. The experimental huts measure 6.5 m long, 3.5 m wide and 2.5 m high at 
the roof apex. They are made of galvanized pipe framework, the roof is made of corrugated 
iron sheets and the inner walls are made of removable mud panels while outer walls are 
covered with canvas. The outer roof is grass thatched. This provides cool temperatures 
inside huts just like in local houses. Each experimental hut has one door and four windows. 
The huts have open spaces (eaves) between the roof and the wall similar to local huts. This 
results in volume, surface area, temperature and air-flow profiles similar to local homes, 
which is extremely important when measuring spatially active vector control tools. Half of 
the eaves and all of the windows are fitted with exit traps suspended outside the huts to trap 
those mosquitoes that attempt to leave. The traps are made of metal frames and UV resistant 
black plastic coated fibreglass netting (Phifer, USA). The traps are fitted with cotton sleeves 
through which mosquitoes can be collected. On the eaves there are spaces left between 
traps. These spaces are fitted with netting baffles through which mosquitoes enter huts but 
cannot leave. Mosquitoes can only leave through exit traps. Previous studies indicated that 
entry behaviour of mosquitoes in experimental huts was similar to local houses [17]. 
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Study design 
A partially-randomized fully-balanced 4 × 4 Latin square design was performed to 
determine efficacy of DDT used as IRS, Transfluthrin and Metofluthrin coils in four 
experimental huts. The treatments were tested for four nights per week and were rotated 
weekly. Therefore, one balanced round of experiments was completed in 16 days. Four 
rounds of 16 days were performed (n = 64 nights). The treatments tested were: 1) standard 
control – DDT IRS; 2) negative control – no insecticide used; 3) two Transfluthrin coils 
(0.03%) per hut each night and 4) two Metofluthrin (0.00625%) coils per hut each night. 
The huts were located approximately 300 metres from local houses and arranged linearly 
along a mosquito-breeding site with 50 metres spaces left between them to minimize 
interaction between treatments. Treatments were randomly allocated to huts with two male 
volunteers. Treatments were not moved between huts on a nightly basis because of the 
possibility of a carryover effect of treatments. The huts were left without treatments during 
the fifth, sixth and seventh night in order to wash out the effect of the previous treatment, 
after which treatments were moved to the next hut. Two coils were placed on the floor in 
the middle of the hut at the start of the experiment and they were replaced with new ones 
when they burnt out. Freshly sprayed DDT mats were used for each round of experiment, 
meaning that sprayed mats were used for one month and kept in a store to be later burnt in 
an incinerator. 
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Mosquito collection 
 
Experiments were conducted between 24
th
 November 2010 and 15
th
 October 2011 for 64 
nights. Experiments took place each night between 1800 hours and 0600 hours. Every 
evening, volunteers removed all insects and predators from exit traps to prepare huts for the 
next experimental night and then they retired to bed. In huts selected for coils, the 
technicians lit two coils and volunteers were given additional coils and instructed to replace 
those that burnt out before 0600 hours. Volunteers slept under untreated bed nets and woke 
up at the top of every hour to collect mosquitoes from exit traps. Mosquitoes were collected 
between 1900 hours and 0600 hours using a mouth aspirator and a spotlight for a maximum 
of 15 minutes each hour. At 0600 hours, all mosquitoes resting inside the huts as well as 
those found on the floor were collected. Mosquitoes were placed in paper cups labelled by 
the time and place of collection (exit traps, resting on hut surfaces and the floor), provided 
with 10% glucose solution soaked on pieces of cotton wool and kept in a field insectary for 
24 hours. Mean temperature inside the insectary was 29.1°C ± 3.0°C during the day and 
26.7°C ± 2.3°C at night, while mean relative humidity was 70.6% ± 17.9% during the day 
and 75.7% ± 13.7% at night. The insectary was located 50 m away from experimental huts. 
 
Mosquito handling and identification 
 
Each morning, mosquitoes previously collected from huts and kept for 24 hours in the 
insectary were morphologically identified as An. gambiae s.l., Mansonia spp. or Culex spp. 
Mosquitoes were also grouped as dead, alive, fed or unfed. A sub sample of the Anopheles 
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genus mosquitoes was randomly selected and transported to the laboratory for further 
identification to species using ribosomal DNA-polymerase chain reaction (PCR) [20]. 
 
Quality control: assessment of the carryover effect of airborne insecticides 
 
During experiments, there was a three-day wash out period after four days of experiments 
when there were no insecticides in the huts. Volunteers entered huts at 1800 hours and slept 
until 0600 hours. They collected mosquitoes in exit traps, from resting surfaces inside huts 
and the floor at 0600 hours. This experiment enabled us to determine whether the three-day 
wash out period was sufficient to reduce any residual airborne insecticides before treatments 
were rotated between huts. 
 
Assessment of residual efficacy of DDT on grass woven mats 
 
The method of evaluating residual efficacy of DDT on grass woven mats was based on the 
WHO insecticide testing guidelines [16]. Two locations on each of the four “walls” of DDT 
sprayed mats were randomly selected. We attached WHO cones on the walls using masking 
tape and 10 laboratory-reared, 2–6 day old female nulliparous An. arabiensis mosquitoes 
were introduced into each cone. The time was noted and mosquitoes were removed from the 
cones after 30 minutes. Mosquitoes removed from cones were kept in the field insectary and 
monitored for 24 hours after which dead and live mosquitoes were recorded. Bioassays 
were conducted a day after spraying and once every week for four weeks during 
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experiments. Additional control bioassays were conducted simultaneously on control mats 
previously sprayed with water only. 
 
4.3.4. Experiment 2: semi-field 
Semi-field system 
Studies were conducted in experimental huts placed inside a Semi-Field System (SFS) in 
Bagamoyo District, Tanzania (Figure 4.2) Use of the SFS [14] allowed replications of 
experiments within a short period of time because laboratory reared mosquitoes were used 
and therefore experiments were not dependent on the season. In addition, laboratory 
mosquitoes are disease free, therefore, not putting volunteers at risk of being infected with 
mosquito-borne diseases. 
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Figure 4.2. Semi-field system. The walls and the roof of the semi-field system (SFS) are 
made of metal frames and fibreglass netting material. It was divided into four equal square 
sections divided by fibreglass netting. An experimental hut was placed in each 
compartment. The SFS [14] allowed replication of experiments within a short period of 
time. Laboratory reared mosquitoes were used and were available throughout the duration 
of experiments hence there were no delays as usually experienced in the field. 
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Mosquitoes 
Insecticide susceptible mosquitoes of the species An. gambiae s.s. (Ifakara strain) were 
used. The colony was maintained by feeding larvae on Tetramin fish food and adults on 
human blood between 3 and 6 days after emergence and 10% glucose solution ad libitum. 
Temperature and humidity within the insectary were maintained between 28 – 29°C and 70 
– 80% respectively. The mosquitoes used in the experiments were female nulliparous, 3–8 
days old An. gambiae s.s. that had never blood fed and were sugar starved for 6 hours prior 
to the start of experiments. 
  
Study design 
 
Four Ifakara design experimental huts (Figure 3.2) fitted with window and eave exit traps 
were used inside the SFS. The huts were placed in individual compartments separated by 10 
metres and a netting screen. A fully-randomized fully-balanced 4 × 4 Latin square design 
was performed to determine efficacy of DDT used as IRS, Transfluthrin and Metofluthrin 
coils in four experimental huts. The treatments were tested for four nights per week. 
Therefore, one balanced round of experiments was completed in 16 days. The treatments 
tested were: 1) standard control – DDT as IRS; 2) negative control – no insecticide used; 3) 
two Transfluthrin coils (0.03%) per hut each night and 4) two Metofluthrin (0.00625%) 
coils per hut each night. Treatments and two male volunteers were randomly allocated to 
each hut. The pair of volunteers was rotated between huts every fourth night while the 
treatments remained in the same huts during the entire study period. Equal numbers of 
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mosquitoes were used in each compartment; hence there was no need to rotate the 
treatments between huts to minimize location bias as is the case in field experiment. 
Experiments began each evening at 1930 hours when volunteers entered respective huts. 
Technicians placed two lit coils on the floor 0.5 m from the volunteer inside respective huts 
(Figure 4.3). After 10 minutes, the volunteers simultaneously released 100 female 
mosquitoes in each hut from netting cages. The volunteers slept on mattresses on the floor 
and did not use bed nets. 
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Figure 4.3. Process of collecting mosquitoes from experimental huts. A: A coil placed 
on the floor 0.5 m from the volunteer B: HN collecting mosquitoes from exit traps using 
a mouth aspirator; C: AM collecting resting mosquitoes using a backpack aspirator; D: 
HN sorting mosquitoes and keeping them in individual tubes for checking oviposition. 
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Mosquito collection and processing 
Technicians collected mosquitoes from exit traps at the top of every hour from 2100 hours 
to 0700 hours using mouth aspirators (Figure 4.3 B). Additional collection was done at 0700 
hours inside the huts to capture resting, knocked down and dead mosquitoes using CDC 
backpack aspirators (Figure 4.3. C). Mosquitoes were placed in labelled paper cups and 
provided with 10% glucose solution. They were kept in an insectary with temperature at 28 
– 29°C and between 70 – 80% relative humidity. Each morning mosquitoes were sorted as 
either dead or alive, and fed and unfed. The total number of mosquitoes in each group was 
recorded. Blood fed mosquitoes were kept in the insectary in individual vials with moist 
filter paper and were left to lay eggs (Figure 4.3.D). The number of eggs in each vial was 
counted and recorded after 3 days. 
Protection of participants and ethical approval 
 
The male persons who slept in experimental huts were recruited on a voluntary basis 
through written informed consent after the risks and benefits of the study were clearly 
explained, and they were free to leave at any time during the study. The participants were 
screened for malaria before the beginning of the study and those participants found malaria 
positive were given artemisinin combination therapy anti-malarial drugs and referred to the 
nearest health centre. Those fit to participate in the study were tested for malaria every two 
weeks. Adverse events such as respiratory symptoms were monitored. The participants were 
also compensated for their time and effort. The ethical review boards of Ifakara Health 
Institute IHI/IRB/No A-019-2007, the National Malaria Research Institute Tanzania 
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(NIMR/HQ/R.8a/Vol.1X/710) and the London School of Hygiene and Tropical Medicine 
(LSHTM ERB 5552) approved the study. 
 
4.3.5. Statistical analysis 
 
In experiment 1, the mortality of mosquitoes in the field was calculated using the WHOPES 
formula due to the low number of dead mosquitoes collected, while deterrence (Experiment 
1), contact irritancy and excito-repellency, feeding inhibition and fecundity, (Experiment 2) 
were analyzed using the R statistical software version 3.02 [21] with a significance level of 
0.05 for rejecting the null hypothesis. All generalized linear mixed models (GLMMs) were 
conducted using the lme4 package [22]. 
 
Assessment of residual efficacy of DDT on grass woven mats 
 
Mortality of mosquitoes in different cone assays was calculated as a proportion of the total 
number of those exposed to the chemical. 
Deterrence 
 
Deterrence was determined using GLMMs. The model included the number of mosquitoes 
as the response variable (dependent variable) and the independent variables included the hut 
(because only 4 huts were used in the study) and treatment as fixed factors and the day of 
experiment as a random variable. The first model did not account for overdispersion in the 
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data (performing a Poisson GLMM), the second model accounted for overdispersion by 
fitting a random intercept for each row of the data (performing a log-normal Poisson 
GLMM) and the third model was fitted with an interaction term between hut and treatment 
and accounted for overdispersion. The models were compared using Aikaike‟s Information 
Criterion (AIC) [23] and the second model was chosen because it had the smallest AIC. 
 
Toxicity 
 
The proportion of mortality in the field study was calculated using the following formula: 
100 × (Dt–Dc)/Ec (The proportion of dead mosquitoes Dt = number of mosquitoes dead in 
treated hut, Dc = number of mosquitoes dead in control hut and Ec = total number of 
mosquitoes in control hut. This formula is used to calculate the overall insecticidal effect of 
treatment inside huts [16]). Mortality in the semi-field studies was determined by fitting a 
GLMM with binomial error and a logit link function. The dependent variable was the 
proportion of dead mosquitoes and independent variables were treatment and trap (exit or 
floor or resting) included as fixed factors while the day of experiment was set as a random 
variable. 
 
Contact irritancy and excito-repellency 
 
The number of mosquitoes that exited huts was compared to those that stayed inside the 
huts that had insecticides relative to the control. A GLMM with a binomial error and a logit 
link function was fitted. The dependent variable was the proportion of exiting mosquitoes. 
 132 
Independent variables included treatment as fixed factor and day as a random factor. 
The rate at which mosquitoes left huts that had insecticides was compared to the control 
huts using survival analysis and Kaplan-Meier survival graphs. Analysis was conducted 
with survival and splines survival packages in R 3.02 [21]. The time at which an individual 
mosquito left the hut was considered to be the “event”. 
 
Blood feeding inhibition 
 
The proportion of blood-fed mosquitoes was compared between the treatment and control 
huts in the semi-field experiments. This was determined by fitting a GLMM with binomial 
error and logit link. The dependent variable was the proportion of unfed mosquitoes and 
independent variables included treatment, volunteer and trap type as fixed factors and day 
as a random variable. 
 
Reduced fecundity 
 
The data was analysed in two different ways. The first method was to determine the 
proportion of mosquitoes that laid eggs after blood feeding in the presence of insecticides in 
semi-field experiments. This was determined by fitting a GLMM with binomial error and 
logit link. Treatment was included as a fixed factor and day of experiment as a random 
variable. 
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The second method was used to determine the number of eggs laid by blood fed mosquitoes 
exposed to insecticides compared to the control. The effect on number of eggs laid was 
determined using a GLMM. A Poisson model was fitted with the number of eggs as the 
dependent variable and the independent variables included treatment as a fixed factor and 
the day of experiment as a random variable. The best fitting model as measured by AIC did 
not account for overdispersion. 
 
4.4. Results 
4.4.1. Experiment 1 field 
 
The total number of mosquitoes collected was 30,280 of which 19,593 mosquitoes were An. 
gambiae s.l., 2016 were Mansonia sp. 7829 were Culex quinquefasciatus, 136 were 
Stegomyia aegypti [24] and 706 were An. coustani. PCR analysis was conducted on species 
of An. gambiae s.l., 100% (n = 975) of all successful amplifications were An. arabiensis 
mosquitoes [25]. 
 
Quality control: assessment of the carryover effect of airborne insecticides 
During the three-day wash period, the total number of mosquitoes inside huts increased 
gradually from the first day to the second day but there was no significant difference 
between the first day and the last two days (Table 4.2). There was no significant difference 
in the number of mosquitoes between huts that previously contained insecticides and the 
control hut (Table 4.3).
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Table 4.2: Total mosquitoes collected from experimental huts in the field during the 3 – day wash out period (experimental nights; n = 
12). 
Day of wash out N
 
Median
 
IQR
 
Odds
 
Odds Ratio
 
z Value p Value 
1 1064 42.00 22.80 – 91.80 
48.92 1.00 
NA NA 
2 1232 46.50 37.50 – 123.00 54.73 1.12 0.237 0.812 
3 1187 71.00 33.30 – 92.30 59.61 1.22 0.418 0.676 
This table illustrates the indoor densities of mosquitoes of experimental hut that previously had coils and DDT. Entry of mosquitoes was measured for 3 days. N - 
Total number of mosquitoes; Median
 – Number of mosquitoes per experimental day; IQR – Interquartile range. 
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Table 4.3: Total mosquitoes that entered untreated huts that previously had insecticides (experimental nights; n = 12) 
Treatment N
 
Median
 
IQR
 
Odds
 
Odds ratio
 
z Value p Value 
No insecticide  1048 47.00 22.00 – 110.30 53.67 1.00 NA NA 
Transfluthrin coils 737 71.00 28.00 – 92.50 53.70 1.00 0.006 0.995 
Metofluthrin coils 877 67.00 39.80 – 103.00 61.02 1.14 1.220 0.223 
DDT 2gm² 821 42.50 37.50 – 72.30 49.10 0.91 -0.832 0.406 
This table illustrates the indoor densities of huts that previously had coils and DDT. The mosquitoes were collected during the wash period when the huts had no 
insecticides. N = Total number of mosquitoes; Median = Number of mosquitoes per hut per night;
 
IQR – Interquartile range 
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Deterrence 
All compounds deterred malaria vectors from entering huts but coils had a 
greater impact than DDT (Table 4.4). Transfluthrin coils reduced entry of 
An. arabiensis mosquitoes by 38% (RR – 0.62 [0.47 - 0.87]; z = -6.37, p < 
0.001) and Metofluthrin coils reduced An. arabiensis mosquitoes by 30% 
(RR – 0.70 [0.50 - 0.98]; z = -4.77, p < 0.001) (Table 4). Both Metofluthrin 
and Transfluthrin coils reduced entry of Mansonia spp. mosquitoes by more 
than three quarters while DDT reduced them by half (Table 4.4). There was 
no significant difference in the number of Cx. quinquefasciatus mosquitoes 
entering control, DDT and Transfluthrin huts although Metofluthrin coils did 
reduce their entry. 
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Table 4.4: Indoor mosquito densities in field experimental huts that had 
mosquito coils and DDT compared to huts that did not have insecticides (n=64 
nights). 
Treatment N
 
Median IQR
 
RR
 
95% CI
 
z Value p 
Value 
Anopheles arabiensis 
No 
insecticide 
5650 70.00 50.25 – 104.50 NA NA NA NA 
Transfluthri
n coils 
3881 47.00 27.25 – 75.25 0.62 [0.47 - 0.87] -6.37 <0.001 
Metofluthrin 
coils 
4249 54.00 35.50 – 82.00 0.70 [0.50 - 0.98] -4.77 <0.001 
DDT 2gm² 5813 67.00 41.50 – 108.75 0.92 [0.65 - 1.20] -1.22 0.224 
Culex quinquefasciatus 
No 
insecticide 
2300 26.00 19.50 – 46.25 NA NA NA NA 
Transfluthri
n coils 
1782 26.50 13.00 – 39.25 0.87 [0.73 - 1.05] -1.46 0.143 
Metofluthrin 
coils 
1645 22.50 13.75 – 36.25 0.72 [0.61 - 0.85] -3.80 <0.001 
DDT 2gm² 2102 27.00 16.75 – 44.00 1.13 [1.01 - 1.28] -1.40 0.161 
Mansonia spp. 
No 
insecticide 
947 12.00 8.75 NA NA NA NA 
Transfluthri
n coils 
150 2.00 1.00 0.16 [0.07 - 0.19] -8.17 <0.001 
Metofluthrin 
coils 
185 2.00 0.75 0.12 [0.09 - 0.24] -7.56 <0.001 
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DDT 2gm² 734 9.00 5.75 0.50 [0.33 - 0.77] -3.16 0.002 
N- Total number of mosquitoes; Median – number of mosquitoes per hut per night; IQR – 
Interquartile range; RR – Relative rate; CI – Confidence intervals 
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Toxicity 
Mortality of mosquitoes after 24 hours in field experiments was very low. Only 
0.02% mortality of all mosquito species collected was observed. 
Residual efficacy of DDT on grass woven mats 
 
Cone bioassays conducted on DDT mats on the second day and a week after 
spraying showed 100% mortality of mosquitoes after 24 hours. Mortality 
dropped in the second, third and fourth week to 73%, 92% and 90%, 
respectively. It is likely that DDT flaked off from mats when they were moved 
between huts resulting in reduced residues hence reduced toxicity. There was no 
mortality in the bioassays conducted on control mats. 
4.4.2. Experiment 2: semi-field 
 
Seventy percent (n = 4476/6400) of the mosquitoes released in the huts were 
recaptured. The relatively low recovery rate could be explained by loss of 
mosquitoes that might have been eaten by predators and those that escaped 
through small cracks in the huts or when the door was opened briefly. However 
analysis was conducted on recovered mosquitoes and not released mosquitoes. 
Contact irritancy and excito-repellency 
 
The proportion of mosquitoes that left huts that had DDT, Transfluthrin and 
Metofluthrin coils was significantly higher than the control (Table 4.5). 
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Approximately 48% (95% CI: [0.44 -0.53]; z = 9.950, p < 0.001) of the 
mosquitoes left DDT huts (Table 4.5). In huts with Transfluthrin and 
Metofluthrin coils approximately 56% (95% CI: [0.51 - 0.60]; z = 12.779, p < 
0.001) and 55% (95% CI: [0.51 -0.60]; z = 12.890, p < 0.001) mosquitoes left 
huts, respectively. The rate at which mosquitoes left huts throughout the night is 
illustrated using Kaplan Meier survival curves (Figure 4.4). The highest exodus 
of mosquitoes from huts was observed in the first half of the night (2100 – 0000 
hours) regardless of treatment or control, but overall, more mosquitoes exited 
when huts contained DDT, Transfluthrin or Metofluthrin coils compared to the 
control. 
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Table 4.5: The proportion of mosquitoes that left experimental huts that had mosquito coils and DDT compared to the hut that did not 
have insecticides in the semi field system (experimental hut nights = 16).  
Treatment Proportion of 
mosquitoes
 a 
OR [95% CI] 
Mean proportion 95% CI
 
z value p value 
Control 313/1067 1.00 [0.00 - 2.00] 0.27 [0.22 - 0.34] -6.68 NA 
DDT 581/1185 2.32 [0.45 – 4.55] 0.48 [0.44 -0.53] 9.95 <0.001 
Transfluthrin coils 599/1067 3.08 [0.61 - 6.08] 0.56 [0.51 - 0.60] 12.78 <0.001 
Metofluthrin coils 645/1157
 
3.03 [0.63 - 5.98] 0.55 [0.51 -0.60] 12.89 <0.001 
a = mosquitoes in exit traps/total number of mosquitoes recaptured from the hut; CI – Confidence intervals CI – Confidence intervals; OR – Odds ratios of the 
proportion of mosquitoes 
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Figure 4.4. Survival curves illustrating the rate at which mosquitoes left huts with 
DDT, transfluthrin and metofluthrin coils. The curves represent the rate at which 
mosquitoes exit huts that have different insecticides compared to the control. Analysis was 
based on a Kaplan-Meier stepped survivorship function. Each curve represents one 
treatment. 
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Toxicity 
The proportion of mortality in control huts was 18% (n = 193/1067). Therefore, Abbot‟s 
correction formula was used to correct for mortality induced by tested insecticides because 
mortality in the control huts was more than 10% [15]. There was a much higher proportion 
of mortality induced by insecticides in the semi-field study compared to the field. DDT 
induced 64% (95% CI: [0.60 - 0.67]; z = 22.49, p < 0.001), Transfluthrin induced 66% 
(95% CI: [0.63 - 0.70] z = 23.32, p < 0.001) and Metofluthrin 61% (95% CI: [0.57 - 0.64]; p 
< 0.001; z = 21.96) mortality (Table 4.6). More than 90% of the mosquitoes collected inside 
huts that had mosquito coils and DDT had died within 24 hours unlike in the control hut 
(Table 4.7). Out of the mosquitoes collected from exit traps of DDT, Transfluthrin and 
Metofluthrin huts, 49%, 46% and 57%, respectively died after 24 hours (Table 4.7). 
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Table 4.6: The proportion of the mortality of mosquitoes 24 hours after collection from experimental huts  
Treatment Total dead 
mosquitoes 
Total 
mosquitoes 
recaptured  
Crude mortality OR [95% CI] Corrected mortality⌘ z value p value 
Mean 
proportion 
[95% CI] 
 
Mean 
proportion 
[95% CI]
 
Control 193 1067 0.17 [0.13 - 0.22] 1.00 [0.00 – 2.00] 0.00 [0.00 - 0.00] -10.04 NA 
DDT 836 1185 0.70 [0.65 - 0.74] 9.68 [4.19 – 21.00] 0.64 [0.60 - 0.67] 22.49 <0.001 
Metofluthrin coils 763 1157 0.67 [0.63 - 0.72] 8.77 [2.34 – 17.79] 0.61 [0.57 - 0.64] 21.96 <0.001 
Transfluthrin coils 727 1067 0.72 [0.68 - 0.76] 10.85 [1.53 – 21.01] 0.66 [0.63 - 0.70] 23.32 <0.001 
Experiments were conducted in experimental huts within a semi field system. Mortality of mosquitoes is compared between huts that had mosquito coils, DDT 
and no insecticide. Experiments were conducted for 16 nights. CI – Confidence intervals. ⌘ - Corrected using Abbott‟s formula; OR – Odds ratios of the 
proportion of mosquitoes 
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Table 4.7: Mortality of mosquitoes collected from exit traps compared to those collected inside experimental huts  
Treatment Mosquitoes in exit traps  Mosquitoes indoors 
 Dead 
mosquitoes/Total 
mosquitoes
 
Median IQR
 
 
Dead 
mosquitoes/Total 
mosquitoes 
Median
2
 IQR 
Control 91/313 0.35 0.19 – 0.43  102/754 0.15 0.09 -0.18 
DDT 286/581 0.52 0.30 – 0.75  550/604 1.00 0.94 – 1.00 
Transfluthrin coils 273/599 0.49 0.34 – 0.55  454/468 1.00 1.00 - 1.00 
Metofluthrin coils 333/645 0.35 0.25 – 0.73  430/512 1.00 1.00 - 1.00 
The proportion of mortality induced by insecticides was measured in experimental huts in a semi field system for 16 nights. Mortality was compared between 
huts that had mosquito coils, DDT and no insecticides. Median – median proportion of mosquitoes per hut per night; IQR – Interquartile range 
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Blood feeding inhibition 
Blood-feeding inhibition was the most pronounced mode of action in all 
three treatments. Transfluthrin and Metofluthrin coils had the highest impact 
on feeding of mosquitoes. Transfluthrin coils reduced feeding by 98% (95% 
CI: [0.96 - 0.99]; z = 22.03, p < 0.001), Metofluthrin reduced it by 93% 
(95% CI: [0.90 – 0.95]; z = 25.57, p < 0.001) and DDT by 77% (95% CI: 
[0.73 - 0.81]; z = 24.10, p < 0.001) (Table 4.8). 
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Table 4.8: Insecticide induced blood-feeding inhibition of mosquitoes in experimental huts  
Treatment Proportion of 
unfed 
mosquitoes 
a 
OR [95%CI] Mean proportion [95% CI]
 
z value p value 
Control 321/1120 1.00 [0.00 – 2.00] 0.15 [0.10 - 0.22] -7.49 NA 
DDT 881/1047 13.21 [9.96 – 29.04] 0.77 [0.73 - 0.81] 24.10 <0.001 
Transfluthrin coils 1164/1184 144.87 [67.19 – 382.05] 0.98 [0.96 - 0.99] 22.03 <0.001 
Metofluthrin coils 1085/1146
 
44.27 [37.03 – 110.97] 0.93 [0.90 – 0.95] 25.57 <0.001 
The proportion of mosquitoes that were inhibited from blood feeding on humans was measured inside experimental huts inside a semi field system 
for 16 nights. The proportion of unfed mosquitoes was compared between mosquito coils, DDT and no insecticide. 
a
 - unfed mosquitoes /total 
number of mosquitoes recaptured from the hut; OR – Odds ratios of the proportion of mosquitoes that are likely not to feed; CI – Confidence 
intervals 
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Reduced fecundity 
 
The difference in the number of mosquitoes that laid eggs versus those that 
did not lay eggs was determined from the number that acquired blood meals. 
The proportion of mosquitoes that laid eggs was low in all huts (Table 4.9). 
There was no difference in the proportion of mosquitoes that laid eggs 
between treatments relative to the control. DDT reduced the total number of 
eggs laid per female by 90% (RR – 0.10 [0.04 - 0.26]; z = -4.57, p < 0.001), 
Transfluthrin coils by 97% (RR – 0.03 [0.01 - 0.15]; z = -4.13, p < 0.001 and 
Metofluthrin coils by 91% (RR – 0.09 [0.03 - 0.27]; p < 0.001; z = -4.28) 
(Table 4.10). 
 
 149 
Table 4.9: The fecundity of mosquitoes after exposure to mosquito coils and DDT in experimental huts  
Treatment Total mosquitoes 
that laid eggs /Total 
blood fed 
mosquitoes 
OR [95%CI] Mean 
proportion 
[95% CI]
 
z value p value 
Control 202/614 1.00[0.00 – 2.00] 0.33 [0.28 - 0.37] -7.36 NA 
DDT 19/76 0.68[-0.32 – 1.41] 0.20 [0.13 - 0.30] -2.41 0.016 
Transfluthrin coils 1/6 0.41[-0.36 – 3.02] 0.15 [0.02 - 0.61] -0.94 0.347 
Metofluthrin coils 11/34
 
0.96[-0.57 – 5.98] 0.24 [0.13 - 0.40] -1.13 0.258 
Legend: Fecundity was measured by determining the proportion of mosquitoes that laid eggs out of those that successfully blood fed. Fecundity was compared 
between mosquitoes exposed to mosquito coils, DDT and no insecticide inside experimental huts in the semi field system for 16 nights. 
CI – Confidence intervals; OR – Odds ratios of the proportion of mosquitoes 
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Table 4.10: The number of eggs laid by mosquitoes collected from experimental huts 
Treatment Total number of eggs Median
 
IQR
 
RR
 
[95% CI]
 
z Value p Value 
Control 10089 649.0 443.5 - 943.0 NA NA 18.66 NA 
Transfluthrin coils 57 0.0 0.0 - 0.0 0.03 [0.01 – 0.15] -4.13 <0.001 
Metofluthrin coils 526 0.0 0.0 - 57.5 0.09 [0.03 - 0.27] -4.28 <0.001 
DDT 2gm² 837 42.0 6.0 - 82.5 0.10 [0.04 - 0.26] -4.57 <0.001 
Blood fed mosquitoes collected from huts that had mosquito coils, DDT and no insecticides were kept in individual oviposition tubes and the number of eggs laid 
was compared between mosquitoes that had been collected from huts that had different insecticides. The number of eggs was fitted in a Poisson model because 
the number of eggs was count data. IQR – Interquartile range; RR – Relative rate; CI – Confidence intervals 
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4.5. Discussion 
Traditionally, efficacy of insecticides for disease control is attributed to 
toxicity while other effects are considered less important. The spread of 
insecticide resistance threatens the sustainability of insecticides applied to 
kill mosquitoes [26, 27]. While development of new insecticides is an 
undisputed requirement to fight insecticide resistance, management of 
existing insecticides to prolong their usefulness is also necessary. 
A critical look at the modes of action of insecticides by several authors 
indicate that toxicity may not be the single most important action of 
insecticides as far as malaria transmission is concerned [7, 10, 28, 29]. 
Experimental hut studies enable detailed observation of the impact of 
insecticides on mosquito behaviour [30, 31]. This study substantiates the 
mode of action of reduced blood feeding by mosquitoes [9] and irritancy [7, 
32] (Figure 4.5). It is worth noting that despite the irritant effect of 
chemicals, 49% 46% and 57% of the mosquitoes that left DDT, 
Transfluthrin and Metofluthrin huts respectively died after 24 hours (Table 
4.7). Moreover this study shows that the magnitude of these effects was 
similar between coils and DDT (Figure 4.5). 
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Figure 4.5. Overall impact of insecticides on mosquito behaviour insides 
houses. The graph illustrates the mode of action of DDT, Transfluthrin and 
Metofluthrin coils on mosquito behaviour. The outcomes measured included 
deterrence, irritancy, feeding inhibition and toxicity. The value of deterrence was 
derived from the effect of insecticides on An. arabiensis mosquitoes from field 
experiments and irritancy, feeding inhibition, mortality and fecundity of An. 
gambiae s.s. mosquitoes from the semi field system experiment. 
 
Using figures collected from the field (deterrence) and the semi field experiments 
(irritancy, feeding inhibition, mortality and fecundity) it can be seen that in a 
scenario where 100 mosquitoes approach a house, deterrence comes into play in 
the first instance and only approximately 62, 70 and 92 mosquitoes enter the 
house with Transfluthrin, Metofluthrin coils and DDT respectively. The next 
behavioural effect of the insecticides is then likely to be irritancy or excito–
repellency. After mosquitoes are repelled and exit a house, 35, 39 and 44 would 
remain inside the house with Transfluthrin, Metofluthrin coils and DDT 
respectively. Of those, approximately 1, 3 and 10 mosquitoes would manage to 
acquire a blood meal, which in turn directly influences the proportion of eggs laid, 
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i.e. female mosquito fecundity. Lastly, the survival rate of mosquitoes in 
Transfluthrin and Metofluthrin huts would be close to 0 and approximately 10 in 
DDT huts (Figure 4.6). This implies that through deterrence, irritancy and feeding 
inhibition of pyrethroid coils and DDT, more than 90% of the mosquitoes would 
be prevented from contacting humans inside houses before mortality is even 
considered. By reducing human-vector contact, coils and DDT directly influence 
the biting rate of mosquitoes (ma): an important parameter of malaria transmission 
Vectorial capacity equation, subsection). The data collected on DDT, agrees with 
field observations [9] of feeding inhibition and population level data that 
consistently demonstrate a reduction in the Human Blood Index (HBI) after DDT 
is applied to dwellings [33, 34]. However, the experimental design does have the 
limitation of combining data from two species: An. arabiensis and An. gambiae 
s.s. 
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Figure 4.6. Impact of insecticides on mosquito behaviour around and insides 
houses. The graph illustrates the effect of DDT, Transfluthrin and Metofluthrin 
coils on the house entry and behaviour of 100 female An. arabiensis and An. 
gambiae s.s. mosquitoes are approaching the house. Assumptions made included 
the fact that deterrence was the first mode of action followed by irritancy, feeding 
inhibition, toxicity and fecundity. The data used was derived from field 
experiments for deterrence and semi-field system experiments for irritancy, 
feeding inhibition, toxicity and fecundity. 
 
Studies have been conducted on the host preference and time and place of biting 
and resting in Kilombero. It is known that An. arabiensis, the dominant Anopheles 
species in Kilombero, readily enter houses [17], and exit to rest outside whereas 
An. gambiae s.s. feed and rest indoors (K. Kreppel, unpublished). The human 
blood index (HBI) of An. arabiensis is related to the availability of human hosts, 
and since cattle are not common in Kilombero due to the Tanzanian Government 
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forcibly relocating Pastoralists and their 250,000 cattle, An. arabiensis feeds 
almost exclusively on humans in the area, indoors and outdoors (K. Kreppel, 
unpublished). As the impact of spatial repellents indoors was being measured, a 
standard laboratory strain of An. gambiae s.s. for repellent testing was used [15]. 
Previous unpublished work in local houses demonstrated that An. arabiensis 
demonstrated a similar response to 0.03% Transfluthrin coils as that measured in 
experimental huts with >95% feeding inhibition as measured by human landing 
catch. It is possible that mortality data was overestimated because An. arabiensis 
might be more likely to leave treated huts than An. gambiae s,s., although the vast 
majority of An. gambiae s.s. in the semi-field did leave experimental huts unfed 
and subsequently died. It would be worthwhile to repeat the study with An. 
arabiensis, mosquitoes. 
Coils and DDT induced more than two-thirds mortality of mosquitoes in the semi-
field experiments compared to about 2% in the field. The mortality (18%) 
observed in control huts may be attributed to poor handling of mosquitoes during 
collection. Resting mosquitoes were collected using backpack aspirators that may 
have caused mechanical damage to mosquitoes and increased mortality. However, 
mortality in the treatments was corrected using Abbots formula. Higher mortality 
observed in semi-field experiments compared to the field experiments may be due 
to the fact that in the semi-field studies, volunteers did not sleep under bed nets 
and were consequently more attractive to host seeking mosquitoes that spent more 
time around the host trying to feed. In the field where volunteers were protected 
by untreated bed nets mosquitoes may have given up and left the huts. It is 
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possible that availability of an unprotected host and the need to obtain blood 
outweighs the irritant or excito-repellency effects of insecticides, meaning that 
mosquitoes spend more time in the house trying to obtain a blood meal, hence 
acquire more lethal insecticides. These observations provide useful insights for 
malaria control programmes and demonstrate that spatial repellents are useful for 
locations where people do not use nets for cultural reasons [35] or where vectors 
bite before people go to bed [36, 37]. The mortality of mosquitoes induced by 
coils was as high as that of DDT. More than 60% of the mosquitoes collected 
from huts after exposure to coils died within 24 hours, having acquired lethal 
doses. This has implications for vector control programmes as it is thought that 
irritancy or excito-repellency of insecticides used on LLINs attenuates efficacy by 
preventing contact of mosquitoes with treated surfaces [38, 39]. In this study it is 
shown that coils are capable of dispensing lethal doses of airborne insecticides 
and have the potential to reduce mosquito densities (m) and indirectly reduce 
chances that a mosquito would survive (p) long enough to become infectious. This 
study also shows that airborne pyrethroids reduce fitness of mosquitoes by 
reducing the number of eggs laid. Reduced fecundity is an indirect measure of 
pyrethroids on mosquito densities (m). However, further studies will be performed 
to investigate the combined impact (additional or deleterious) of indoor spatial 
repellents combined with LLINs on mosquito mortality and feeding success. 
Among challenges facing malaria control, insecticide resistance could be 
considered top of the list. In this particular study area susceptibility of An. 
arabiensis mosquitoes is within the WHO set range of 80% - 97% at which 
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resistance is suspected [40]. Therefore low mortality observed in the field could 
be attributed to slow emerging resistance [41-43]. A study carried out in Benin 
indicated that coils were effective against highly kdr resistant Cx. 
quinquefasciatus quinquefasciatus (Raphael Nguessan pers. comm). This 
indicates that spatial repellency may still provide protection where resistance has 
developed because airborne pyrethroids have an olfactory mode of action at low 
concentrations [44], different from the sodium channel target. These data warrant 
further investigation to see whether pyrethroid-resistant mosquitoes react 
differently to spatial repellents in ways that would affect vectorial capacity and 
malaria transmission. 
The risk of mosquitoes being diverted to non-users of spatial repellents is likely to 
be increased if mosquitoes are prevented from feeding and continue host seeking 
[45]. A recent study has shown that topical repellents increase the proportion of 
mosquitoes to nearby non-users by approximately 4 times [46]. Nevertheless, the 
high toxicity of coils observed in the semi-field study might contribute to 
community protection. Toxicity coupled with the spatial activity of coils 
conferring protection in a defined area, may minimize the risk to non-users. In 
addition, almost half of the mosquitoes that left huts with mosquito coils and DDT 
died after 24 hours, consequently minimizing the population of mosquitoes that 
would be diverted to non-users within a community. 
Nevertheless, it is necessary to improve delivery formats of airborne insecticides 
with the aim of expanding protection to a household or a community. In addition, 
it is essential to quantify the effect of using spatial repellents among non-users at 
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different coverage levels and determine the implications on malaria transmission 
at a community level through large-scale trials before they are considered as a 
public health intervention. 
Effectiveness of any vector control tool is influenced by whether or not it protects 
users against nuisance bites. Results from this study indicate that only 
Metofluthrin coils reduced house entry of Cx. quinquefasciatus mosquitoes by 
almost 28% in Lupiro village while DDT and Transfluthrin coils had no effect. 
The impact of all compounds on the entry of Mansonia spp. mosquitoes was 
outstanding (Table 4.4). All compounds reduced entry by more than 50%. It is 
necessary to develop spatial repellents that are equally effective against nuisance 
mosquito species in order to enhance compliance. 
It should be noted that mosquito coils need to be used on a daily basis and 
produce smoke that could be harmful in long term exposure and might not be 
desirable to many people. The development of safer, effective, long lasting 
passive delivery formats is underway [47, 48]. 
 
4.6. Conclusion 
It is critical to determine the impact of spatial repellents on malaria transmission. 
This study outlines several important entomological parameters that should be 
quantified in a proof of concept clinical trial in order to effectively determine the 
impact of spatial repellents on malaria epidemiology. In this study spatial 
repellents reduce human – vector contact and induce mortality, hence directly 
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affect ma, m and p which are among the most important parameters of the 
vectorial capacity of a mosquito population. In addition, the role of spatial 
repellents in integrated approach of malaria control should be critically considered 
with an aim of complementing existing mainstream tools. Most available control 
tools, such as LLINs, require daily compliance by the user and may only be fully 
effective where malaria vectors still bite indoors late at night. Spatial repellents 
may be a suitable supplementary option where mosquitoes feed in the early 
evening and/or rest outdoors. In addition, because they render a given space 
mosquito free, they will protect multiple individuals in this space. The 
development of a passive spatial repellent that delivers the same mosquito control 
benefits of the mosquito coils tested in this study, but lasts for several weeks 
without the need for user compliance would contribute considerably to vector 
borne disease prevention. 
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CHAPTER FIVE 
5     The mode of action of spatial repellents and their 
impact on vectorial capacity of Anopheles gambiae sensu 
stricto 
5.1. Abstract 
 
Malaria vector control relies on toxicity of insecticides used in bednets and indoor 
residual spraying only, despite evidence of reduced malaria transmission due to 
prevention of human – vector contact.  
The overall aim of this study was to determine the impact of sub-lethal 
insecticides on host seeking and blood feeding of mosquitoes. Taxis boxes were 
used to study mosquito responses towards or away from Transfluthrin coils. 
Protective distance of coils was measured in the semi-field tunnel. In addition, 
short-term and long-term effects of sub-lethal pyrethroids on blood feeding were 
measured in a semi-field tunnel and in the Peet Grady chamber. Experiments were 
conducted on laboratory reared susceptible Anopheles gambiae sensu stricto 
mosquitoes.  
In the taxis boxes experiment a higher proportion of mosquitoes were activated 
and flew towards the human in the presence of Transfluthrin. Hence coils did not 
hinder attraction of mosquitoes towards the human but increased it. Coils reduced 
biting by 86% (95% CI [0.66; 0.95]) when coils were placed 0.3m around a 
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human in a „bubble” compared to a 65% (95% CI (0.51; 0.76) reduction when 
coils were used as a “point source”. Results indicated that coils used, as a 
“bubble” were more effective than the “point source”. 
Mosquitoes exposed to Transfluthrin coils in an enclosed space were prevented 
from feeding and only resumed normal feeding behaviour 12 hours later. However 
there was no effect on free flying and caged mosquitoes exposed to Transfluthrin 
in the semi-field tunnel. 
These findings indicate that airborne pyrethroids influence mosquito behaviour in 
ways other than killing by minimizing human - vector contact through fewer 
blood feeding events. This study provides critical information necessary for the 
development of target product profiles of spatial repellent products that can be 
used to complement existing mainstream malaria vector control tools. 
 
5.2. Introduction 
 
The probability of mosquito vectors successfully transmitting disease pathogens 
to a host depends on their ability to effectively locate the host and feed. Among 
factors that influence the rate at which new human malaria infections are 
disseminated per day by a mosquito (i.e. vectorial capacity), is the man-biting rate 
of mosquitoes [1]. Man-biting rate describes the frequency with which mosquitoes 
contact humans to obtain blood. For malaria parasites to be transmitted from one 
person to another, mosquitoes need to feed at least twice: once to become infected 
and once to infect, hence it has profound effect on vectorial capacity and 
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consequently malaria transmission [2]. Factors that interfere with host seeking of 
mosquitoes influence man-biting rate. Even though man-biting rate is just one 
component of the vectorial capacity, it substantially contributes to variation in the 
stability of malaria transmission in different areas and is especially critical where 
vectors are anthropophilic, i.e. prefer feeding on humans [3]. 
The efficient malaria vectors Anopheles gambiae sensu stricto (s.s.) and An. 
funestus s.s have evolved innate feeding preferences for humans due to their 
ability to discern human kairomones from other hosts [4]. This enhances the 
ability of mosquitoes to locate and orient towards hosts at distances [5, 6] as far as 
30 meters [7]. Several human odours have been identified as olfactory cues that 
govern mosquito host seeking and feeding behaviour [8, 9]. Studies of the insect 
olfactory system have led to identification and development of synthetic chemical 
compounds that attract insects to hosts [10]. This knowledge is successfully 
applied in the agricultural sector in the control of crop pests [11], tsetse flies [12, 
13, 14] as well as mosquitoes [15, 16, 17]. 
Other volatile compounds, commonly known as repellents, interfere with 
mosquitoes‟ host finding ability and consequently prevent blood feeding. They are 
intended to reduce human-mosquito contact and lately have been shown to reduce 
disease transmission [18]. Repellency has been described as: 1) “taxis”: - 
immediate directional movement of target insects such as mosquitoes away from 
the source of the chemical and; 2) “orthokinesis”: - increased mosquito activity 
after contact with insecticides [19, 20]. Other studies indicate that volatile 
compounds such as DEET, linalool, dehydrolinalool, catnip oil and citronella 
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interfere with attraction of mosquitoes to host odours by blocking natural response 
to attractants, hence acting as attraction inhibitors and not repellents [21 ,22, 23]. 
On the other hand, Lucas et al (2007) suggest that even in the presence of airborne 
pyrethroids, mosquitoes are able to detect host odours but are inhibited from 
feeding: “When mosquitoes detected host odours, flew upwind and landed, the 
majority of insects were still inhibited from biting. This effect is probably a result 
of pyrethroid – induced neural hyperexcitation, which can occur at much lower 
doses than those required for insect knockdown and mortality” [24].  
Mosquito behaviour elicited in response to airborne compounds including 
movement away from a chemical stimulus, loss of host detection, anti-feeding as 
well as knockdown and mortality are collectively referred to as spatial repellency. 
Spatial repellents do not require physical contact of the mosquito with treated 
surfaces, as is the case of chemicals used in Indoor Residual Spraying (IRS) and 
Long Lasting Insecticidal Nets (LLINs) but act in the volatile state at a distance. 
Mosquito coils, candles and emanators impregnated with volatile pyrethroids and 
other compounds including plant terpines are collectively known as spatial 
repellents. Among these products, coils have been most extensively studied [25] 
and are commonly used to control mosquitoes [26]. Coils prevent mosquitoes 
from entering houses, induce early exit and reduce human biting [25, 27]. Despite 
numerous evaluations of coils, their mode of action is not clear: Do they interfere 
with orientation of mosquitoes towards humans, inhibit blood feeding or even 
induce both processes? It is essential to ascertain which of these actions is at play 
to aid the development of effective spatial repellents. This study aimed to 
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distinguish between repellency as described by Dethier [20] and attraction 
inhibition [28] induced by airborne pyrethroids. The taxis box system [7] was 
used to measure orientation of An. gambiae s.s. mosquitoes towards and away 
from humans in the presence of airborne pyrethroids. Protective distance 
conferred by coils was determined in the semi-field system by measuring reduced 
blood feeding by mosquitoes and whether exposure of mosquitoes to different 
doses of pyrethroids prolonged feeding inhibition beyond the immediate effect in 
a way that could impede human-mosquito contact and reduce malaria 
transmission.  
 
5.3. Materials and Methods 
5.3.1. Test compounds 
 
Transfluthrin coils contained a range of doses of Transfluthrin: 0.015%, 0.03% 
and 0.045%. Blank coils used contained no active ingredient.  
5.3.2. Mosquitoes 
 
Insecticide susceptible mosquitoes of the species An. gambiae s.s. Ifakara strain 
were used. Larvae were fed on Tetramin fish food while adults were fed on human 
blood between 3 and 6 days after emergence and offered 10% glucose solution ad 
libitum. Temperature within the insectary was maintained between 28 – 29ºC, 
between 70 - 80% relative humidity and natural light periods (12:12 hours light: 
dark periods). Female nulliparous 3-8 days old mosquitoes that had never blood 
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fed and were sugar starved for 6 hours prior to starting experiments were used for 
all studies. 
 
5.3.3. Experiment 1: Orientation of mosquitoes in the presence of 
coils and humans 
 
Taxis boxes system 
 
A new assay using taxis boxes to measure long-range mosquito responses to 
different stimuli developed at IHI [7] was used to measure effect of coils on the 
orientation of mosquitoes towards humans. Briefly, taxis boxes consist of three 
chambers measuring 40 x 40 x 40 cm separated by metal sheets: one chamber 
facing the stimuli, the middle chamber and one chamber facing away from the 
stimuli. The middle chamber has a “letter box slit” (30cm long and 2.5cm wide) 
on either side, which allows mosquitoes to leave the middle but reduces the 
likelihood of them returning. During the experimental period the sheets were 
lifted using a simple pulley mechanism comprising a rope and lever located 10 
meters from the boxes, which opened the slits and allowed mosquitoes to fly 
through. The boxes were raised 15cm off the floor and placed into plastic cups 
with water and grease to prevent predators from entering.  
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Experimental design 
A fully randomized study was conducted. The study involved 6 treatments; 1) a 
positive control – human without a coil; 2) human + blank coil; 3) human + 
0.015% coil; 4) human + 0.03% coil; 5) human + 0.045% coil and 6) a negative 
control – no human and no coil. The last treatment was included in order to 
measure mosquito response in the absence of any stimulus. The response of 
mosquitoes was measured in taxis boxes placed 1m away from the treatment 
(Figure 5.1). A treatment was randomly allocated to an experimental night using 
the lottery method. The treatments were tested four times using four human 
volunteers randomly assigned on a nightly basis to give an average human 
response. Two taxis boxes were used to increase the sample but each box was 
treated as a separate factor in the analysis to ensure independence of experimental 
replicates.  
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Figure 5.1: Taxis boxes experimental design 
Two taxis boxes placed 1m away from the human and or human and a coil. Mosquitoes 
were introduced in the middle chamber of each taxis box and the stimulus was changed 
each day to determine the effect on orientation of mosquitoes. The semi-field tunnel 
measures 100m long, 2m wide and 2.5m high. 
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Procedure 
Experiments were conducted between 1830 and 2200 hours. Wind speed and 
direction were measured nightly using a hand-held anemometer (Heavy weather 
WS - 2300 or WS – 2310). Wind speed was consistently less than 0 m/s even 
though experiments were conducted outdoors. Thirty female mosquitoes were 
placed in the middle chamber of each taxis box and left to acclimatize for 20 
minutes. The metal barriers were pulled up and left open for 2 hours, allowing 
mosquitoes time to respond to the stimulus, after which they were closed. The 
next morning, mosquitoes were collected from the chambers using mouth 
aspirators. 
5.3.4. Experiment 2: Protective distance of coils against outdoor 
biting mosquitoes 
 
Semi-field tunnel cage 
The semi-field tunnel (SFT) is 100 meters long, 2m wide and 2.5 high.. The walls 
and roof of the tunnel are screened with fiberglass netting supported by metal 
frames. A palm-thatch roof approximately 1m above the netting roof protects the 
tunnel from direct sunlight and rain. The tunnel was operated at temperatures of 
24°C - 29°C at night. 
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Experimental design 
Point source experiments 
A partially randomized study was conducted inside the SFT. Treatments included 
1) control (human alone) and 2) treatment (two 0.03% Transfluthrin coils next to a 
human). The SFT was divided into two equal compartments, each measuring 30m 
x 2m x 1.5 m. A plastic sheet between the compartments prevented airflow 
between them. On the first night of experiments, treatments and two volunteers 
were randomly allocated to each compartment. This was followed by a pairwise 
rotation of volunteers and treatments between compartments on consecutive 
experimental nights. The control was always conducted first in the chosen 
compartment followed by the treatment in the other compartment after 2 hours on 
the same night. In the treatment, two 0.03% Transfluthrin coils were placed at a 
specified distance from the volunteer, hence creating a single source from which 
the chemical was released (Figure 5.2). This arrangement is referred to as “point 
source”. The protective distance of coils was evaluated by placing two coils at six 
different distances from the human at 0.3m, 1m, 5m, 10m, 15m, 20m and 30m. 
These distances were randomly allocated to each experimental night and each 
distance was repeated four times. 
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Figure 5.2: Point source experimental set up 
Two coils were placed on one side of the human conducting human landing catches. The 
distance between the coils and the human was changed each day to determine the 
protective distance. In the control no coils were used. Mosquitoes were released within 
the tunnel and left to acclimatize for 10 minutes before the human started conducting 
mosquito catches. The semi-field tunnel measures 100m long, 2m wide and 2.5m high. 
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Bubble experiments 
A partially randomized study was conducted. Treatments included 1) control 
(human alone) and 2) treatment (two 0.03% Transfluthrin coils next to a human). 
The same two volunteers from the “point source” experiment also conducted the 
“bubble” experiment. Experiments were conducted in a 60m long compartment. 
Unlike the point source, treatments had to be tested on separate days from the 
control to minimize contamination of the control experiment with residues from 
burning coils. Treatments were allocated to day one and day two and a volunteer 
was allocated to each night. Volunteers were switched between nights such that at 
the end of 4 days both volunteers had been paired with the control and treatment 
once, which resulted into a four – day block. Six distances (0.3m, 1m, 5m, 10m, 
15m, 20m and 30m) were randomly allocated to each four – day block. In this set 
up, one coil was placed equidistant on the left hand side and another coil on the 
right hand side of the volunteer at the designated distance creating a “bubble” of 
chemical around the volunteer (Figure5. 3). 
Experiments were started at 1830 hours each evening. One hundred female An. 
gambiae s.s. aged between 3 and 8 days and previously starved for 6 hours were 
released from cages placed inside the tunnel by a pulley system (Figure 5.3) and 
operated from outside the tunnel. Mosquitoes were left to acclimatize for 20 
minutes after which a volunteer entered the tunnel. Volunteers collected 
mosquitoes that landed on the bare legs and feet for 2 hours using mouth 
aspirators. Mosquitoes were kept in labelled paper cups for counting the following 
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morning. All mosquitoes were kept in the testing room whose temperature was 
maintained between 28 – 29ºC and 70 - 80% relative humidity. 
 
15m 15m15m 15m
 
Figure 5.3: Bubble experimental set up 
A coil was placed equidistantly on either side of the human. The distance was changed 
each night to determine the protective distance. Coils were not used in the control. 
Mosquitoes were released within the tunnel and left to acclimatize for 10 minutes 
before the human started conducting mosquito catches. 
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5.3.5. Experiment 3: Resumption to blood feeding of mosquitoes 
after exposure to coils  
Peet Grady chamber tests 
Experimental design  
A fully randomized study was conducted. Treatments included; 1) a negative 
control (no coil) 2) blank coil; 3) 0.015% coil; 4) 0.03% coil and 5) 0.045% coil. 
These treatments were randomly assigned to five days of experiments in a 5 x 5 
Latin square design. One hundred female mosquitoes exposed to a treatment were 
randomly divided into equal batches of 10 mosquitoes per cup. Two cups of 
mosquitoes were randomly assigned to each blood feeding time regime, namely 
15 minutes, 1 hour, 12 hours and 24 hours blood feeding after exposure to coils. 
Each treatment was repeated five times. 
 
Procedure  
 
The Peet Grady chamber [29] was fitted with a battery operated fan to provide 
ventilation. One hundred female mosquitoes were placed in 30cm by 30cm netting 
cages at 1830 hours. A treatment was applied (e.g. a 0.03% Transfluthrin coil was 
lit) inside the chamber and after 10 minutes, the cage containing mosquitoes was 
placed inside on a stool. Mosquitoes were exposed to the burning coil for two 
minutes after which they were transferred to the laboratory and the coil was 
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extinguished. Mosquitoes were kept in a testing room with temperature 
maintained between 28ºC – 29ºC and between 70 - 80% relative humidity. 
Mosquitoes were gently aspirated and placed into paper cups labelled with the 
allotted blood feeding time. Pieces of cotton wool soaked in 10% glucose solution 
were placed on the remaining paper cups. The cotton wool was removed six hours 
prior to each specific feeding time. After each time interval had elapsed, a human 
arm was placed above the paper cups and mosquitoes were allowed to feed 
through the netting for 15 minutes. The number of fed and unfed mosquitoes in 
each cup was counted and recorded. Experiments with the control were conducted 
in the same way except that mosquitoes were not exposed to a coil.  
 
Semi-Field Tunnel tests 
 
The experiment included two treatments in the SFT; 1) control (no coil) and 2) 
treatment (two 0.03% Transfluthrin coils). Treatments were randomly allocated to 
two days of experiments and one treatment was tested each day. Female 
mosquitoes were simultaneously exposed to the treatments in the SFT in two 
different ways; 1) caged mosquitoes and 2) free flying mosquitoes. Experiments 
were conducted in a 20-meter long SFT lined with white plastic sheets to enable 
easy location of mosquitoes that were knocked down. Both treatments were 
repeated four times.  
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Procedure  
 
Experiments were started at 1830 hours. In the caged mosquitoes set up, 25 
female mosquitoes were each placed in four 30 cm by 30cm netting cages. Cages 
were suspended inside the tunnel one meter above the floor approximately half a 
meter apart from each other and from two burning 0.03% Transfluthrin coils 
placed on the floor. In the free flying mosquitoes set up, 100 female mosquitoes 
were placed in a 30 cm by 30cm netting cage. The cage was placed in the middle 
of the chamber. A pulley was operated outside the tunnel to release mosquitoes to 
fly freely inside the tunnel. For both assays, mosquitoes were left in the tunnel for 
two hours after which caged mosquitoes were removed and free flying mosquitoes 
were recaptured using mouth aspirators. Knocked down and dead mosquitoes 
were collected from the floor. All mosquitoes were kept in the testing room whose 
temperature was maintained between 28ºC – 29ºC and 70 - 80% relative humidity. 
Live mosquitoes were placed into paper cups. Two paper cups were allocated to 
each blood feeding time regime. The time regimes were 1 hour, 12 hours, 18 
hours, and 24 hours after mosquitoes had been exposed to burning coils or the 
control. Mosquitoes were blood fed at the allocated time by placing an arm above 
the cup for 15 minutes and the number of fed and unfed mosquitoes was recorded. 
Pieces of cotton wool soaked in 10% glucose solution were placed on paper cups 
to maintain mosquitoes in between blood feeding. The glucose pads were 
removed six hours prior to blood feeding.  
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5.3.6. Protection of participants and ethical approval 
 
The volunteers were recruited on a voluntary basis through written informed 
consent. The risks and benefits of the study were clearly explained, and they were 
free to leave at any time during the study. Volunteers were provided with clothing 
that protected them from the cold temperature at night and were advised to dress 
in shorts that reached the knees with covered shoes to avoid bites on the feet. 
They were required not to smoke, take alcohol or use scented soaps and 
deodorants six hours prior to experiments. The participants were screened for 
malaria at the beginning of the study and those found with malaria were given 
Artemisinin Combination Therapy antimalarial drugs and referred to the nearest 
health centre. Those fit to participate in the study were tested for malaria every 
two weeks. Adverse events such as respiratory symptoms were monitored. The 
participants were also compensated for their time and effort. The ethical review 
boards of Ifakara Health Institute IHI/IRB/No A-019-2007, the National Malaria 
Research Institute Tanzania (NIMR/HQ/R.8a/Vol.1X/710) and the London 
School of Hygiene and Tropical Medicine (LSHTM ERB 5552) approved the 
study. 
5.3.7. Statistical analysis  
 
Data was analyzed using the R statistical software version 2.15.0 [30] with 
significance level of 0.05 for rejecting the null hypothesis. All generalized linear 
mixed models (GLMMs) were conducted using the lme4 package [31]. 
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Experiment 1: Orientation of mosquitoes in the presence of coils 
and humans 
Activation of mosquitoes to the stimulus 
It was assumed that the distribution of mosquitoes in the taxis boxes is a result of 
movement in response to stimuli. We set the proportion of mosquitoes that were 
activated by the stimuli equal to the proportion of mosquitoes that left the middle 
chamber. This was determined by dividing the total number of mosquitoes in the 
away and towards chamber by the total number of mosquitoes in the taxis boxes 
including those in the middle chamber. Generalized mixed effects models with 
binomial error structure and logit link function were used to analyze the behaviour 
of mosquitoes in taxis boxes. The dependent variable was the proportion of 
activated mosquitoes. Independent variables included treatment and taxis box 
code as fixed factors. The taxis boxes were considered as a fixed effect because 
only two boxes were used. Day was a random factor.  
 
Attraction of mosquitoes to the stimuli 
 
Mosquitoes that were collected from the chamber towards the stimuli were 
considered to be attracted to the stimulus. Therefore, the proportion of attracted 
mosquitoes was determined by dividing the number of mosquitoes found in the 
chamber towards the stimuli by the total number of mosquitoes in the taxis box. 
Attraction of mosquitoes was analyzed using a GLMM with binomial error 
structure and logit link function. The dependent variable was the proportion of 
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attracted mosquitoes. The independent variables were treatment and taxis box 
code as fixed factors and day as a random factor.  
 
Repellency of mosquitoes by the stimuli 
 
Mosquitoes found in the chamber away from the stimuli were considered to be 
repelled. This was determined by dividing the number of mosquitoes in the away 
chamber by total number of mosquitoes in the taxis boxes. Mosquitoes repelled 
were analyzed using a GLMM with binomial error structure and logit link 
function. The dependent variable was the proportion of repelled mosquitoes. The 
independent variables were treatment and taxis box code as fixed factors and day 
as a random factor. 
 
Experiment 2: Protective distance of coils against outdoor biting 
mosquitoes 
 
Data from the point source and bubble experiments were analyzed separately. 
GLMMs were used to determine the proportion of biting mosquitoes at different 
distances with reference to the control. The dependent variable was the proportion 
of blood fed mosquitoes while the independent variables included treatment 
(control and coil), distance and their interaction, which were fixed categorical 
variables. The day of experiment was included as a random variable. The models 
were fitted with a binomial error and a logit link function.  
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Experiment 3: Resumption to blood feeding of mosquitoes after 
exposure to coils 
 
The data from the Peet Grady, caged and free flying experiments were analyzed 
separately. GLMMs were fitted with a binomial error and a logit link function. 
The dependent variable was the proportion of blood fed mosquitoes. Treatment, 
time regime at which mosquitoes were offered blood and their interaction were set 
as fixed categorical variables and day of experiment as a random variable.  
5.4. Results 
5.4.1. Experiment 1: Orientation of mosquitoes in the presence of 
coils and humans 
Activation of mosquitoes 
The proportion of activated mosquitoes increased with increasing Transfluthrin 
dose (Table 5.1). About 82% of the mosquitoes left the middle chamber when 
0.045% coils were placed next to the human. The activation of mosquitoes by all 
the three doses of Transfluthrin was significantly higher compared to the 
proportion of mosquitoes activated where there was a human alone (Table 5.2). 
The proportion of activated mosquitoes was lowest (42% – 49%) when there was 
no Transfluthrin.  
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Table 5.1: Dose response of mosquitoes to Transfluthrin coils with a human using taxis boxes 
Treatment Total 
a
 Activated 
b
 % Activated 
c 
95%CI Attracted 
d
 %Attracted 
e 
95%CI Repelled 
f 
% Repelled
 g 
95%CI 
No stimulus 189 90 48 [0.40 – 0.55] 71 38 [0.30 – 0.45] 19 10 [0.06 – 0.15] 
Human 169 71 42 [0.35 – 0.50] 55 33 [0.26 – 0.40] 16 9 [0.06 – 0.15] 
Human + blank 189 93 49 [0.42 – 0.57] 73 39 [0.32 – 0.46] 20 11 [0.07 – 0.16] 
Human + 0.015% 178 116 65 [0.58 – 0.72] 103 58 [0.50 – 0.65] 13 7 [0.04 – 0.12] 
Human + 0.030% 178 121 68 [0.61 – 0.75] 90 51 [0.43 – 0.58] 31 17 [0.12 – 0.23] 
Human + 0.045% 185 151 82 [0.75 – 0.87] 128 69 [0.62 – 0.76] 23 12 [0.08 – 0.18] 
 
a – total number of mosquitoes recovered from all chambers of the taxis boxes; b – sum of mosquitoes in the towards and away chamber; c – percentage 
proportion of mosquitoes in the towards and away chamber divided by total mosquitoes in the taxis box; 
d
 – number of mosquitoes in the towards chamber; e – 
percentage proportion of mosquitoes in the towards chamber divided by total mosquitoes in the taxis box; 
f – number of mosquitoes in the away chamber; g – 
percentage proportion of mosquitoes in the away chamber divided by total number of mosquitoes in the taxis box, CI – Confidence intervals. 
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Table 5.2: The proportion of activated mosquitoes in taxis boxes placed 1 meter away from different doses of mosquito coils and a 
human.  
Treatment Odds ratio 95% CI Proportion 
activated 
a 
95% CI 
 
z Value p Value 
Human 1.00 [0.57 – 2.18] 0.42 [0.30 – 0.54] - - 
Human + blank 1.34 [0.87 – 3.27] 0.49 [0.32 – 0.66] 0.824 0.410 
Human + 0.015% 2.58 [1.62 – 6.66] 0.67 [0.49 – 0.80] 2.845 0.004 
Human + 0.030% 2.93 [1.90 – 7.30] 0.68 [0.51 – 0.81] 3.034 0.002 
Human + 0.045% 6.13 [3.95 – 15.92] 0.82 [0.69 – 0.91] 4.988 0.001 
No stimulus 
b 1.25 [0.80 – 3.13] 0.48 [0.31 – 0.65] 0.735 0.462 
 
a 
- Model estimated mean proportions of activated mosquitoes; CI – Confidence intervals; b – There was no human or coil, representing movement of mosquitoes 
in response to nature. The proportion of activated mosquitoes was calculated by dividing the number of mosquitoes collected from the chambers of taxis boxes 
facing towards and away the treatment by mosquitoes collected from all chambers of the taxis box.  
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Attraction and repellency of mosquitoes  
Approximately half of the mosquitoes were attracted when 0.015% and 0.03% 
Transfluthrin coils were used (Table 5.1 and Table 5.3). The highest dose of 
Transfluthrin (0.045%) induced a significantly higher proportion of attracted 
mosquitoes (69%) relative to the human alone (33%) (z = 5.160; p= 0.001) (Table 
5.3). 
The proportion of repelled mosquitoes ranged between 7% and 17% (Table 5.1) 
and was not significantly different from the human alone (human + blank coil: z = 
0.296; p = 0.767, human + 0.0015%: z = -0.656; p = 0.572, human + 0.03%: z = 
1.895; p = 0.058, human + 0.045%; z = 0.789; p = 0.430, human alone: z = 0.185; p 
= 0.853). This indicates that the taxis boxes did not detect movement of mosquitoes 
away from coils and humans.  
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Table 5.3: The proportion of attracted mosquitoes in taxis boxes placed 1 meter away from different doses of mosquito coils and a 
human.  
Treatment Odd ratios 95% CI Proportion 
attracted 
a 
95% CI 
 
z Value p Value 
Human 1.00 [0.70 – 1.74] 0.32 [0.23 – 0.42] - - 
Human + blank 1.30 [0.97 – 2.43] 0.38 [0.25 – 0.53] 0.917 0.359 
Human + 0.015% 2.85 [2.08 – 5.41] 0.58 [0.43 – 0.72] 3.639 0.001 
Human + 0.030% 2.12 [1.57 – 3.95] 0.50 [0.36 – 0.65] 2.531 0.011 
Human + 0.045% 4.65 [3.43 – 8.81] 0.69 [0.55 – 0.81] 5.160 0.001 
No stimulus 
b 1.25 [0.92 – 2.34] 0.38 [0.25 – 0.52] 0.822 0.411 
a 
- Model estimated proportions of attracted mosquitoes; CI – Confidence intervals; b – There was no human or coil, representing movement of mosquitoes in 
nature. The proportion of attracted mosquitoes was calculated by dividing the number of mosquitoes collected from the chambers of taxis boxes facing towards 
the treatment by mosquitoes collected from all chambers of the taxis box. 
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5.4.2. Experiment 2: Protective distance of coils against outdoor 
biting mosquitoes 
Coils placed on one side of the human: ‘point source’.  
Smoke from Transfluthrin coils prevented mosquitoes from effectively locating 
hosts with fewer mosquitoes landing in the presence of coils. Coils were most 
effective when placed 0.3m away from volunteers. Approximately 20% (95% CI 
[0.12; 0.31]) of the mosquitoes fed when the coil was 0.3m away compared to 
65% (95% CI (0.51; 0.76) when there was no coil (z = 12.206; p = <0.001) (Table 
4). The proportion of feeding mosquitoes also decreased when coils were placed 
between 1m and 20m (Table 5.4). There was no significant reduction of blood 
feeding mosquitoes when coils were placed 30m away (Table 5.4). 
 
Coils placed on the left and right side of the human: ‘bubble’  
Coils were most effective when they were placed 0.3m away from the human 
(Table 5.5). Approximately 4% (95% CI [0.01; 0.13]) of the mosquitoes fed when 
the coil was 0.3m away compared 86% (95% CI [0.66; 0.95] when there was no 
coil (z = -5.546; p <0.001) (Table 5.5). The odds of mosquitoes landing on a 
human next to a coil increased slightly as the distance between the coils and the 
human increased (Table 5.5). There was no significant difference in the proportion 
of landing mosquitoes when coils were placed 30m away (Table 5.5). 
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Table 5.4: The proportion of mosquitoes that blood feed on humans in the 
presence of 0.03% Transfluthrin coils placed as a point source at different 
distances 
Treatment Distance Biting 
/Total  
Mean 
proportion 
a 
95% CI z Value p Value Odds ratio 
Control 
0.3m 
257/400 0.65 [0.51 - 0.76] - - 1.00 
Treatment 80/400 0.20 [0.12 - 0.31] -12.206 <0.001 0.14 
Control 
1m 
167/400 0.41 [0.28 - 0.55] - - 1.00 
Treatment 88/400 0.21 [0.12 - 0.31] -6.153 <0.001 0.39 
Control 
5m 
177/400 0.44 [0.31 - 0.58] - - 1.00 
Treatment 114/400 0.28 [0.18 - 0.41] -4.709 <0.001 0.50 
Control 
10m 
394/400 0.90 [0.83 - 0.94] - - 1.00 
Treatment 274/440 0.63 [0.49 - 0.75] -9.017 <0.001 0.19 
Control 
15m 
344/440 0.79 [0.67 - 0.87] - - 1.00 
Treatment 252/440 0.57 [0.43 - 0.71] -6.595 <0.001 0.37 
Control 
20m 
347/440 0.80 [0.69 - 0.88] - - 1.00 
Treatment 273/400 0.63 [0.48 - 0.75] 5.535 <0.001 0.44 
Control 
30m 
147/400 0.33 [0.22 - 0.47] - - 1.00 
Treatment 156/400 0.36 [0.24 - 0.50] 0.713 0.476 1.10 
Legend: 
a – Model estimated mean proportions, CI Confidence intervals 
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Table 5.5: The proportion of mosquitoes that blood feed on humans in the 
presence of 0.03% Transfluthrin coils creating a „bubble‟ 
Treatment Distance Biting 
/Total  
Mean 
proportion 
a 
95% CI z Value p Value Odds ratio 
Control 
0.3m 
80/100 0.86 [0.66 - 0.95] - - 1.00 
Treatment 4/100 0.04 [0.01 - 0.13] -5.546 <0.001 0.01 
Control 
1m 
259/600 0.43 [0.36 - 0.51] - - 1.00 
Treatment 12/600 0.02 [0.01 - 0.04] -11.950 <0.001 0.02 
Control 
5m 
331/600 0.41 [0.35 - 0.48] - - 1.00 
Treatment 5/800 0.01 [0.00 - 0.01] -10.580 <0.001 0.009 
Control 
10m 
216/600 0.35 [0.29 - 0.43] - - 1.00 
Treatment 8/600 0.01 [0.01 - 0.03] -10.210 <0.001 0.02 
Control 
15m 
83/100 0.84 [0.63 - 0.94] - - 1.00 
Treatment 39/100 0.37 [0.17 - 0.63] -2.808 0.005 0.13 
Control 
20m 
70/100 0.71 [0.46 - 0.87] - - 1.00 
Treatment 37/100 0.37 [0.17 - 0.62] -1.891 0.060 0.25 
Control 
30m 
90/100 0.92 [0.77 - 0.97] - - 1.00 
Treatment 78/100 0.79 [0.56 - 0.92] -1.353 0.176 0.39 
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5.4.3. Experiment 3: Resumption to blood feeding of mosquitoes 
after exposure to coils 
 
Experiments in the Peet Grady chamber 
 
The proportion of fed mosquitoes was lowest at 12% (95% CI [0.06; 0.22]), (z = -
5.301; p <0.001) 15 minutes after exposure to 0.03% Transfluthrin coils. The 
presence of smoke without the insecticide (blank coil) significantly inhibited 
feeding after 15 minutes (Table 5.6) but the proportion of mosquitoes inhibited 
from feeding was lower than when Transfluthrin coils were used. The effect of 
Transfluthrin coils demonstrated a dose response relationship although increasing 
the dose beyond 0.03% had little effect (Figure 5.4).  
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Figure 5.4: The effect of Transfluthrin coils on blood feeding behaviour of mosquitoes. 
Mosquitoes were exposed to different doses of Transfluthrin coils inside a Peet Grady chamber and later offered blood 
meals at different time intervals. The proportion of blood fed mosquitoes was significantly lower than the control in all 
treatments after 25 minutes (
a
) and 1 hour (
a
). At 12 hours only 0.03% Transfluthrin coils significantly (
b
) reduced feeding 
compared to the control while after 24 hours there was no significant difference between all treatments and controls (
c
).  
 
Exposure to burning coils also influenced subsequent blood feeding. The 
proportion of mosquitoes that took blood up to 12 hours after exposure to 0.03% 
and 0.045% Transfluthrin coils were significantly lower compared to the control 
(Table 5.6). In addition, the propensity of mosquitoes to feed increased gradually 
with time irrespective of whether they were exposed to Transfluthrin coils or not. 
Results indicate that at some point between 12 and 24 hours, there was no 
difference in the proportion of fed mosquitoes between the control and coils 
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(Table 5.6), showing that mosquitoes resume normal feeding one day after indoor 
exposure to Transfluthrin coils. 
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Table 5.6: The proportion of mosquitoes that blood fed at different time intervals 
following exposure to different doses of Transfluthrin coils inside a Peet Grady 
chamber 
Treatment Time 
(Hours) 
Fed 
/Total 
Mean 
proportion 
a 
95% CI z Value p Value Odds 
ratio 
Control 
0.25 
61/98 0.63 [0.49 - 0.76] - - 1.00 
Blank 42/100 0.39 [0.27 - 0.53] -2.409 0.174 0.53 
0.015% 23/99 0.25 [0.15 - 0.38] -3.815 0.002 0.18 
0.030% 12/99 0.12 [0.06 - 0.22] -5.301 <0.001 0.08 
0.045% 20/100 0.19 [0.11 - 0.31] -4.393 <0.001 0.08 
Control 
1 
74/100 0.76 [0.62 - 0.85] - - 1.00 
Blank 47/98 0.45 [0.32 - 0.59] -3.115 0.025 0.32 
0.015% 26/98 0.29 [0.18 - 0.42] -4.674 <0.001 0.13 
0.03% 43/100 0.43 [0.29 - 0.54] -3.267 0.015 0.13 
0.045% 39/99 0.39 [0.26 - 0.53] -3.610 0.005 0.23 
Control 
12 
78/98 0.81 [0.69 - 0.89] - - 1.00 
Blank 58/93 0.61 [0.47 - 0.73] -2.254 0.245 0.42 
0.015% 55/100 0.58 [0.45 - 0.71] -2.544 0.126 0.31 
0.030% 41/94 0.43 [0.30 - 0.58] -3.810 0.002 0.20 
0.045% 60/93 0.65 [0.50 - 0.77] -1.842 0.516 0.47 
Control 
24 
71/93 0.78 [0.65 - 0.87] - - 1.00 
Blank 66/93 0.70 [0.57 - 0.81] -0.915 0.992 0.76 
0.015% 69/96 0.75 [0.63 - 0.84] -0.379 1.000 0.79 
0.03% 71/88 0.82 [0.69 - 0.90] 0.443 1.000 1.29 
0.045% 64/85 0.76 [0.62 - 0.86] -0.273 1.000 0.94 
Legend: 
a – Model estimated mean proportions, CI Confidence intervals 
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Experiments in the Semi-Field Tunnel 
 
Two Transfluthrin coils (0.03%) did not influence the feeding behavior of free 
flying mosquitoes exposed outdoors in the netting tunnel. The proportion of 
mosquitoes that fed after exposure to coils was not significantly different from the 
control (z = -0.943; p = 0.346); around 53% (42/76) (95% CI [0.43; 0.67]) blood 
fed after 1 hour after exposure to Transfluthrin compared to 61% (48/80) (95% CI 
[0.48; 0.71]) in the control. More than three quarters of the mosquitoes had fed 
after 12 hours and subsequent time feeding intervals. There was no significant 
difference between the proportion of fed mosquitoes in the control and the 
treatment at subsequent feeding times (12 hours: z = 0.526; p = 0.599, 18 hours: z 
= -0.169; p = 0.866, 24 hours: z = -0.098; p = 0.922).  
There was a slight impact on the feeding behaviour of caged mosquitoes. After 1 
hour, 56% (35/62) (95% CI [0.43; 0.69]) mosquitoes exposed to Transfluthrin fed 
compared to 79% (61/77) (95% CI [0.69; 0.88]) in the control (z = -2.937; p = 
0.003) and after 18 hours 84% (59/70) (95% CI [0.74; 0.92]) mosquitoes had 
blood fed compared to 72% (39/54) (95% CI [0.58; 0.84]) in the treatment (z = -
2.445; p = 0.015). However, more than three quarters of the mosquitoes fed after 
12 hours and 24 hours and this was not significantly different between the control 
and the treatment (12 hours: z = -1.341; p = 0.180, 24 hours: z = -0.006; p = 
0.996). 
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5.5. Discussion 
 
This study highlights challenges in the measurement of mosquito responses to 
different stimuli whilst outdoors. Mosquito activity such as orientation towards 
hosts, oviposition and resting sites are largely influenced by external stimuli such 
as atmospheric carbon dioxide, light sources, humans, animals and wind. In the 
taxis box experiment, mosquitoes moved between chambers even when there was 
no coil or human (no stimuli). This shows that mosquitoes may have been 
responding to external stimuli within the taxis boxes, making it quite difficult to 
discern between mosquito responses to experimental or external stimuli. Despite 
these challenges, taxis boxes have been used to successfully demonstrate 
orientation of malaria mosquitoes towards attractive stimuli outdoors in field 
conditions [7]. In the current study, taxis boxes were used to determine attraction 
and repellency of airborne pyrethroids. 
Here, Transfluthrin coils placed next to a human increased movement of 
mosquitoes within the taxis boxes. A higher proportion of mosquitoes left the 
middle chamber and flew towards the human. The presence of transfluthrin did 
not hinder movement of mosquitoes towards the human, hence they did not inhibit 
attraction. In fact, an increase in the dose of transfluthrin increased activation and 
attraction of mosquitoes. This behaviour has been previously reported in other 
study as excito-repellency [25]. Pyrethroid coils are thought to cause excitation 
and increased activity of mosquitoes. This may explain high activation observed 
in the current study. A low proportion of mosquitoes (7% and 17%) moved away 
from the human even when there was a coil. This indicates that Transfluthrin coils 
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did not induce movement away from the coil. However, there was no difference 
between the proportion of mosquitoes that moved away from the human alone and 
the human and coil. This questions the suitability of taxis boxes to accurately 
measure repellency outdoors where there are a lot of competing stimuli, 
highlighting the need for better methods to test repellency in the field. 
Mosquitoes seen to fly towards humans even in the presence of coils indicated 
that coils did not inhibit attraction to the human. It is possible that coils actually 
work at close range resulting in other responses such as bite prevention [24]. 
Similar observations are reported elsewhere describing the effect of metofluthrin 
emanators and pyrethroid coils [24,32,33]. Catnip and 1-methylpiperazine acts at 
short distances to prevent mosquitoes from landing and biting humans but do not 
prevent attraction to attractive stimuli [34,35]. This study reinforces the fact that 
airborne pyrethroids do not prevent attraction of mosquitoes to their hosts but 
likely interfere with the mosquito feeding process at the last stages after attraction 
to the host and prevent blood feeding. Other studies show that airborne 
pyrethroids exert multiple effects on a range of odorant receptors (ORs) and 
gustatory receptors located on antennae and feeding appendages of mosquitoes. 
They block, inhibit, or induce a number of different responses and scramble the 
host seeking process [22,36,37].  
In this experimental design, mosquitoes were presented with conflicting stimuli: 
attraction to host odours versus the insecticide. A previous study showed that in 
such a case the need to feed can overpower the effect of the insecticide, hence the 
mosquito is still attracted to the host but is prevented from feeding [38]. This is 
 202 
evident with the use of insecticide treated bed nets, where mosquitoes are attracted 
to humans and attempt to feed through treated nets but then become irritated and 
move away without feeding [38]. This information is useful in the development of 
“push – pull” strategies that include compounds thought to chase mosquitoes from 
humans and attract them to odour-baited traps [11,34]. 
Coils used as a “point source” reduced bites by almost half when coils were 
placed 0.3m away from the human and were effective even when the human was 
20m away from coils (Table 5.4). Interestingly the “bubble” was highly effective 
providing approximately 80% protection against bites when coils were 0.3m away 
from the human (Table 5.5). Hence coils were more effective when used as a 
“bubble” rather than the “point source”. This highlights the need to consider 
presentation of the source of the active ingredient as a bubble around humans in 
order to achieve maximum efficacy. These results show the spatial activity and 
efficacy of volatile pyrethroids against mosquito bites. Efficacy of coils outdoors 
indicates that volatile pyrethroids may be an appropriate tool against outdoor 
biting mosquitoes and may be used outdoors in bars, restaurants, backyards or 
verandas especially when multiple sources of repellent are used to ensure 
saturation of the space with active ingredient.  
Previous studies indicate that mosquitoes inhibited by topical repellents from 
blood feeding are diverted to neighbouring people who are not protected [39]. 
This may not be the case with volatile insecticides such as mosquito coils. This 
study shows that coils prevented bites when they were placed as far as 15m away 
(Table 5.4 and 5.5.), thus they provided area wide protection and hence are likely 
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extend protection to the non users at a particular distance from the source and 
reduce risk of diversion of mosquitoes. A study testing this hypothesis is currently 
being analyzed (Maia pers. comm.).  
In addition to the spatial mode of action of coils, this study also shows that they 
offer temporal protection. In a closed laboratory setting (Peet Grady chamber), 
mosquitoes did not resume normal blood feed behaviour up to 12 hours after they 
had been exposed to coils. We suggest that in addition to a spatial bubble, 
prolonged feeding inhibition may also protect non-users of coils to a certain 
extent, which would also reduce the risk of diversion. Similar results were 
reported in a study where the time of activation and flight of Cx. quinquefasciatus, 
An. albimanus and Stegomyia aegypti mosquitoes was reduced significantly 24 
hours after they had been exposed to sublethal doses of Deltamethrin and 
Permethrin [40]. In the current study, mosquitoes resumed normal feeding after 24 
hours. If mosquitoes miss one feeding opportunity due to exposure to coils, this is 
likely to prolong the gonotrophic cycle and may change the vectorial capacity of 
the mosquitoes [41]. 
However, when free-flying mosquitoes were exposed to coils under outdoor 
conditions in the SFT, there was no effect. This may be attributed to limited 
ventilation in the Peet Grady chambers resulting in reduced airflow accompanied 
by increased insecticide particles per area. This enabled mosquitoes to contact 
insecticides more easily, resulting in the large effect on blood feeding inhibition in 
mosquitoes exposed in the chambers. The effect of coils in the SFT was less 
pronounced probably due to the large surface area of the facility as well as natural 
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airflow within the tunnel. It is hypothesize that sparse distribution of insecticide 
particles within the tunnel due to high airflow resulted in low concentration of 
insecticide particles. Therefore, mosquitoes did not contact sufficient insecticides 
in the SFT. It should be noted that coils used under outdoor conditions contained 
the standard dose of Transfluthrin (0.03%) meant for indoor use. It is therefore 
necessary to explore the effect of increasing the dose for products that are 
intended for outdoor use, in particular by advising users to put several coils 
around the area that they are occupying to create the “bubble effect”. In addition, 
there is need to determine the No observed effect level (NOEL) of airborne 
chemicals whilst in use outdoors.  
The human biting rate of mosquitoes is one of the most important parameters that 
influences malaria transmission [3]. Hence, chemicals that interfere with feeding 
behaviour of mosquitoes or prevent feeding altogether are likely to reduce 
transmission. This study emphasizes the importance of reduced blood feeding as 
the main indicator for efficacy of airborne pyrethroids used against outdoor biting 
mosquitoes.  
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5.6. Conclusion 
 
This study indicates that coils do not prevent attraction to the human, but mainly 
prevent blood feeding. It is possible that pyrethroid based coils, specifically 
Transfluthrin, target gustatory receptors involved in feeding rather than olfactory 
receptors. It is essential to conduct further studies to determine target sites of 
pyrethroid - based airborne particles in mosquitoes. This study provides critical 
information necessary for the development of target product profiles of spatial 
repellent products that can be used to complement existing mainstream malaria 
vector control tools. 
Increased reports of outdoor biting and resting mosquitoes in endemic areas 
[42,43] indicate that mainstream malaria control tools that target indoor biting and 
resting mosquitoes (LLINs and IRS) may not be sufficient to eliminate malaria 
especially when transmission occurs outdoors [44]. This study demonstrates the 
potential benefit of airborne pyrethroids for use against outdoor biting mosquitoes 
by reducing the outdoor man-biting rate, an important parameter of malaria 
transmission. It is worthwhile to conduct large scale clinical studies with 
entomological correlates of mosquito human-landing also observed to determine 
whether outdoor use of airborne insecticides in addition to the use of LLINs 
translates into additional protection from malaria, therefore complementing 
existing tools used against indoor biting and resting mosquitoes. 
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CHAPTER SIX 
6     Spatial repellency of transfluthrin-treated hessian 
strips against laboratory-reared Anopheles arabiensis 
mosquitoes in a semi-field tunnel cage 
 
6.1. Abstract 
Background 
Vapour phase spatial repellents deter mosquitoes from attacking one or more 
humans in a protected space. Simulation models indicate that high coverage of 
spatial repellents can enhance the impact of Long Lasting Insecticidal Nets 
(LLINs) and indoor residual spraying (IRS) where mosquito vectors commonly 
bite humans outdoors. Here we report a preliminary evaluation of an effective, 
user-friendly prototype product for delivering spatial repellents to protect against 
malaria vector mosquitoes. 
Findings 
Protective efficacy of a 4.0 × 0.3 m strip of hessian sacking treated with 10 ml of 
transfluthrin was evaluated in a 60 m × 2 m ×2.5 m netting tunnel with malaria-
free insectary-reared Anopheles arabiensis Patton mosquitoes. Personal 
protection, in terms of proportional reduction of exposure to bites, was measured 
by comparing human landing catches of volunteers with treated and untreated 
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strips. A freshly treated hessian strip reduced mosquito attack rate on human 
volunteers by > 99% and consistently conferred > 90% protective efficacy for a 
period of 6 months. Over the entire study period, only 22 out of 1400 released 
mosquitoes bit volunteers using the treated sacking strip while 894 out of 1400 
mosquitoes released into cages containing volunteers using an untreated strip fed 
upon them. 
Conclusion 
Locally available natural fibres may be promising absorbent substrates for 
delivering spatial repellents, such as transfluthrin, to protect against mosquitoes in 
tropical settings. However, these observations relate to a single prototype 
specimen of this particular device, therefore, much more detailed, well replicated 
studies are essential to establish long-term efficacy, effectiveness, practicability 
and affordability. 
Keywords: Outdoor mosquito control; Spatial repellency; Hessian strips 
 
6.2. Findings 
 
Long lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) have 
successfully reduced malaria in many endemic regions of Africa [1-4]. These 
measures have successfully reduced malaria vectors, which predominantly feed 
upon humans (anthropophagic) and rest (endophilic) and feed (endophagic) 
indoors [5-11]. Despite impressive successes, these tools are less effective against 
exophagic, and exophilic mosquito vectors [12, 13]. It is therefore critical to find 
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new tools that would protect people whilst outdoors. 
Recently developed mathematical models suggest that highly efficacious spatial 
repellents are likely to be effective when used outdoors in areas where 
transmission commonly occurs outside of houses [14] or is mediated by 
mosquitoes which primarily feed upon animals (Kiware et al, Unpublished). 
Examples of spatial repellent products include mosquito coils and vaporizer mats 
[15]. Kerosene lamps containing transfluthrin and vegetable oil is a cheap and 
effective means of dispensing repellents, use of which is well matched to the 
times and locations of peak human activity [16]. These delivery formats require 
frequent replacement of the active ingredient and external sources of energy such 
as combustion or electricity. 
Passive methods of delivering spatial repellents without external energy input are 
highly desirable for impoverished populations in developing countries. Existing 
products typically consist of paper or plastic strips impregnated with fluorinated 
pyrethroids, such as metofluthrin or transfluthrin, and have exhibited high efficacy 
of protection against mosquito bites in some parts of Southeast Asia [17, 18]. 
These pyrethroids are less polar and highly volatile than conventional pyrethroids 
and therefore evaporate at room temperature without the need for any external 
source of energy [19]. Such strips can produce vapour for 18 weeks, during which 
time it repels mosquitoes or prevents them from feeding on humans [18, 19]. 
Interestingly, the level of repellency achieved by treated paper strips has been 
shown to be more short lived than plastic strips treated in exactly the same 
manner, demonstrating how different substrates can affect the duration of efficacy 
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exhibited by a given active ingredient [19]. 
Natural fibres are readily available and affordable in all tropical countries. Initial 
assessments to compare the physical properties of hessian sacking materials, 
commonly used for storing and transporting goods in Tanzania, indicated that it 
had far greater absorbent capacity than commonly available alternatives. The 
hessian fabric used in this study is made from fine sisal fibres woven together. 
The fabric is imported from India and is used to make cereal storage bags. 
We evaluated the spatial repellency of a hessian sacking strip treated with 
transfluthrin, in terms of its ability to prevent attack by vectors of malaria in 
Africa when used outdoors. 
Hessian strips 4 m long and 30 cm wide were impregnated with 10 ml technical 
grade transfluthrin (SC Johnson Home Hygiene Products). A volume of 10 ml of 
transfluthrin was mixed with 90 ml Axion
® 
liquid detergent (Orbit Chemical 
Industries Ltd, Nairobi and Colgate-Palmolive East Africa Ltd) to enable its 
solubility in 400 ml of water. The strips were dipped in the mixture in a plastic 
basin and suspended indoors at ambient temperature where they were left 
overnight to dry. A negative control was treated exactly the same way using the 
mixture of detergent and water only, without any transfluthrin active ingredient. 
Experiments were conducted in a screened tunnel measuring 60 m long, 2 m wide 
and 2.5 m high at the Ifakara Health Institute (IHI) facility in Ifakara, Morogoro, 
United Republic of Tanzania. The tunnel was divided into three equal-sized 
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experimental units (A, B and C) separated by plastic sheets. Each unit was 20 m 
long (Moore et al. unpublished). 
We conducted tests with Anopheles arabiensis mosquitoes previously collected 
from Sakamaganga village, Kilombero valley, South East of the United republic 
of Tanzania. The mosquitoes were reared in an insectary built within the IHI 
semi-field system [20]. The temperature in the insectary was between 28 - 29°C 
and 70-80% relative humidity. Mosquito larvae were fed on tetramin fish food and 
adults were given 10% glucose solution and blood meals. Nulliparous female, 
insectary-reared, 2 to 6 day old mosquitoes that had never had a blood meal were 
used. 
Personal protection in terms of the proportion of reduction in mosquitoes 
attacking volunteers was measured by comparing the number of mosquitoes that 
landed upon a volunteer with a treated sacking strip and the one who had an 
untreated strip. Experiments were conducted in units A and C while unit B was 
used as a buffer zone with no experiments between these two experimental units 
to minimize the risk that the transfluthrin-treated sacking in one unit would affect 
mosquitoes in the unit containing the negative control. 
Each strip was suspended 1 m above the ground in the middle of each unit on a 
square frame of 4 wooden poles 1 meter apart, thus creating approximately 1 m
2 
sitting space (Figure 1). Treated and untreated strips were randomly assigned to 
the units on the first night of every round of 4 nights of experimentation, they 
were exchanged between units on the third day, and remained in that arrangement 
for the fourth day. A cage containing 25 mosquitoes was placed at each of the two 
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opposite ends of each unit so that, at the start of the experiment, a total of 50 
mosquitoes were released in each unit. Mosquitoes were released at 1900 hours by 
pulling strings attached to mosquito netting cages placed on each side of the 
volunteer. Mosquitoes were recaptured by human landing catches simultaneously 
in both units for 2 hours each night. The two male participants involved in the 
study were randomly assigned to the experimental units on the first night using 
the lottery method. They exchanged positions on the second night. On the third 
night volunteers were randomly assigned to the units again and exchanged 
positions on the fourth night. Each round of rotation of volunteers and strips 
between experimental units was completed in 4 nights. One round of 
experimentation was repeated once every month to check for residual activity of 
transfluthrin on the hessian strips. The strips were kept in separate plastic basins 
and stored uncovered at ambient room temperature indoors. 
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Figure 6.1: Transfluthrin hessian strip. The hessian strip is made from fine sisal 
fibre woven together to make sacking fabric. The strip is 4 × 0.3 m long. It is treated 
with transfluthrin. The strip is suspended on 4 wooden poles making approximately 
1 m
2 
area surrounding the human participant conducting mosquito catches. 
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This study was approved by The National Institute of Medical Research 
(NIMR/HQ/R.8 C/VOL.1/100). Participants signed a written informed consent 
form before commencing the study. 
The freshly treated sisal strip provided > 99% protective efficacy against 
mosquitoes: In the first round of assays only 1 mosquito out of 200 that were 
released was recovered by the volunteer in the experimental unit with a treated 
strip, while 148 out of 200 released mosquitoes were recovered in the unit with an 
untreated control. The treated strip continued to consistently confer > 99% 
protective efficacy for a period of 6 months and all assay rounds, except one 
during the fourth month, indicated approximately 91% protective efficacy. Over 
the entire study period only 22 out of 1400 mosquitoes released into the 
experimental unit with the treated sacking strip were recovered by the protected 
human catcher. In stark contrast, 894 out of 1400 released mosquitoes bit the 
volunteers using an untreated sacking strip (Figure 6. 2). 
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Figure 6.2: The number of mosquitoes recovered by human landing catches with 
transfluthrin and untreated strips. A graph comparing the number of mosquitoes 
recovered by human landing catches during rounds of experiments with transfluthrin 
treated and untreated strips during six months. The graph indicates a reduction in the 
number of bites occurring on a human participant who had a treated strip compared to 
one with an untreated strip. Each data point represents a single release of mosquitoes in a 
single experimental unit with either a treated or untreated strip of hessian sacking. 
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While a generalized linear mixed model with a Poisson distribution indicated a clear 
effect of the treatment status of the hessian strip (P < 0.001), there was no apparent 
difference between the participants in terms of their attractiveness to mosquitoes (P = 
0.208), but the experimental units were significantly different (P = 0.027). The latter 
effect could be explained by external factors such as light from the nearby security lights 
shining through one of the units. 
Such a prototype conferring such high apparent protective efficacy against outdoor-biting 
Anopheles mosquitoes may well be useful for preventing malaria transmission that 
mostly occurs outdoors. Our results indicate that hessian sacking substrates may be an 
efficient means for delivering transfluthrin vapour into an occupied space to protect 
humans against mosquito bites. Hessian and other natural fibres can be affordably 
produced in tropical countries, even locally within afflicted communities themselves, thus 
reducing potential costs of transportation and importation because only the active 
ingredient needs to be manufactured in bulk by specialist chemical manufacturers. 
Hessian fibres are a versatile fabric that can be readily woven into a variety of practical 
formats such as treated wall hangings, door mats or curtains. It might even be possible to 
weave it into items that can be worn on the body, such as wrist bands, head bands or 
anklets, so long as the absorbent fibre can be packaged within porous, untreated coating 
materials that preclude human dermal exposure to the active ingredient. 
These preliminary results demonstrated efficacy of transfluthrin strips against mosquitoes 
under the near-natural conditions of an outdoor semi-field system. However, these 
observations relate to a single, un-replicated prototype specimen of this particular device 
[21] so more intensive, well replicated studies in both semi-field systems and full field 
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settings will be required in order to establish these results and characterize the properties 
of such devices. In particular, it would be important to conduct experiments in which the 
control and treatment are exposed to mosquitoes alongside each other at a range of 
proximities within a single semi-field chamber or in full field settings. 
The long-term efficacy of the prototype will need to be evaluated at frequent time 
intervals after formulation and initiation of routine, representative use in target 
communities. Also, the relationship between protective efficacy and distance from the 
product will need to be assessed. In particular, the possibility that vapour-phase repellents 
which prevent mosquitoes from feeding on humans without killing them might pose a 
risk to nearby non-users by diverting mosquitoes to them [22, 23], as is known to occur 
when using some topical repellents [24] will need to be investigated. 
 
When considering use of spatial repellents, it is necessary to take into account how these 
can be used with existing tools such as LLINs and IRS in order to complement, rather 
than reduce, their efficacy [14, 22, 23, 25]. Recently developed models indicate that 
insecticides which deter mosquitoes from entering houses may undermine the 
community-level impact upon malaria transmission by the contact toxicity of less volatile 
conventional pyrethroids applied in the form of LLINs and IRS [14, 25]. This is because 
mosquitoes deterred by sub-lethal doses of an insecticide are prevented from making 
contact with toxic doses on treated surfaces and are therefore not killed directly. For 
settings where malaria transmission is dominated, or has historically been dominated, by 
vectors that typically feed indoors upon humans, it will therefore be essential to assess 
the mode of action, and community-level impact upon transmission, of products relying 
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upon vapour phase active ingredients when applied both indoors and outdoors to ensure 
that they complement rather than attenuate the impact of existing front-line LLIN and 
IRS technologies. 
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CHAPTER SEVEN 
7     General discussion 
 
7.1. The mode of action of spatial repellents against mosquitoes 
 
Rapid toxicity of neuro-toxic insecticides is considered the main outcome indicator of 
efficacy of mosquito control tools such as LLINs and IRS, while sub-lethal effects of 
insecticides that include spatial repellency, irritancy and reduced human biting rate are 
considered secondary attributes, and perhaps negative effects of insecticides because they 
do not result in a directly measurable death of that insect. Several studies have shown that 
indoor spraying with DDT led to the reduction of malaria transmission through such 
sublethal effects [1]. More importantly, DDT functions first as a spatial repellent and then 
a feeding inhibitor [2] while toxicity comes into action slowly and later after repellency 
[3, 4]. 
Despite several studies conducted on the topic of spatial repellency, the mode of action 
and the mechanisms driving the range of behaviours exhibited by mosquitoes are still 
under debate by the vector-control community. A repellent was described as a chemical 
that caused the responder to move away from the source of the chemical [5]. More 
recently the terms irritancy and spatial repellency have been used to distinguish between 
directed movement away after physical contact with the stimulus and oriented movement 
away after contact with odour or airborne stimulus, respectively [4]. Miller et al suggest 
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that use of these terms may not be appropriate especially where directional movement is 
not proven [6]. They suggest reverting to Dethier et al where repellency is described with 
regards to the mechanisms involved. Repellency is described by two terms i.e. taxis – 
immediate directional avoiding reaction, and orthokinesis – irritating effect, causing 
insects to increase activity resulting in decreased number on the surface [5, 6]. The term 
excito-repellency has also been used by some authors to refer to the hyper - locomotor 
activity observed when some insects contact insecticides [7, 8]. In this thesis spatial 
repellency generally refers to a range of behaviours exhibited by insects after exposure to 
airborne chemicals and resulting in reduced human-vector contact. It was hypothesized 
that airborne insecticides 1) induce mosquitoes to move away from them, 2) interfere 
with host detection and blood feeding behaviour of mosquitoes and also 3) prevent 
mosquitoes from flying [9]; and the overall goal of this thesis was to determine the range 
of mosquito behaviours exhibited by airborne pyrethroids that minimize human - vector 
contact and consequently reduce malaria transmission by the major Afro-Tropical vectors 
An. gambiae s.s. and An. arabiensis. 
 
7.1.1. Irritancy and excito-repellency 
 
One notable feature of this study was that the rate at which mosquitoes left huts was 
measured throughout the night (excito-repellency and irritancy) [10]. More mosquitoes 
left huts earlier than normal where both Transfluthrin ad Metofluthrin coils and DDT 
were used. In the semi-field studies reported in Chapter 4, almost half of the mosquitoes 
(56%, 55% and 48%) prematurely left huts that had Transfluthrin coils, Metofluthrin 
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coils, and DDT, respectively [10]. High irritancy (82% and 87%) by pyrethrum coils on 
An. gambiae s.l. mosquitoes has been reported [11] while another study indicated 14% 
irritancy of Aedes aegypti by DDT [4]. There are several possible explanations as to why 
mosquitoes rapidly leave houses upon contact with DDT and airborne pyrethroids. The 
first one is that mosquitoes contact airborne insecticides and they are irritated or excited 
(orthokinsesis) [5] hence they move around faster than usual [2, 12]. This mechanism 
may be as a result of the action of DDT and pyrethroids on the voltage-gated sodium 
channel of insect nerve cells resulting in restlessness, un-coordination and hyperactivity 
of the insects [13]. It is not clear how this rapid locomotion of mosquitoes causes them to 
leave houses. Kennedy suggests that mosquitoes are inclined to move towards light and 
that is why they leave through open spaces in a house [14]. Several experimental hut 
studies concur with this explanation as demonstrated by exit of mosquitoes through eave 
gaps [15, 16]. The second explanation may be that low concentrations of insecticides 
induce loss of response to host cues [17] and prevents mosquitoes from feeding and 
therefore mosquitoes leave huts in search of other blood sources. Insecticides that cause 
mosquitoes to leave treated houses before or after they have fed are likely to attenuate 
efficacy of interventions such as IRS that rely on resting behaviour of mosquitoes. 
Irritancy and excito-repellency are likely to prevent mosquitoes from contacting lethal 
insecticides and thus reduce mortality of mosquitoes. Despite this widespread notion, it is 
also believed that irritancy by DDT led to tremendous success in malaria control [3, 18]. 
This may be explained by reduced human biting rate and thus reduced malaria 
transmission. There is need to conduct further studies to determine whether spatial 
irritancy by spatial repellents (SR) is likely to increase transmission. 
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7.1.2. Directional taxis and feeding inhibition 
 
In the semi-field experiments in Chapter 5, airborne pyrethroids produced by burning 
coils did not induce taxis (directional movement away from coils) of mosquitoes. 
Interestingly, the taxis boxes results were congruent with experimental hut results [10] 
and indicated activation of mosquitoes and therefore excito-repellency as the main mode 
of action of the coils. Increasing the dose of Transfluthrin to 0.045% increased the 
activity of mosquitoes, implying a dose response relationship. More mosquitoes were 
activated to move towards the human especially in the presence of coils. This shows that 
airborne pyrethroids do not hinder attraction of mosquitoes to humans at short distance 
away from them.  
These results are congruent with other studies of airborne pyrethroids. For example in the 
presence of metofluthrin dispensed by emanators, mosquitoes detected host odours and 
flew upwind towards the host but they were prevented from biting [19]. Further studies 
with pyrethroid coils also indicate that coils did not induce repellency but “interfered” 
with host seeking and prevented feeding [20] and (Chapter 5). This behaviour has been 
observed with Permethrin treated bed nets. Mosquitoes stayed far much longer on treated 
bed nets because of the desire to blood feed on humans protected by the nets despite the 
irritating effect of pyrethroids. Similarly the pyrethroids did not inhibit attraction to 
humans [21]. It should be noted that chemicals other than pyrethroids such as DEET have 
been shown to inhibit attraction of mosquitoes to humans [22]. Despite the controversies 
surrounding the mode of action of DEET, evidence suggests that DEET affects feeding 
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behaviour of Drosophila through the activation of gustatory receptor neuron and hence 
induces avoidance and suppresses feeding [23]. This might explain the effect of coils on 
the feeding behaviour of mosquitoes in the Peet Grady chamber and in the SFS. Other 
studies indicate that DEET inhibits positive olfactory responses to attractive compounds 
such as Lactic acid and octan-3-l [22, 24] or acts as a “confusant” through direct 
modulation of olfactory receptor activity and interferes with behavioral responses such as 
attraction of mosquitoes to human odours [25, 26]. A comprehensive study on the effect 
of insect repellents of different chemical structures and repellent pyrethroids on odorant 
receptors in mosquitoes implies that all repellents modulate the function of odorant 
receptors. This is either through inhibiting odorant-evoked currents mediated by odorant 
receptors or through responses elicited in the absence of odours [27, 28]. These studies 
elucidate mechanisms underlying the response of mosquitoes to repellent compounds. 
This information is useful in the development of better repellents. For instance pyrethroid 
repellents act on olfactory receptors rather than target the sodium-gated channels are 
potential chemicals for spatial repellent products because low amounts of repellent may 
be needed to achieve high efficacy and this is likely to slow down the development of 
resistance. 
 
7.1.3. Feeding inhibition 
 
Exposure of mosquitoes to airborne Transfluthrin in the Peet Grady chamber seemed to 
“jam” the mosquito feeding system for 12 hours when mosquitoes were unable to blood 
feed (Chapter 5). The prolonged feeding inhibition status is an extremely important 
 234 
finding because it is likely to also protect non-users of SR by reducing diversion of unfed 
mosquitoes to unprotected individuals. Similar results have been reported in a study 
where the time of activation and flight of Cx. quinquefasciatus, An. albimanus and 
Stegomyia aegypti mosquitoes was reduced significantly for 24 hours after exposure to 
sublethal doses of Deltamethrin and Permethrin [29]. In the current study, mosquitoes 
resumed normal feeding after 24 hours. It is hypothesized that if mosquitoes miss one 
feeding opportunity due to exposure to SR, they are likely to continue host seeking and 
therefore this may prolong the gonotrophic cycle and in return change the vectorial 
capacity of mosquitoes [30]. However, when free-flying mosquitoes were exposed to 
coils under outdoor conditions in the SFT, there was no effect on successive blood 
feeding as depicted by similar proportions of blood fed mosquitoes in the control and 
treatment. The different results observed in the Peet Grady chamber may be attributed to 
limited ventilation that resulted in increased insecticide particles per area and a higher 
dose of insecticide obtained by the mosquito, hence the enormous reduction in blood 
feeding. The effect of coils in the SFT was less pronounced probably because of the large 
surface area of the facility and increased airflow, consequently a low dose of 
Transfluthrin was distributed within a large area and mosquitoes contacted much lower 
doses that did not affect their feeding. It should be noted that the coils used in the SFT 
contained the standard dose of Transfluthrin (0.03%) that is meant for indoor use. 
Therefore increasing the dose is likely to enhance efficacy of the coils. These results 
emphasize the need to consider the dose of the active ingredient required to confer 
maximum protection for different settings such as indoors and outdoors. 
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7.1.4. Location of repellent and its efficacy 
 
Coils used as a “point source” reduced bites by almost half when coils were placed 0.3m 
away from the human (Chapter 5). Interestingly the “bubble” reduced bites by more than 
three quarters when coils were placed 0.3m away from the human (Chapter 5). The 
“bubble” reduced bites by approximately 40% when coils were placed between 1m - 15m 
from the human compared to the “point source” where bites were reduced by less than 
27% when coils were placed between 1m - 15m. This study highlights the need to 
consider presentation of the source of the active ingredient around humans. In order to 
achieve maximum efficacy, there should be a chemical barrier between the human and 
mosquitoes. The “bubble” provided a chemical barrier in all directions around the human 
and ensured maximum saturation of the space with the active ingredient.  
It should be noted that the An. gambiae s.s. mosquitoes used in the semi-field studies 
were anthropophilic, endophagic and endophilic. Therefore these results should be 
regarded with caution. This study indicates that SRs are likely to have pronounced effects 
on human biting rate and indoor mosquito densities where mosquitoes bite and rest 
indoors. This is due to high irritancy that forces mosquitoes to leave houses prematurely 
as well as reduction in feeding.  
Unfortunately this study could not measure irritancy on exophilic An. arabiensis 
mosquitoes in field experimental huts. This is because mosquitoes were removed from 
experimental huts at the top of every hour and thus there was no way of knowing how 
many mosquitoes were left inside the hut at a specific time. This meant that the 
proportion of mosquitoes that left huts was known but the proportion of the ones that did 
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not leave was unknown. It is worthwhile noting that mortality reported in the semi-field 
was a lot higher (66% by Transfluthrin and 61% by Metofluthrin coils and 64% by DDT) 
than the field (0.02% overall mortality). These discrepancies can be explained by the fact 
that in field experimental huts human baits slept under untreated bed nets while in the 
semi-field, mosquitoes were allowed to feed freely on unprotected humans. It is 
hypothesized that in the semi-field, mosquitoes likely spent more time inside huts 
because they were tempted to blood feed on unprotected individuals and the time spent 
inside huts was sufficient to pick up lethal insecticides. In the field, mosquitoes might 
have left earlier than usual due to irritation of the insecticides and inability to blood feed. 
A study by Miller and Gibson indicates that despite irritancy caused by Permethrin on 
bed nets, mosquitoes spent more time on nets due to the need to feed [21]. This might 
have happened in the semi-field experiments too, leading to high mortality of mosquitoes. 
It should be noted that laboratory reared An. gambiae s.s. mosquitoes were used in the 
semi-field compared to wild ones in the field, this might have also contributed to a lesser 
extent to high mortality. However this is highly unlikely because mortality was measured 
with reference to the control in the particular experiment.  
Spatial repellents can be used outdoors for personal protection. In this case they would 
reduce human biting rate only, and are unlikely to be used at concentrations high enough 
to induce mortality due to the high cost of the compounds and toxicity accompanied with 
high doses of insecticide that might render them unsafe for humans or non-target 
organisms. It is necessary to conduct further studies in different geographical settings in 
order to determine the effect of SR on mosquitoes of different behaviours and the effect 
on malaria transmission as well as nuisance mosquitoes because efficacy against these 
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mosquitoes will encourage uptake of the tool and regular use by the community. 
It is important to consider the overall mode of action of SR on the mosquito population 
structure and the behaviour. The effect of LLINs on mosquito behaviour was not 
considered until recently when it has been shown that high coverage may have prompted 
species shift or behaviour change of mosquitoes [31]. Therefore it seems worthwhile to 
consider the effect that long-term, widespread use of SR would have on mosquito 
behaviour as early as possible. This study highlights subtle effects of SR such as the 
effect on feeding behaviour and fecundity. Sufficiently high doses of SR delay the 
resumption of the normal feeding process of mosquitoes, but mosquitoes can resume 
feeding after 12 hours – they do not become refractory. This is might shift the feeding 
cycle of mosquitoes forward to different biting times as has been observed with LLINs 
[32]. By preventing man-vector contact LLINs can disrupt the feeding process of 
mosquitoes hence increase the length of the oviposition cycle of the overall population. 
This mechanism might explain the immediate change in biting cycles of both An. farauti 
and An. koliensis after LLINs distribution in Papua New Guinea [32]. Another study also 
showed that females that failed to obtain blood during the previous night were likely to 
start host seeking early in the evening of the next day [33]. Such studies conducted at 
large scale under natural settings would be beneficial in the long run if SR will be proven 
to complement existing tools by reducing malaria prevalence and transmission. 
This study highlights the need for standardizing testing procedures for airborne 
chemicals. Testing conditions such as temperature, humidity, wind speed, wind direction 
and the presence or absence of the human influence the results. The WHOPES recently 
published guidelines for testing SR[9]. They include laboratory studies which provide 
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information on critical outcome measures for testing active ingredients comprising; 
movement of mosquitoes away from chemicals, host attraction-inhibition as well as dose-
response relationships. The guidelines also include a section on testing formulations in 
semi-field trials. In the semi-field trials experiments can be conducted using free-flying 
pathogen free mosquitoes in screened enclosures [9]. Some of the experiments reported 
in this study were conducted according to the semi-field trial guidelines. Feeding 
inhibition, irritancy and excito-repellency were measured accurately in experimental huts 
enclosed in a screen house (Chapter 5).  
 
7.2. The effect of spatial repellents on malaria transmission 
 
Mosquito control measures are aimed at interrupting disease transmission by significantly 
reducing vectorial capacity over a prolonged period of several years to induce disease 
interruption. Effective vector control tools target several stages of the mosquito‟s feeding 
cycle thereby reduce the probability of mosquitoes to transmit diseases. According to the 
vectorial capacity equation, changes to different aspects of the life cycle of mosquitoes 
will have differential impact on malaria transmission [34]. A reduction in mosquito 
density (m) leads to an equal reduction in vectorial capacity because of their linear 
relationship, while a reduction in biting rate (ma) leads to a two-fold reduction in 
transmission due to the quadratic relationship (arising from the fact that mosquitoes need 
to feed twice to transmit malaria: once to become infected and once to infect) [34]. This 
study shows that through deterrence, irritancy and feeding inhibition of SR, more than 
90% of the mosquitoes are prevented from contacting humans inside houses before 
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mortality occurs. By reducing human-vector contact, SR directly influence the biting rate 
of mosquitoes (ma): an important parameter of malaria transmission. In addition results 
from the semi-field system indicate that SR lead to delayed mortality of mosquitoes and 
therefore affect mosquito densities (m) and indirectly reduce chances that a mosquito 
would survive (p) long enough to become infectious. This study also shows that airborne 
pyrethroids reduce fitness of mosquitoes by reducing the number of eggs laid. Reduced 
fecundity is an indirect measure of pyrethroids on mosquito densities (m). This study 
suggests that SRs are likely to have greater impact on malaria transmission than initially 
considered because they influence more than one parameter of the vectorial capacity 
equation. This study underlines entomological parameters that are affected by SR and 
highlights the need for further field studies to confirm the results and demonstrate 
epidemiological impact. 
 
7.3. Where do SR fit in the malaria vector control strategies?  
 
The WHO currently recommends diagnosis of malaria cases and treatment with effective 
medicines; distribution of LLINs, to achieve full coverage of populations at risk of 
malaria; and IRS to reduce epidemic transmission and eliminate malaria at low 
transmission [35]. In endemic areas everyone should sleep under an LLIN irrespective of 
the age group [36]. LLINs are highly effective where mosquitoes are highly 
anthropohilic, endophagic, endophilic and bite late at night. Increasing reports of changes 
in mosquito behaviour or species shift of malaria vectors threaten the efficacy of bed 
nets. Mosquitoes have been shown to exhibit a range of behaviours that may attenuate 
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efficacy of LLINs including early evening and outdoor biting, exophily and avoidance of 
insecticide treated houses [31].  
7.3.1. Outdoor mosquito control 
 
Currently there are no vector control tools that target outdoor biting mosquitoes apart 
from insecticide treated materials such as pyrethroid treated clothing, hammock nets and 
use of topical repellents that are being used for personal protection against outdoor biting 
mosquitoes. Among these tools, topical repellents [37, 38] and long lasting insecticidal 
hammocks [39] have been shown to reduce malaria prevalence. Topical repellents are 
especially effective for personal protection but the effect on malaria control in a 
community may be undermined where there is minimal coverage and minimal 
compliance by users. This is because topical repellents prevent mosquitoes from feeding. 
Therefore mosquitoes that don‟t feed are likely to be diverted to non-users of the 
repellent [40]. Larviciding may also be used to control outdoor biting mosquito densities 
through larval source management where larval habitats can be identified and targeted. 
However it is likely to be inappropriate for rural settings in most parts of Africa where 
there are numerous larval habits that are not easy to identify and may be left out during 
treatment [41]. This study indicates that SR may be useful against early evening and 
outdoor biting mosquitoes because unlike personal protection tools they are likely to offer 
household protection due to the area wide effect which extends over several distances up 
to 15 meters. In addition to reduction of human biting rate SR used indoors also delay 
future mosquito feeding episodes and hence, they are likely to prevent diversion to non-
users and also reduce mosquito fitness by reducing fecundity. Therefore long-lasting 
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passive SR are likely to be superior to personal protection tools for community or 
programmatic control because they affect more than just the human biting rate of 
mosquitoes [10]. 
 
7.3.2. Combination with other control tools 
 
Mathematical modeling suggests that adding SR indoors in the same space as LLINs may 
reduce their efficacy. It is suggested that SR through excito-repellency may prevent 
mosquitoes from reaching bed nets and acquiring lethal doses [42]. This underscores the 
need to determine the effect of SR in the presence of LLINs as well as IRS. Laboratory 
and semi-field trials should be conducted to evaluate the effect of using SR products 
alongside LLINs and IRS that are treated with different active ingredients. Different 
techniques of combining SR with existing tools without influencing their efficacy should 
be developed. For instance SR may be used exclusively outdoors where mosquitoes are 
exophagic and exophilic when people are outdoors at the same times when vectors are 
active there. Another method may be combining a SR and an LLIN. A novel long lasting 
polymer-coating multi-layer technique was previously used to combine different 
repellents with pyrethroid treated nets. DEET combined with a permethrin treated bed net 
increased knock down, contact toxicity, spatial repellency and also reduced biting [43]. 
This technique is likely to be useful for adapting use of SR for malaria vector control. 
Lessons may be learnt from studies conducted to determine the effect of combining 
LLINs and IRS or durable wall linings [44-47]. Combining LLINs and non-pyrethroid 
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durable wall lining was shown to be more effective than using pyrethroid durable wall 
linings and the combination of interventions was less likely to select for resistance [47].  
 
7.3.3. Resistance management 
 
Resistance against pyrethroids has been reported in many endemic areas [48]. Increased 
use of pyrethroids through use of spatial repellent is likely to fuel development of 
pyrethroid resistance. May be it is worthwhile to develop other SR from new compounds 
that are not pyrethroids in order to lessen the burden of insecticide resistance. Despite 
this, a study carried out in Benin indicated that coils were effective against highly kdr 
resistant Cx. quinquefasciatus quinquefasciatus (Raphael N'Guessan pers. comm). 
Efficacy of SR against resistant mosquitoes may be explained by the fact that airborne 
repellent pyrethroids modulate the action of numerous odorant receptors and lead to 
multiple behavioral responses of mosquitoes that include reduced feeding and avoidance 
[27]. The target sites for repellent modes of action of pyrethroids are different from those 
involved in toxic effects that result in knock down and mortality of mosquitoes and this is 
to which insecticide resistance has developed. The most important question is whether 
resistance is likely to develop towards the anti-feeding and avoidance effects elicited 
through the effect of repellent pyrethroids on odorant receptors.  
7.3.4. Community studies 
 
It is important to consider mosquitoes that are prevented from feeding. Where do they 
go? Are they diverted to non-users leading to increased infectious bites? A study 
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conducted in Kilombero valley, Tanzania indicated that topical repellents that also 
prevented biting, increased the density of mosquitoes to nearby non-users by four fold 
[40]. Spatial repellents may be of minimal risk because apart from reducing feeding 
instantly, they delay feeding for hours and also induce mortality of mosquitoes. 
Nevertheless, it is necessary to conduct further studies that measure whether SR result to 
diversion when used at a large scale in the community. 
It is essential to not only develop SR products that are effective but also those that are 
readily acceptable by the targeted user. It is important to determine the preferences and 
choice of SR products. This will enable development of suitable delivery formats that are 
desirable and therefore increase compliance by users. In developing countries, there is 
need to develop affordable tools that do not require an external source of energy such as 
electricity. Paper emanators impregnated with metofluthrin have been shown to be 
effective against indoor and outdoor biting mosquitoes [49-51]. Development of 
emanators that last for several weeks or months is underway. In this study a delivery 
format for dispensing Transfluthrin from hessian strips was developed and evaluated 
[52]. Transfluthrin treated hessian strips reduced bites by more than 90% for more than 6 
months without retreating the fabric [52]. Long-term efficacy of the strips may be 
attributed to the high dose of Transfluthrin used. Two percent Transfluthrin (10ml of 
Transfluthrin/500ml of the solvent) was impregnated on a 4 x 0.3m long strip. The strips 
were used outdoors therefore the risk of users inhaling toxic amounts was lower due to 
increased airflow. However, toxicology studies giving a No Observed effect Level for 
chronic outdoor exposure will be needed before this product can be adapted for inclusion 
in vector control strategies. This information is useful in determining the minimal active 
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ingredient required to provide protection against mosquito bites as well as ensure safety 
for users. Application of the strip for use in a household was heavily criticized because 
the strips were presented in close proximity to users and which increased the risk of skin 
contact with the treated material. Further studies are being conducted with the aim to 
modify current strips into more user-friendly formats. The new formats will include 
reduced doses of Transfluthrin as well as improved formats that prevent direct skin or 
oral contact with chemical. If proven effective, the new formats will be a great tool for 
protecting people whilst outdoors in verandas especially in coastal tropical areas where 
evening and night temperatures are quite high; hence people rest, play, cook or sleep 
outdoors. The tools can also be used in outdoor restaurants in the early evening and late 
at night or by night watchmen. 
 
7.4. Conclusion 
 
This study elucidates the mode of action of SR. Spatial repellents mainly interfere with 
host seeking and thus ultimately prevent mosquitoes from blood feeding. This 
information is critical for the development of target product profiles for spatial repellent 
products. 
This study highlights the potential of SR for mosquito and malaria control and underlines 
several important entomological parameters that should be quantified in a proof of 
concept clinical trial in order to effectively determine the impact of SR on malaria 
epidemiology.  
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This study distinguishes between taxis and orthokinesis and reveals that airborne 
Transfluthrin elicits orthokinesis and do not prevent attraction of mosquito to humans but 
prevent them from blood feeding. This study also indicated that coils provide area wide 
protection and provided insights on how to use SR to provide a chemical “bubble that 
provides maximum efficacy. In addition, this study demonstrates that locally available 
natural fibres such as hessian/sisal [52] are promising absorbent substrates for dispensing 
volatile insecticides, such as Transfluthrin, without the need for electricity and they are 
likely to protect people against outdoor biting mosquitoes in tropical settings.  
Spatial repellents may be a suitable complementary option where mosquitoes feed in the 
early evening and/or rest outdoors. The role of SR in integrated approach of malaria 
control should be critically considered with an aim of complementing existing 
mainstream tools rather than undermining existing control efforts.  
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Glossary 
Anthropophilic: Tendency of hematophagous anthropods to prefer human hosts [53]. 
Attraction inhibition: Compounds with an effect that results in a reduction of the 
number of organisms that respond to an attractive stimulus [54]. In the case of insects this 
is accomplished by inhibition or excitation of olfactory receptor neurone responses [55]. 
Behavioristic avoidance: Also known as behaviouristic resistance or protective 
avoidance- modified behaviour whereby endophilic mosquito populations sometimes 
adapt to exophily in response to pressure of indoor residual spraying with excitorepellent 
insecticide [53]. 
Deet: N,N-diethyl-3-methylbenzamide (originally known as N,N-diethyl-meta-
toluarnide), usually abbreviated to deet or deet in literature. It is the dominant repellent 
used worldwide since the 1960s [53]. 
Deterrence: In the repellent context, something that inhibits feeding or oviposition when 
present in a place where insects would, in its absence, feed or oviposit [5]. It also refers to 
when mosquitoes are prevented from entering insecticide treated houses [56, 57]. 
Diversion: Movement of a haematophagous arthropod from a protected to unprotected 
target caused by the use of repellents [58]. 
Endophilic: Tendency of insects (especially female Anopheles mosquitoes of some 
species) to come into houses for biting nocturnally and resting diurnally [53]. 
Exophilic: Behavioral tendency of female insects to stay outdoors [53]. 
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Excito-repellency: A chemical that causes insects to make undirected movements that 
set them apart from the source [5]. This is due to a combination of orthokinesis 
undirected changes in the speed and klinokinesis undirected changes in the rate of turning 
of an organism depending on the intensity of the stimulus. When exposed to excito-
repellent insecticides such as DDT mosquitoes tend to move towards to the light resulting 
in escape from treated houses [14]. 
Feeding inhibition: An inhibitor is a compound that suppresses the action with another 
compound. Several repellents have been shown to suppress insect attraction to a resource, 
e.g. inhibitor of attraction [22]. Therefore feeding inhibition is whereby mosquitoes are 
prevented from biting and/or feeding on humans [56].  
Irritancy: The terms irritancy and excito-repellency are used interchangeably to refer to 
increased undirected activity of mosquitoes through orthokinesis or klinokinesis arising 
after 1) tarsal contact with insecticide treated surfaces “contact irritancy” or 2) airborne 
insecticides, “non-contact irritancy” [4].  
Knockdown: Sublethal incapacitation; early symptom of an insect responding to a 
pesticide; not necessarily lethal because metabolic recovery may occur [53]. 
Olfactory receptor Perception of chemicals in the environment by insects begins when 
compounds activate ionotropic receptors (IR), gustatory receptors (GR) and odorant 
receptors (ORs) located on the dendritic surface of olfactory receptor neurons (ORNs), 
chemosensory neurons housed in a head appendage (e.g. antenna or palp) [59]. Olfactory 
receptors recognize biologically meaningful chemical ligands, governing their sensitivity 
and specificity thus regulating innate and learned olfactory behaviours including 
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attraction and repellency [60]. The expression of ORs follows the general rule of one OR 
to one ORN. Rather than binding specific ligands, olfactory receptors may display an 
affinity for a range of odour molecules, and conversely a single odorant molecule may 
bind to a number of olfactory receptors with varying affinities, with some such as 
pheromone receptors showing high affinities (specificities). The insect odorant receptors 
are atypical 7-transmembrane domain proteins that form ligand-gated ion channels by 
assembling a ligand-selective subunit with the olfactory correceptor Orco [61]. 
Orthokinesis: Irritation effect which causes insects to move undirected to stimulus 
gradient and increase their activity with the result that there would be a decreased number 
on the surface [5]. 
Pyrethroids: Numerous synthetic organic compounds, mostly based on the 
chrysanthemate moiety of pyrethrum, having analogous neurotoxic modes of action 
causing rapid knockdown and insecticidal effects [53]. 
Repellent: a chemical that causes insects to make oriented movements of avoidance 
without having made actual tarsal contact with the chemical stimulant [5]. 
Spatial repellent: refers to all mosquito behavioural reactions induced by any airborne 
chemicals that cause mosquitoes to eventually sit apart from the source of stimulation [6]. 
Taxis: Immediate directional avoiding reaction [5]. 
Vectorial capacity: the expected number of new human malaria infections disseminated 
per human per day, by a mosquito population from a single case, presuming that all 
vector females feeding on the case become infective [62]. 
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Zoophilic: Tendency of hematophagous insects to bite or prefer hosts other than humans 
[53]. 
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United States  
Environmental Protection Agency 
Office of Prevention, Pesticides and Toxic Substances 
(7505P) 
_______________________________________________________ 
Pesticide 
Fact Sheet 
 
Name of Chemical: Metofluthrin 
Reason for Issuance: New Chemical 
 Nonfood Use 
Date Issued: September 2006 
_______________________________________________________ 
 
 
Description of Chemical
 
IUPAC name: 2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl (EZ)-
(1RS,3RS;1RS,3SR)-2,2-dimethyl-3-prop-1-
enylcyclopropanecarboxylate 
 
CAS name: [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 
2,2-dimethyl-3-(1-propenyl)cyclopropanecarboxylate 
 
Common Name:   Metofluthrin 
 
Empirical Formula: C18H20F4O3
 
EPA Chemical Code: 109709 
 
Chemical Abstracts  
Service (CAS) Number:  240494-70-6 
 
Chemical Class:   Pyrethroid ester  
 
Registration Status:   New Chemical, nonfood use 
 
Pesticide Type:   Insecticide repellent not applied to human skin 
 
U.S.Technical Registrant : Sumitomo Chemical Company, LTD. 
 1330 Dillon Hghts. Ave. 
 Baltimore, MD 21228 
  
 
Use Pattern and Formulations 
 
Currently there are two end use products being proposed for metofluthrin. 
DeckMate ™ Mosquito Repellent Strip is an impregnated paper strip (~3,528 cm2) 
containing 1.82 percent metofluthrin as the active ingredient.  The product also contains 
Bitrex ™ to discourage oral exposure to children or animals.  The product is for use on 
patios, campsites, decks, cabanas, and other outdoor areas.  One strip is applied per 10 ft 
× 10 ft outdoor area.  Indoors the application rate is two strips per 50 m3. There are 
approximately 200 mg of metofluthrin initially in the strip.  The strips can provide up to 
one week of protection   Metofluthrin evaporates readily and therefore requires no 
external heat. 
  
Norm 1- is a personal outdoor insect repellent product consisting of a holder containing a 
replaceable cartridge insert coated with up to 50 mg of metofluthrin.  The product is 
activated by turning on a battery powered fan to release the metofluthrin into the air 
surrounding the individual.  The device can be worn by adults or children for up to 12 
hours although a specific time is not presented on the proposed label.  A time of 12 hours 
was used in the exposure study and was used by the Agency.  There are no label 
restrictions on who can use the products or the use frequency.   
 
There are no proposed agricultural or occupational uses for metofluthrin.   
 
Science Findings 
 
Available product chemistry data supporting the use of flufenoxuron are summarized 
below in Tables 1 and 2.   
TABLE 1 Nomenclature and Physiochemical Properties of Metofluthrin 
Chemical Structure 
 
Empirical Formula C18H20F4O3
Common name Metofluthrin 
Company 
experimental name 
S-1264 
IUPAC name 2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl (EZ)-(1RS,3RS;1RS,3SR)-2,2-
dimethyl-3-prop-1-enylcyclopropanecarboxylate 
CAS name [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2-dimethyl-3-(1-
propenyl)cyclopropanecarboxylate 
CAS Registry 
Number 
240494-70-6 
End-use product/EP SumiOne®, Eminence® 
Chemical Class Pyrethroid ester  
 
TABLE 2 Physiochemical Properties of Technical Grade Metofluthrin 
Molecular Weight 360.34 
Melting point/range NA 
pH 5.24 at 25°C (1% aqueous solution) 
Density 1.21 at 20°C 
Water solubility (20°C) 0.67 mg/L (20°C) for (S-1264RTE) 
0.50 mg/L (20°C) for (S-1264RTZ) 
Solvent solubility (20°C to 25°C) 
(g/L) 
Acetone 303.4, methanol 312.2, ethyl acetate 307.6, toluene 326.9, 
n-hexanes 328.7, dichloromethane 318.9, n-octanol 325.1, isopropyl 
alcohol 313.2 
Vapor pressure (25°C) 1.47x10-5 Torr 
Dissociation constant, pKa Could not be measured 
Octanol/water partition coefficient, 
logPOW (25°C) 
5.03 (S-RTE) 
4.97 (S-RTZ) 
UV/visible absorption spectrum In 100% methanol: peak maximum = 273 nm, extinction coefficient 
= 1670 M-1cm-1, band width 23 nm 
  
TOXICOLOGY SUMMARY 
The Registrant submitted the studies listed in Tables 3 and 4, which include a number of 
toxicity studies.  These include the usual acute studies for metofluthrin technical.  The 
Registrant has also submitted oral, dermal and inhalation studies as well as chronic, 
carcinogenicity and developmental studies as shown in Table 4. 
 
 
TABLE 3 Acute Toxicity Profile – Test Substance 
 
Guideline No./ 
Study Type 
 
MRID 
No. 
 
Results 
 
Toxicity Category 
 
870.1100 Acute 
oral toxicity 
 
46406719 
 
LD50 > 2000 
mg/kg 
 
III 
 
870.1200 Acute 
dermal toxicity 
 
46406721 
 
LD50 >= 2000 
mg/kg 
 
III 
 
870.1300 Acute 
inhalation 
toxicity 
 
46406723 
 
LC50 > 1.08 and 
< 1.96 mg/L 
 
III 
 
870.2400 Acute 
eye irritation 
 
46406724 
 
Not an eye 
irritant 
IV 
 
870.2500 Acute 
dermal irritation 
 
46406724 
 
Mildly irritating 
to the skin (PDI 
= 0.8) 
 
IV 
 
870.2600 Skin 
sensitization 
 
46406726 
 
Not a dermal 
sensitizer 
 
- 
 
 
Table 4  Subchronic, Chronic, and Other Toxicity Profile 
Guideline No./ Study 
Type 
MRID No. (year)/ Classification 
/Doses 
Results 
870.3100 
90-Day oral toxicity 
rats 
(Wistar rats) 
46454109 (2003) 
Acceptable/Guideline 
 
0, 100, 300, 1000,  or 2500 ppm 
M:  0, 6.8, 20.6, 70.4, or 183.6 
mg/kg/day 
F:  0, 7.5, 21.6, 73.0, or 185.6 
mg/kg/day 
NOAEL = 20.6/21.6 mg/kg/day 
LOAEL = 70.4/73.0 mg/kg/day, based on increased 
absolute and relative liver weights in both sexes; 
increased serum total cholesterol and phospholipids 
levels in males, and increased incidences of 
enlarged livers, hepatocellular hypertrophy, and 
basophilia in males; and decreased body weight 
gain in females. 
 
870.3100 
Subchronic (6-month) 
oral toxicity rats 
(Sprague-Dawley rats) 
46406733 (2002) 
Acceptable/Guideline 
 
0, 100, 300, 1000, or 3000 ppm 
M:  0, 5.3, 16.0, 54.1, 164.6 
mg/kg/day 
F:  0, 6.4, 19.0, 65.4, 191.4 
mg/kg/day 
NOAEL = 16.0/19.0 mg/kg/day 
LOAEL = 54.1/65.4 mg/kg/day, based on increased 
relative liver weights, serum phospholipids, and 
total cholesterol levels in males;  increased 
incidences of dark, enlarged livers and 
hepatocellular hypertrophy in both sexes; and an 
increased incidence of slight focal hepatic necrosis 
in females.   
Table 4  Subchronic, Chronic, and Other Toxicity Profile 
Guideline No./ Study 
Type 
MRID No. (year)/ Classification 
/Doses 
Results 
870.3100 
90-Day oral toxicity in 
mice 
(CD-1 mice) 
46454108 (2004) 
Acceptable/Guideline 
0, 100, 1500, 2500, or 3500 ppm 
M:  0, 13.7, 20.9, 35.7, or 48.7 
mg/kg/day 
F:  0, 17.2, 25.2, 43.9, or 58.7 
mg/kg/day 
NOAEL = 35.7/43.9 mg/kg/day 
LOAEL = 48.7/58.7 mg/kg/day, based on findings 
indicative of hepatotoxicity including increased 
absolute and relative liver weights in both sexes; 
increased serum total cholesterol, phospholipids, 
and triglycerides in females; and minimal 
degeneration/necrosis of the liver and minimal to 
moderate hepatocellular hypertrophy in both sexes, 
and increased Kupffer cells in males.  
870.3150  
90-Day oral toxicity in 
dogs (Beagles) 
46406734 (2002) 
Acceptable/Guideline 
 
0, 10, 30, or 100 mg/kg/day 
NOAEL = 30 mg/kg/day 
LOAEL = 100 mg/kg/day, based on tremor and 
vomiting observed in both sexes 
870.3250 
90-Day dermal 
toxicity in rats 
(Sprague-Dawley) 
46556101 (2004) 
Acceptable/Guideline 
 
0, 30, 100, 300, or 1000 
mg/kg/day  
Systemic NOAEL = 300 mg/kg/day 
Systemic LOAEL = 1000 mg/kg/day, based on 
mortality and clinical signs (tremor and salivation) 
 
Dermal NOAEL = not determined 
Dermal LOAEL = 30 mg/kg/day, based on 
hyperactivity and vocalization in the females during 
the daily exposure period 
870.3465  
Subchronic inhalation 
study in rats  
(Sprague-Dawley) 
46406736 (2002) 
Acceptable/Guideline 
 
0, 10, 50, 100, or 200 mg/m3 
0, 0.01, 0.051, 0.099, or 0.196 
mg/L) 
M: 4 hrs/day, 28 days 
F: 4 hrs/day, 29 days 
NOAEL = 0.099 mg/L 
LOAEL = 0.196 mg/L, based on mortality and 
clinical signs including tremors, hypersensitivity, 
ataxic gait, tiptoe gait, lateral position, clonic 
convulsion, and hypothermia in both sexes.  
Clinical signs began on days 1-4 and occurred 
consistently in the males and transiently in females 
thereafter. 
870.3700a 
Prenatal 
developmental in rats  
(Sprague-Dawley) 
46454111 (2002) 
Acceptable/Guideline 
 
0, 5, 15, or 30 mg/kg/day from 
GD6 – GD19 
Maternal NOAEL = 15 mg/kg/day 
Maternal LOAEL = 30 based on increased 
incidence of tremor 
 
Developmental NOAEL = 30 mg/kg/day 
Developmental LOAEL = not observed 
Prenatal 
developmental in rats  
(Sprague-Dawley) 
46454112 (2002) 
Acceptable/Non-Guideline 
 
M: 0, 10, or 20 mg/kg/day 
beginning 2 weeks prior to mating 
through necropsy (57 days) 
F:  0, 10, 20, or 40 mg/kg/day 
beginning 2 weeks prior to mating 
through GD7 
Parental NOAEL = 20 mg/kg/day (both sexes) 
Parental LOAEL = 40 mg/kg/day, based on 
mortality and incidences of tremors and salivation 
in females. 
 
Reproduction NOAEL = 20/40 mg/kg/day M/F 
 
Developmental NOAEL = 40 mg/kg/day in females 
Developmental LOAEL = not observed 
Prenatal 
developmental in rats 
(Sprague-Dawley 
46454113 (2002) 
Acceptable/Non-guideline 
 
0, 5, 15, or 30 mg/kg/day from 
GD6 through LD20 
Maternal NOAEL = 15 mg/kg/day 
Maternal LOAEL = 30 mg/kg/day, based on 
mortality and increased incidences of tremors and 
salivation. 
 
Reproductive NOAEL = 30 mg/kg/day 
Reproductive LOAEL = not observed 
 
Developmental NOAEL = 30 mg/kg/day 
Developmental LOAEL = not observed 
Table 4  Subchronic, Chronic, and Other Toxicity Profile 
Guideline No./ Study 
Type 
MRID No. (year)/ Classification 
/Doses 
Results 
870.3700b 
Prenatal 
developmental in 
rabbits 
(New Zealand White) 
46454114 (2002) 
Acceptable/Guideline 
 
0, 25, 125, or 250 mg/kg/day 
from GD6 – GD27 
Maternal NOAEL = 25 mg/kg/day 
Maternal LOAEL = 125 mg/kg/day, based on 
mortality 
 
Developmental NOAEL = 250 mg/kg/day 
Developmental LOAEL = not observed 
870.4100a 
Chronic toxicity 
rodents 
(Wistar rats) 
46611301 (2005) 
Acceptable/Guideline 
0, 20, 200, 900, or 1800 ppm 
M: 0, 0.8, 8.2, 38.1, or 77.8 
mg/kg/day 
F: 0, 1.0, 10.1, 47.4, or 96.1 
mg/kg/day 
NOAEL = 8.2/10.1 mg/kg/day 
LOAEL – 38.1/47.4 mg/kg/day, based on decreased 
body weights and body weight gains in both sexes; 
increased incidence of hepatic clear cell foci in both 
sexes; increased fatty liver change, and kidney 
lesions (including interstitial fibrosis, lipofuscin, 
mononuclear foci, and glomerulosclerosis) in 
males; increased centrilobular hepatocellular 
hypertrophy in females 
870.4100b 
Chronic toxicity dogs 
(Beagle) 
46454110 (2004) 
Acceptable/Guideline 
 
0, 10, 30, or 100 mg/kg/day 
NOAEL = 10 mg/kg/day 
LOAEL = 30 mg/kg/day, based on increased 
incidence of tremor in males. 
870.4300 
Carcinogenicity mice 
(CD-1 mice) 
46611302 (2005) 
Acceptable/Guideline 
0, 100, 1000, or 1750/2500 ppm 
M: 0, 12, 116, or 209 mg/kg/day 
F: 0, 15, 155, or 277 mg/kg/day 
NOAEL =  116/155 mg/kg/day 
LOAEL = 209/277 mg/kg/day, based on decreased 
body weight gain in both sexes. 
Gene Mutation 
870.5100 Bacterial 
Reverse Gene 
Mutation Assay 
46406742 (2002) 
Acceptable/Guideline 
0, 156, 313, 625, 1250, 2500, or 
5000 μg/plate +/- S9 in S. 
typhimurium TA98, TA100, 
TA1535 and TA1537 and E. Coli 
WP2 uvrA 
There was no evidence of induced mutant colonies 
over background levels. 
Gene Mutation 
870.5100 In vitro 
Bacterial Gene 
Mutation Assay 
46454115 (2004) 
Acceptable/Guideline 
Trial 1 (-S9): 4.88, 9.77, 19.5, 
39.1, 78.1, or 156 μg/plate strains 
TA100, TA1535 
  
Trial 2 (+S9): 19.5, 39.1, 78.1, 
156, 313, or 625 μg/plate  strains 
TA100, TA1535, and TA1537  
 
Trial 3 (+/-S9): 156, 313, 625, 
1250, 2500, or 5000 μg/plate 
strains TA98 and WP2uvrA  
There was no evidence of induced mutant colonies 
over background levels. 
Table 4  Subchronic, Chronic, and Other Toxicity Profile 
Guideline No./ Study 
Type 
MRID No. (year)/ Classification 
/Doses 
Results 
Cytogenetics  
870.5375  In vitro 
Mammalian 
Cytogenics 
(Chromosomal 
Aberration Assay in 
Chinese Hamster Lung 
Fibroblasts) 
46406744 (2002) 
Acceptable/Guideline 
 
Trial 1 (-S9): 50, 70, 90, 110, or 
130 μg/mL  
Trial 1 (+S9): 50, 100, 150, 200, 
or 250 μg/mL 
 
Trial 2 (-S9) 20, 50, 80, or 110 
μg/mL Trial 2 (+S9): 100, 150, 
200, or 250 μg/mL  
There was no evidence of chromosome aberration 
induced over background in the presence or absence 
of S9-activation. 
Other Effects  
870.5395  In vivo 
Mammalian 
Cytogenetics – 
Erythrocyte 
Micronucleus Assay in 
Mice  
46406745 (2002) 
Acceptable/Guideline 
0, 12.5, 25, or 50 mg/kg 
There was no significant increase in the frequency 
of micronucleated polychromatic erythrocytes in 
bone marrow compared to controls. 
870.6200a 
Acute neurotoxicity 
screening battery 
(Sprague-Dawley) 
46406728 (2004) 
Acceptable/Guideline 
 
0, 20, 50, or 100 mg/kg 
NOAEL = 50 mg/kg 
LOAEL = 100 mg/kg, based on mortality, adverse 
clinical signs, FOB (unusual behavior, limb 
twitches/tremors, and abnormal respiration) effects, 
and increased motor activity in both sexes. 
870.6200b 
Subchronic 
neurotoxicity 
screening battery 
(Sprague-Dawley) 
46406729 (2004) 
Acceptable/Guideline 
 
0, 300, 1000, or 3000 ppm 
 
M:  0, 18.3, 59.8, or 178.8 
mg/kg/day 
F:   0, 20.9, 68.8, 206.0 
mg/kg/day 
Systemic NOAEL = 59.8/68.8 mg/kg/day 
Systemic LOAEL = 178.8/206.0 mg/kg/day, based 
on mortality (females only); clinical signs 
(soft/liquid feces and scant feces in the males and 
tremors and twitches in the females); decreased 
body weight, body weight gain, and absolute and 
relative food consumption in both sexes. 
 
Neurotoxicity NOAEL = 59.8/68.8 mg/kg/day 
Neurotoxicity LOAEL = 178.8/206.0 mg/kg/day, 
based on the clinical signs of tremors and twitches 
in the females 
870.7485 
Metabolism and 
pharmacokinetics 
46406746, 46406747, 46406748, 
46414002, and 46414003 (2004) 
Acceptable/Guideline 
 
1 or 20 mg/kg for single dose 
studies 
 
1 mg/kg for 21 day studies 
 
Overall recoveries were 95-97% for both dose 
groups.  Absorption was rapid (detectable plasma 
residues within 30 minutes, Tmax 3.3-8.0 hours) and 
thorough (>80% absorption).  Absorption was not 
dose limited.  At 168 hours post dosing, urinary and 
fecal excretion accounted for 29-71% and 25-66% 
of the total administered dose, respectively.  
Radioactivity increased above plasma levels in both 
liver and kidney, but dissipated 12 hours post-dose.  
46 metabolites were identified, including all major 
metabolites. 
Non-Guideline 
An evaluation of the 
human relevance of 
the metofluthrin-
induced liver tumors 
in rats based on mode 
of action 
 
46756304 (2006) 
Acceptable/Nonguideline 
 
Summary of proposed MOA and weight of the 
evidence.  The MOA for metofluthrin-induced liver 
tumors is postulated to involve liver cytochrome 
P450 enzyme induction leading to stimulation of 
increased cellular proliferation. 
 
MOA not accepted by CARC due to insufficient 
data. 
Table 4  Subchronic, Chronic, and Other Toxicity Profile 
Guideline No./ Study 
Type 
MRID No. (year)/ Classification 
/Doses 
Results 
Non-Guideline 
Study for the mode of 
action of S-1264 for 
liver tumor promotion 
in rats 
(Wistar rats) 
46581501 (2005) 
Acceptable/Nonguideline 
0, 900, 1800, or 3600 ppm in the 
diet for 7 days 
 
Concurrent recovery group fed 
basal diet for 7 days following 
treatment period 
Liver morphology and enzyme induction were 
affected in at 900 ppm and above, as evidenced by  
increased liver weights, hepatocellular hypertrophy, 
replicative DNA synthesis in the hepatocytes, 
induction of CYP 2B and 3A mRNA, and increased 
expression of CYP 2B.  All of these findings were 
reversible on cessation of treatment.  
 
Non-Guideline 
The 2nd study of mode 
of action of S-1264 for 
liver tumor promotion 
in rats 
46756301 (2006) 
Acceptable/Nonguideline 
0, 200, 900, 1800, or 3600 ppm in 
diet for 7 days 
Metofluthrin inhibited gap junction interactions (as 
evidenced by decreased dye transfer) and induced 
oxidative stress (measured by lipid oxidation and 
GSH levels). 
 
Non-guideline 
Study for mode of 
action of S-1264 for 
liver tumor promotion 
in rats (in vitro effects 
of S-1264 on 
cytochrome P450 
activity and mRNA 
levels) 
46756302 (2006) 
Acceptable/Nonguideline 
 
Rat, mouse, and human 
hepatocytes were exposed 50 μM 
metofluthrin for 3 days, and 
comparative metabolic profiles 
were examined. 
Metofluthrin induced CYP 2B mRNA and 7-
pentoxyresorufin O-depentylase activity in rat and 
human hepatocytes, but not in mouse hepatocytes, 
but the induction level was less than that of 
phenobarbital induction in human hepatocytes. 
 
Non-Guideline 
Gene expression 
profiling analysis of 
early phase treatment 
in the liver from S-
1264 treated rats 
 
46756303 (2006) 
Acceptable/Nonguideline 
 
Wistar rats were exposed to 1800 
ppm metofluthrin for 1 week.  
DNA microarray was used to 
evaluate gene expression. 
The majority of genes upregulated by metofluthrin 
were GSTs, CYPs, and UDPGTs.  In general, this 
resembled the upregulation of Phenobarbital, only 
to a lesser degree. 
 
 
 
HAZARD CHARACTERIZATION/ASSESSMENT 
Potential areas of environmental justice concerns, to the extent possible, were considered 
in this human health risk assessment, in accordance with U.S. Executive Order 12898, 
“Federal Actions to Address Environmental Justice in Minority Populations and Low-
Income Populations.”  http://www.eh.doe.gov/oepa/guidance/justice/eo12898.pdf
 
Human Testing:  This risk assessment does not rely on any data from studies in which 
human subjects were intentionally exposed to a pesticide or other chemical. 
 
Hazard and Dose-Response Characterization  
 
The toxicology database for metofluthrin is complete for the proposed use pattern.  
Although metofluthrin is a neurotoxicant, a developmental neurotoxicity (DNT) study is 
not necessary at this time. However, if new uses are proposed, the need for a DNT study 
will need to be re-evaluated.  The risk assessment team is confidant that risk to pregnant 
women and children will not be underestimated due to: 1) regulatory endpoints are based 
on neurotoxicity, 2) no neuropathy or changes in morphometrics were observed in the 
acute and subchronic neurotoxicity studies, and 3)  for pyrethroids where DNT studies 
are available for endpoint consideration, the regulatory endpoints are generally based on 
neurotoxicity to dogs because dogs are more sensitive to pyrethroids than rats (it is 
unlikely that a DNT in rats would produce a lower neurotoxicity NOAEL than the 
NOAEL from the chronic dog study). 
 
 Summary and Discussion of Dose Related Effects 
Metofluthrin, like other pyrethroids, is neurotoxic in rats, rabbits, and dogs; both sexes 
were equally sensitive to metofluthrin.  Clinical signs include tremor (all species), 
vomiting (dog only), and increased salivation (rats and dogs).  Clinical signs appeared 
within 206 hours post-dosing and generally disappeared by the dosing period the 
following day.  All routes of exposure (oral, dermal, and inhalation) elicited neurotoxic 
effects in rats.  Rats appeared to be most sensitive via the inhalation route, based on 
clinical signs including ataxic gait, tremors, tip-toe gait, lateral position, clonic 
convulsion, hypothermia, and mortality in both sexes.  In the acute neurotoxicity battery, 
neurotoxic effects were seen in rats following a single dose of 100 mg/kg/day including 
mortality, tremors/twitches, abnormal respiration, and increased motor activity (acute 
NOAEL = 50 mg/kg/day).  Dermal exposure to 10 mg/kg/day in rats produced increased 
vocalization during the daily application period, which subsided after the removal of the 
chemical.  There were no systemic effects resulting from dermal exposure.   In 
subchronic exposures in rats (based on the subchronic and developmental studies, 
NOAELs ranged 15-20 mg/kg/day) the LOAELs range from 30-54.1 mg/kg/day, based 
on liver effects and neurotoxicity.  Neurotoxicity was not noted in the chronic studies.  
The dose-response curve for neurotoxicity is steep with mortality occurring frequently at 
the LOAEL; death was preceded by tremor, convulsion, salivation, and prostration. 
 
Metofluthrin also targeted the liver in rats and mice, producing increased absolute and 
relative liver weights, hepatocellular hypertrophy, and increase incidence of enlarged, 
discolored livers.  Hepatocellular toxicity was present at or above 48.7 mg/kg/day in mice 
and 54.1 mg/kg/day in rats in the subchronic studies.  In the chronic rat study, exposure 
to metofluthrin was connected to increased incidence of hepatocellular adenomas, 
carcinomas, and combined tumor types at doses greater than or equal to 38.1 mg/kg/day.  
The registrant submitted a proposed mitogenic mode of action (MOA) for hepatocellular 
tumor induction.  While these studies did suggest a mitogenic MOA was plausible, the 
studies did not provide enough information for the Agency to accept their proposed 
MOA.  Metofluthrin is not mutagenic or cytotoxic; it does not induce peroxisomal 
proliferation.  The Agency classified this chemical as “likely to be carcinogenic to 
humans” and generated a Q1* of 1.62x10-2, based on the increased liver tumors in 
female rats. 
 
In utero and/or post-natal exposure to metofluthrin did not produce any evidence of 
increased qualitative or quantitative susceptibility in fetuses or pups.   Four acceptable 
developmental studies in rats and rabbits were submitted for metofluthrin.  Maternal 
toxicity was seen at or above 30 mg/kg/day in rats (tremor, salivation, and mortality) and 
125 mg/kg/day in rabbits (mortality, preceded by tremor/convulsion).  These doses did 
not produce any developmental effects on the fetuses or pups.   A developmental toxicity 
study is not being requested at this time for the following reasons: 1) neurotoxicity is well 
defined within the toxicology database, 2) regulatory endpoints are based on the 
neurotoxicity, and 3)  there were no pathology findings or changes in morphometrics 
noted in either the acute or subchronic neurtoxicity studies.  The FQPA safety factor has 
been reduced to 1x. 
 
Considerations for Infants and Children 
The toxicity database for this chemical is complete for the purposes of this risk 
assessment.  Acceptable neurotoxicity and developmental studies have been submitted 
for review.  Though not required for a non-food use registration, a 2-generation rat 
reproduction study is being conducted.  The Agency has received preliminary results in a 
6(a)(2) document, but the final study report has not been submitted at this time. 
 
Neurotoxicity 
Evidence of neurotoxicity exists throughout the entire toxicology database via the oral 
route of exposure in three species (rats, rabbits, and dogs) and via dermal and inhalation 
routes of exposure in rats.   
 
In the acute neurotoxicity study in rats, a single dose of 100 mg/kg produced tremors, 
twitches, abnormal respiration, increased motor activity, and mortality.  The animals 
found dead or in extremis 24 hours post-dosing (7 out of 20 animals) exhibited signs of 
clonic convulsions, hyperpnea, prostration, lost righting reflex, soft or liquid feces, tonic 
extensor convulsions, salivation, chromorhinorrhea, and chromodachyorrhea.  In the 
subchronic neurotoxicity study, the LOAEL (59.8/68.8 M/F, respectively) was based on 
mortality in the females; clinical signs including tremors and twitches (in females); 
decreased body weight and body weight gain, and absolute and relative food 
consumption in both sexes.  Neither study indicated neuropathy. 
 
In a subchronic oral study in rats, all animals exhibited signs of tremor 2-6 hours post-
dosing during Week 1 of treatment at doses above 164.6 mg/kg/day; 0-2 animals/sex 
exhibited transient tremors throughout Weeks 2-3.  No clinical signs were observed after 
Week 3.  At 100 mg/kg/day in the subchronic dog study, 5/6 males showed signs of 
tremor (1-7 incidences/animal) beginning on Day 23 and 5/6 females showed signs of 
tremor (1-5 incidences/animal) beginning on Day 10.  Mild repetitive jerks or tremors of 
the head, limb or body were seen in 1 animal/sex at Weeks 12-13 (male) and Weeks 11 
and 13 (female); these effects were evidenced during cage-side and table top 
observations. Three developmental rat studies were performed for metofluthrin; all three 
maternal LOAELs were based on tremor and salivation and two maternal LOAELs 
included mortality.   
 
 In the subchronic dermal study in rats, two females were found dead on Day 2 in the 
1000 mg/kg/day dose group.  One female, before being found dead, displayed tremors 
prior to dosing and salivation 3-5 hours post-dosing.  Hyperactivity and vocalization were 
transiently observed in the >= 30 mg/kg/day females and >= 100 mg/kg/day males during 
the daily application period on Days 1-4.  There were no treatment-related clinical signs 
outside of the daily dosing period.   
 
In the 28-day inhalation toxicity study in rats, 7/10 males and 3/10 females in the 0.196 
mg/L dose group died.  At this concentration, tremors of the tail and body were observed 
during the treatment period; tremor, hypersensitivity, ataxic gait, tiptoe gait, lateral 
position, clonic convulsion, and hypothermia were observed.  Onset occurred on Days 1-
4, and clinical signs were transiently seen until Day 26 in males and less frequently in the 
females until Day 24.   
 
No evidence of neurotoxicity was recorded in either the rat or the mouse 
chronic/carcinogenicity studies.  Increased incidence of tremor was observed in males at 
30 mg/kg/day in the chronic dog study.  Tremor was observed in the head, limbs, or body 
of all males beginning on Day 96 (1-5 incidences/dog except one male with 46 
incidences) and in only one female and only on Day 289.  Tremors were observed 2-6 
hours post-dosing and disappeared by the time of observation the next morning. 
 
Developmental Toxicity 
Acceptable guideline developmental toxicity studies in rats and rabbits have been 
submitted for review, along with two acceptable non-guideline developmental studies in 
rats.  In the three rat studies (MRID 46454111, 46454112, 46454113) maternal toxicity 
was observed in the form of neurotoxicity (tremors and salivation) and death.  Neurotoxic 
effects were observed 2-3 hours post dosing and disappeared by the following day.  The 
maternal NOAELs ranged from 15-20 mg/kg/day, and the maternal LOAELs ranged 
from 30-40 mg/kg/day.  No developmental effects were seen in the rat studies up to 40 
mg/kg/day.  In one non-guideline study (MRID 46454112) males and females were dosed 
during the premating and mating periods all the way through gestation day (GD)7 for 
females.  No reproductive effects were noted in either the males or females up to 20/40 
mg/kg/day (males/females, respectively, highest dose tested).    In the other non-guideline 
study (MRID 46454113), the female rats were dosed from GD6 (implantation) through 
lactation day (LD)20.  Reproductive effects were not observed in the P or F1 generations.  
There were no offspring effects noted with regard to FOB results, sensory reflexes, 
clinical signs, developmental landmarks, body weights, or gross pathology up to the 
highest dose tested of 30 mg/kg/day.   
 
In the rabbit developmental study, one female in the 125 mg/kg/day group exhibited 
sneezing and convulsions before death on GD23.  One female in the 250 mg/kg/day dose 
group was found dead on GD14.  These deaths were considered treatment related because 
another female was found dead with convulsions preceding death in the range finding 
study at 200 mg/kg/day.  There were no other mortalities or clinical signs; the LOAEL 
was determined to be 125 mg/kg/day.   The maternal NOAEL is 25 mg/kg/day.  There 
were no treatment-related effects on developing fetuses;  the developmental LOAEL was 
not observed.  The developmental NOAEL was determined to be 250 mg/kg/day, the 
highest dose tested. 
 
Reproductive Toxicity 
A reproductive study in rats has not been submitted to the EPA at this time.  However, 
the Agency has received a 6(a)(2) document indicating that a 2-generation reproduction 
study in rats is being performed.  Preliminary findings include neurotoxic effects 
(tremors, convulsions, and salivation) in the F1 and F2 generations.  When the final study 
report is submitted, a full review of the data will be conducted.   
 
 
Pre-and/or Postnatal Toxicity 
There were no effects on fetal growth or development up to 40 mg/kg/day in rats or 250 
mg/kg/day in rabbits; doses at which maternal toxicity was present.  There were no 
treatment related effects on the numbers of litters, fetuses (live or dead), resorptions, sex 
ratio, or post-implantation loss.  There were no effects on fetal body weights or skeletal 
ossification; and no external, visceral, or skeletal malformations or variations were 
observed. 
 
Developmental Neurotoxicity  
A DNT study is not being requested at this time; however, because this chemical is part 
of the pyrethroid class, the need for a DNT study will be re-evaluated for all future 
proposed uses 
 
Summary of Toxicological Doses and Endpoints for Metofluthrin for Use in Human 
Risk Assessments 
Table 3.4.2  Summary of Toxicological Doses and Endpoints for Metofluthrin for Use in Non-
Occupational Human Health Risk Assessments 
Exposure/ 
Scenario 
Point of 
Departure 
Uncertainty 
Factors 
Level of 
Concern for 
Risk 
Assessment 
Study and Toxicological Effects 
Incidental Oral 
Short-Term (1-
30 days) 
NOAEL = 
15  
mg/kg/day 
UFA= 10x 
UFH=10x 
 
Residential 
LOC for MOE 
= 100 
Developmental Rat Study 
LOAEL = 30 mg/kg/day based on 
increased incidence of tremor in 
maternal animals 
Dermal Short-
Term (1-30 
days) 
NOAEL= 
300 
mg/kg/day 
 
 
UFA= 10x 
UFH= 10x 
 
Residential 
LOC for MOE 
= 100 
 
 
90-Day Dermal Rat Study 
LOAEL = 1000 mg/kg/day based on 
mortality and clinical signs  
Inhalation  
Short-Term 
(ALL 
DURATIONS) 
NOAEL = 
16 
mg/kg/day 
 
UFA= 10x 
UFH =10x 
 
Residential 
LOC for MOE 
= 100 
28-Day Inhalation Study in Rats 
LOAEL = 32 mg/kg/day based on 
mortality and clinical signs including 
tremors, ataxia, hypersensitivity, ataxic 
gait, tiptoe gait, lateral position, clonic 
convulsion, and hypothermia in both 
sexes 
Cancer (oral, 
dermal, 
inhalation) 
Likely to 
be a human 
carcinogen 
Q1* = 
1.62x10-2 
(mg/kg/day)-
1 
Dermal 
absorption 
factor = 
17% 
 Based on female rat liver combined 
adenoma and carcinoma tumor rates 
NOAEL = no observed adverse effect level.  LOAEL = lowest observed adverse effect level.  UF = 
uncertainty factor.  UFA = extrapolation from animal to human (interspecies).  UFH = potential variation in 
sensitivity among members of the human population (intraspecies).  UFDB = to account for the absence of 
key data (i.e., lack of a critical study).  FQPA SF = FQPA Safety Factor.  PAD = population adjusted dose 
(a = acute, c = chronic).  RfD = reference dose.  MOE = margin of exposure.  LOC = level of concern.  N/A 
= not applicable. 
 
Public Health and Pesticide Epidemiology Data 
Metofluthrin is a new active ingredient; therefore, no epidemiological data is available at 
this time. 
 
Dietary Exposure/Risk Characterization 
There are no proposed agricultural uses for metofluthrin at this time; therefore dietary 
exposure is not expected. 
 
Residential (Non-Occupational) Exposure/Risk Pathway 
The aggregate exposure assessment is based solely on residential use patterns.  Due to the 
seasonal nature of insect repellents, only short-term exposure scenarios were considered.  
The incidental oral endpoint for children was based on maternal neurotoxicity in the rat 
developmental study (NOAEL = 15 mg/kg/day).  This endpoint was selected because of 
the appropriate time period in which the maternal neurotoxic effects were seen.  The 
short-term dermal endpoint for adults and children (15 mg/kg/day) was selected from the 
same developmental rat study based on neurtoxic effects because no systemic toxicity 
was present in the 90-day dermal study.  A dermal penetration study in rats was 
submitted for metofluthrin, which suggests a 17% dermal absorption rate.  This 17% 
dermal absorption rate was applied to all dermal exposure scenarios.  The 28-day 
inhalation study in rats provided a sensitive inhalation endpoint (0.099 mg/L) based on 
mortality and neurotoxic effects (including tremors, hypersensitivity, ataxic gait, tip-toe 
gait, clonic convulsion, and hypothermia.  The default absorption value of 100% was 
applied to the inhalation exposure assessment.  All levels of concern are set at 100, based 
on a 10x interspecies extrapolation safety factor and 10x intraspecies variability safety 
factor.  The FQPA safety factor was reduced to 1x. 
 
As a part of every pesticide risk assessment, the Agency considers a large variety of 
consumer subgroups according to well-established procedures.  The Agency estimates 
risks to population subgroups from pesticide exposure that are based on patterns of that 
subgroup’s food and water consumption, and activities in and around the home that 
involve pesticide use in a residential setting.  Extensive data on food consumption 
patterns are compiled by USDA under the Continuing Survey of Food Intake by 
Individuals (CSFII) and are used in pesticide risk assessments for all registered food uses 
of a pesticide.  These data are analyzed and categorized by subgroups based on age, 
season of the year, ethnic group, and region of the country.  Additionally, the Agency is 
able to assess dietary exposure to smaller, specialized subgroups and exposure 
assessments are performed when conditions or circumstances warrant.  Whenever 
appropriate, nondietary exposures based on home use of pesticide products and 
associated risks for adult applicators and for toddlers, youths, and adults entering or 
playing on treated areas post-application are evaluated.  Further considerations are 
currently in development as the Agency has committed resources and expertise to the 
development of specialized software and models that consider exposure to bystanders and 
farm workers as well as lifestyle and traditional dietary patterns among specific 
populations.   
 
Estimated Cancer Risk 
The Q1* for metofluthrin was based on female hepatocellular adenomas, carcinomas, and 
combined adenomas/carcinomas in rats.    The Q1* is 1.62 x 10-2 (mg/kg/day) -¹. This 
cancer assessment is conservative in assuming that the product will be used 12 times per 
year for 50 years out of a 70 year lifespan.   
 
A high-end worst case inhalation cancer assessment was performed for the metofluthrin 
products (DeckMate and NORM-1).   The saturation concentration of 0.28 mg/ m3 was 
used, with a 12 hour / day exposure time (half a day).  An adult breathes 20 m3 of air per 
day.  The use frequency was 12 applications per year from the use survey conducted by 
the Residential Exposure Joint Venture (REJV).  The users are expected to use the 
products over a 50 year period in their 70 year lifetime.  This results in a Lifetime 
Average Daily Dose (LADD) of 0.000939 mg/kg/day.   The LADD is multiplied by the 
Q1*, which results in an estimated cancer risk of 1.5 x 10-5. 
 
Aggregate Exposure Assessment 
Metofluthrin is proposed for residential use only at this time.  No food uses exist.  
Residues in water are unlikely.  An aggregate exposure assessment is not needed at this 
time. 
 
Cumulative Risk Characterization/Assessment 
Metofluthrin is a member of the pyrethroid class of pesticides.  Although all pyrethroids 
alter nerve function by modifying the normal biochemistry and physiology of nerve 
membrane sodium channels, EPA is not currently following a cumulative risk approach 
based on a common mechanism of toxicity for the pyrethroids. Although all pyrethroids 
interact with sodium channels, there are multiple types of sodium channels and it is 
currently unknown whether the pyrethroids have similar effects on all channels.  Nor do 
we have a clear understanding of effects on key downstream neuronal function e.g., nerve 
excitability, nor do we understand how these key events interact to produce their 
compound specific patterns of neurotoxicity.  There is ongoing research by the EPA’s 
Office of Research and Development and pyrethroid registrants to evaluate the 
differential biochemical and physiological actions of pyrethroids in mammals.  This 
research is expected to be completed by 2007.  When available, the Agency will consider 
this research and make a determination of common mechanism as a basis for assessing 
cumulative risk.  For information regarding EPA’s procedures for cumulating effects 
from substances found to have a common mechanism on EPA’s website at 
http://www.epa.gov/pesticides/cumulative/. 
 
 
Occupational Exposure/Risk Pathway 
Only residential uses are proposed for metofluthrin at this time; dietary and occupational 
risk assessments are not necessary at this time.   
 
 
ENVIRONMENTAL FATE AND EFFECTS SUMMARY 
Metofluthrin, like other synthetic pyrethroids, is practically non-toxic to mammals and 
birds, but it is highly to very highly toxic to aquatic animals and insects.  Its repellency 
power is related to its insecticidal character.  The published literature supports its 
character both as a repellent and as an insecticide.  No Level of Concern was exceeded, 
but the insecticidal properties of metofluthrin imply that it will pose a risk to non-target 
insects and to species federally listed as endangered or threatened by the United States 
government.  
 
Since there is no geographic restriction on metofluthrin’s use, it will be used in every 
place where there are mosquitoes.    The proposed use is not expected to stress aquatic or 
terrestrial vertebrates or aquatic invertebrates even though it is toxic to them, because it is 
not expected to have a high aquatic concentration.  
 
Environmental Effects  
The registrant has submitted adequate effects and fate data needed to complete a Tier 1 
Risk Assessment.  A summary of all submitted studies are shown in Table 5 and 6 below.  
Metofluthrin’s effect on aquatic organisms is estimated from acute, subacute and chronic 
laboratory studies submitted to the Agency.  The registrant has submitted acute and 
chronic studies on aquatic vertebrates and invertebrates.  Freshwater fish, e.g., bluegill 
sunfish (Lepomis macrochirus), rainbow trout (Oncorhynchus mykiss) and fathead 
minnow (Pimephales promelas) are used as surrogates for all freshwater fish species.  
Freshwater fish are used as surrogates for aquatic-phase amphibians.  No acute bluegill 
sunfish (§72-1a) was submitted.  A common carp study was ruled “supplemental,” 
because it is not a standard species.  The Agency shall require confirmatory data to 
satisfy the acute bluegill sunfish data requirement. 
 
The effect of metofluthrin on all bird species is estimated from acute, subacute and 
chronic studies on two species, bobwhite quail (Colinus virginianus) and mallard duck 
(Anas platyrhynchos).  These species also act as surrogates for reptiles and terrestrial-
phase amphibians.  Effects on mammals are estimated from acute and chronic rat studies 
submitted to and reviewed by the Agency. 
 
No studies have been submitted that address toxicity to insects.  The registrants have 
requested a waiver for a study on beneficial insects (bees), but this has not been granted.  
There are no published field surveys or monitoring data.  Published information 
(Kawada, et al.) found that metofluthrin kills insects (mosquitoes) in a cage.  All 
experimental mosquitoes directly under a paper strip were killed within 24-hours.  This 
was not quantified nor was a measure of toxicity (LD50, etc.) calculated.   The Agency 
shall require confirmatory data to satisfy this data requirement. 
 
 
 
 
 TABLE 5 Measures of  Envrionmental Effects of metofluthrin 
Guidelines   Data Requirements   Measures Of Effect 
  71-1(a)   Acute Avian Oral Quail or 
Duck   LD50 >2250 mg/kg-bw.   
  71-2(a)   Avian Dietary/Quail   LC50 >5760 mg/kg-bw 
  71-2(b)   Avian Dietary/Duck   LC50 >5760 mg/kg-bw.   
  OPPTS 870.1100   Rat Acute Oral LD50   LD50 >2,000 mg/kg 
  Non-guideline   Rat reproductive 
development study 
 NOAEL = 20 mg/kg bw/day dose based on maternal mortality 
during the 57 days of dosing  
  72-1   Fish Toxicity- Common carp   LC50 = 2.61 
  72-1(c)   Fish Toxicity Rainbow Trout   LC50 = 1.2 
  72-2(a)   Invertebrate Toxicity, 
Daphnid   48-hr LC50 = 4.7 ppb 
 
 
Table 5.  Environmental Fate properties of metofluthrin. 
PARAMETER VALUE(S)  SOURCE 
Solubility  
in water (20 oC) 
0.50 mg/L (Z-isomer) 
0.67 mg/L (E-isomer) MRID 46406754 
Vapor Pressure (20 oC) 1.47 x 10-5 mmHg MRID 46402005 
Henry’s Law Constant  
(20 oC)  
1.5 x 10-5 atm m3/mol (Z-
isomer) 
1.1 x 10-5 atm m3/mol (E-
isomer) 
Estimated from vapor  pressure & solubility1
Hydrolysis Half-life  
(25 oC) 
pH 4 & 7:  Stable 
pH 9: 33 days MRID 46406750 
Aqueous Photolysis  
Half-life      (pH 4) 6 days 
MRID 46406754 
(Based on 12-hour light/12-hour dark cycle 
with Xe lamp) 
Aerobic Soil 
Metabolism Half-life 
MS sandy loam:  DT50 =  3-8 
days 
CA sandy loam:  DT50 =  1-3 
days 
MRID 46406751 
Soil Partition 
Coefficient (Kd) 
57.5, 75.8, 85.3, 163 
mL/g 
MRID 46406753 
(calculated,  based on submitted data) 
Organic Carbon 
Partition 
Coefficient (Koc) 
3704, 4489, 5414, 7187 
mL/goc
MRID 46406753 
(Calculated,  based on calculated Kd) 
1 Estimated as Hg = vapor pressure (atm) ÷ solubility (mol/L) 
 
 
 
 
 
 
 
 
 
 
 
Contact Person at USEPA 
 
Mailing address: 
 
Mark Suarez 
Product Manager (10) 
Environmental Protection Agency 
Office of Pesticide Programs 
Registration Division (7505P) 
Insecticide Branch 
1200 Pennsylvania Avenue NW 
Washington, D.C. 20460 
 
Office location and telephone number:  
 
Room S-7246, One Potomac Yard 
2777 S. Crystal Drive 
Arlington, VA 22202 
703-305-0120 
 
 
DISCLAIMER: The information in this Pesticide Fact Sheet is for information only 
and is not to be used to satisfy data requirements for pesticide registration. The 
information is believed to be accurate as of the date on the document.  
APPENDIX I 
GLOSSARY OF TERMS AND ABBREVIATIONS 
ADNT Acute delayed neurotoxicity 
a.i. Active Ingredient 
aPAD Acute Population Adjusted Dose 
ARI Aggregate Risk Index 
BCF Bioconcentration Factor 
CAS Chemical Abstracts Service 
ChE Cholinesterase 
ChEI Cholinesterase inhibition 
cPAD Chronic Population Adjusted Dose 
%CT Percent crop treated 
DAT Days after treatment 
DEEM-FCID Dietary Exposure Evaluation Model - Food Consumption Intake Database  
DNA Deoxyribonucleic acid  
DNT Developmental neurotoxicity  
DIT Developmental immunotoxicity  
DWLOC   Drinking Water Level of Comparison.  
EC Emulsifiable Concentrate Formulation  
EEC  Estimated Environmental Concentration. The estimated pesticide 
 concentration in an environment, such as a terrestrial ecosystem.  
EPA U.S. Environmental Protection Agency  
FQPA Food Quality Protection Act  
GLC Gas Liquid Chromatography  
GLN Guideline Number  
LC50    Median Lethal Concentration. A statistically derived concentration of a 
substance that can be expected to cause death in 50% of test animals. It is 
usually expressed as the weight of substance per weight or volume of 
water, air or feed, e.g., mg/l, mg/kg or ppm.  
LD50   Median Lethal Dose. A statistically derived single dose that can be 
expected to cause death in 50% of the test animals when administered by 
the route indicated (oral, dermal, inhalation). It is expressed as a weight of 
substance per unit weight of animal, e.g., mg/kg.  
LOAEL Lowest Observed Adverse Effect Level  
LOAEC Lowest Observed Adverse Effect Concentration  
LOC Level of Concern  
LOD Limit of Detection  
LOQ Limit of Quantitation  
mg/kg/day Milligram Per Kilogram Per Day  
mg/L Milligrams Per Liter  
MOE Margin of Exposure 
MRID Master Record Identification (number), EPA's system of recording and 
tracking studies submitted  
MTD Maximum tolerated dose  
NA Not Applicable  
NOEC No Observable Effect Concentration  
NOEL No Observed Effect Level  
NOAEL No Observed Adverse Effect Level  
NOAEC No Observed Adverse Effect Concentration  
NPDES National Pollutant Discharge Elimination System  
OP Organophosphate  
OPP EPA Office of Pesticide Programs  
OPPTS EPA Office of Prevention, Pesticides and Toxic Substances  
PAD Population Adjusted Dose  
PAG Pesticide Assessment Guideline  
PAM Pesticide Analytical Method  
PHED Pesticide Handler's Exposure Data  
PHI Preharvest Interval  
ppb Parts Per Billion  
PPE Personal Protective Equipment  
ppm Parts Per Million  
PRZM/EXAMS  Tier II Surface Water Computer Model  
RAC   Raw Agriculture Commodity  
RBC Red Blood Cell  
RED Reregistration Eligibility Decision  
REI Restricted Entry Interval  
RfD Reference Dose  
SCI-GROW Tier I Ground Water Computer Model  
SF Safety Factor  
TGAI Technical Grade Active Ingredient  
UF Uncertainty Factor  
µg micrograms  
µg/L Micrograms Per Liter  
µL/g Microliter per gram  
USDA United States Department of Agriculture  
WPS Worker Protection Standard 
APPENDIX II 
 
Citations Considered to be Part of the Data Base Supporting the Registration of 
Metofluthrin.  
 
MRID Citation Receipt Date 
46406701 
Todd, R. (2004) Product Identity and Disclosure of 
Ingredients of S-1264 Technical Grade. Project Number: 
QAP/0034. Unpublished study prepared by Insect Control 
and Research Inc. 5 p. 
12-Nov-2004 
46406702 
Suzuki, M. (2004) Description of Beginning Materials and 
Manufacturing Process for S-1264: Description of 
Formation of Impurities. Project Number: QAP/0033. 
Unpublished study prepared by Sumitomo Chemical 
Company, Ltd. 18 p. 
12-Nov-2004 
46406703 
Inoue, H. (2002) Preliminary Analysis of S-1264 Technical 
Grade: Final Report. Project Number: 3771, QAP/0016. 
Unpublished study prepared by Sumitomo Chemical 
Company, Ltd. 38 p. 
12-Nov-2004 
46406704 
Todd, R. (2004) Certification of Ingredient Limits of S-
1264 Technical Grade. Project Number: QAP/0035. 
Unpublished study prepared by Insect Control and Research 
Inc. 9 p. 
12-Nov-2004 
46406705 
Inoue, H. (2002) Enforcement Analytical Methods of S-
1264 Technical Grade: Final Report. Project Number: 3679, 
QAA/0009. Unpublished study prepared by Sumitomo 
Chemical Company, Ltd. 106 p. 
12-Nov-2004 
46406706 
Sweetapple, G.; Lentz, N. (2003) Determination of 
Physical-Chemical Properties of S-1264. Project Number: 
QAP/0020, 015682/1. Unpublished study prepared by 
Ricerca Biosciences, LLC. 44 p. 
12-Nov-2004 
46406707 
Sweetapple, G.; Lentz, N. (2004) Determination of 
UV/Visible Absorption and Boiling Point of S-1264. 
Project Number: 015681/1, 015681. Unpublished study 
prepared by Ricerca Biosciences, LLC. 36 p. 
12-Nov-2004 
46406708 
Walsh, K.; Lentz, N. (2003) Determination of Water 
Solubility - S-1264. Project Number: 015634/1, QAP/0019, 
015634. Unpublished study prepared by Ricerca 
Biosciences, LLC. 112 p. 
12-Nov-2004 
46406710 Beckwith, R.; Lentz, N. (2003) Determination of Dissociation Constant (pKa) - S-1264. Project Number: 12-Nov-2004 
MRID Citation Receipt Date 
015635/1, QAP/0021, 015635/0. Unpublished study 
prepared by Ricerca Biosciences, LLC. 34 p. 
46406711 
Walsh, K.; Lentz, N. (2003) Determination of n-
Octanol/Water Partition Coefficient - S-1264. Project 
Number: 015633/1, QAP/0023, 015633/0/1. Unpublished 
study prepared by Ricerca Biosciences, LLC. 86 p. 
12-Nov-2004 
46406712 
Inoue, H. (2004) Stability of S-1264 Technical Grade to 
Normal and Elevated Temperatures, Metals and Metal Ions: 
Final Report. Project Number: 0007, QAP/0024. 
Unpublished study prepared by Sumitomo Chemical Co. 
Ltd., Envr. Health. 15 p. 
12-Nov-2004 
46406715 
Inoue, H. (2004) Storage Stability of S-1264 Technical 
Grade: Final Report. Project Number: 0001, QAP/0025. 
Unpublished study prepared by Sumitomo Chemical Co. 
Ltd., Envr. Health. 54 p. 
12-Nov-2004 
46406716 
Inoue, H. (2004) Corrosion Characteristics of S-1264 
Technical Grade: Final Report. Project Number: 0002, 
QAP/0026. Unpublished study prepared by Sumitomo 
Chemical Co., Ltd. 11 p. 
12-Nov-2004 
46406717 
Todd, R. (2004) Waiver Rationale for Dielectric 
Breakdown Voltage Study on SumiOne (Metofluthrin). 
Project Number: 110804/DIEL. Unpublished study 
prepared by Insect Control and Research, Inc. 4 p. 
12-Nov-2004 
46406718 
Lentz, N. (2004) Determination of Freezing Point, Solvent 
Solubility, Absorption Spectra and Autoflammability of S-
1264. Project Number: QAP/0030, 016369/1, 016369/0. 
Unpublished study prepared by Ricerca Biosciences, LLC. 
72 p. 
12-Nov-2004 
46406719 
Kunimatsu, T. (2002) Acute Oral Toxicity STudy of S-1264 
in Rats: Final Report. Project Number: QAT/0004, 3670. 
Unpublished study prepared by Sumitomo Chemical Co. 
Ltd., Envr. Health. 30 p. 
12-Nov-2004 
46406721 
Kunimatsu, T. (2002) Acute Dermal Toxicity Study of S-
1264 in Rats: Final Report. Project Number: QAT/0005, 
3671. Unpublished study prepared by Sumitomo Chemical 
Co. Ltd., Envr. Health. 23 p. 
12-Nov-2004 
46406723 
Deguchi, Y. (2002) Acute Inhalation Toxicity Study of S-
1264 in Rats: Final Report. Project Number: 3666, 
QAT/0028, P01096. Unpublished study prepared by 
12-Nov-2004 
MRID Citation Receipt Date 
Sumitomo Chemical Co. Ltd., Envr. Health and Sumika 
Chemical Analysis Service, Ltd. 61 p. 
46406724 
Nakamura, Y. (2001) Skin and Eye Irritation Tests of S-
1264 in Rabbits: Final Report. Project Number: 3634, 
QAT/0014. Unpublished study prepared by Sumitomo 
Chemical Co. Ltd., Envr. Health. 19 p. 
12-Nov-2004 
46406726 
Nakamura, Y. (2002) Skin Sensitization Test of S-1264 in 
Guinea Pigs (Maximization Test): Final Report. Project 
Number: 3684, QAT/0017. Unpublished study prepared by 
Sumitomo Chemical Co. Ltd., Envr. Health. 27 p. 
12-Nov-2004 
46406728 
York, R. (2004) Oral (Gavage) Acute Neurotoxicity Study 
of S-1264 in Rats: Final Report. Project Number: 1119/032, 
QAT/0059, PACA/DE04. Unpublished study prepared by 
Argus Research Laboratories, Inc and Pathology 
Associates, Inc. 451 p. 
12-Nov-2004 
46406729 
York, R. (2004) Oral (Diet) Subchronic Neurotoxicity 
Study of S-1264 in Rats: Final Report. Project Number: 
1119/033, QAT/0060, PACA/DE05. Unpublished study 
prepared by Argus Research Laboratories, Inc and Charles 
River Laboratories and Pathology Associates, Inc. 510 p. 
12-Nov-2004 
46406731 
Kunimatsu, T. (2002) One-Month Oral Toxicity Study of S-
1264 in Rats: Final Report. Project Number: 3641, 
QAT/0029, P01063. Unpublished study prepared by 
Sumitomo Chemical Co. Ltd., Envr. Health. 432 p. 
12-Nov-2004 
46406733 
Kunimatsu, T. (2002) Six-Month Oral Toxicity Study of S-
1264 in Rats: Final Report. Project Number: QAT/0030, 
3663, P01063. Unpublished study prepared by Sumitomo 
Chemical Co. Ltd., Envr. Health. 452 p. 
12-Nov-2004 
46406734 
Uchida, H. (2002) 90-Day Oral Toxicity Study with S-1264 
in Beagle Dogs Followed by 42-Day Recovery Study: Final 
Report. Project Number: QAT/0018, 20142. Unpublished 
study prepared by Panapharm Laboratories Co., Ltd. 230 p. 
12-Nov-2004 
46406735 
Furukawa, H. (2004) A 90-Day Repeated Dose Dermal 
Toxicity Study of S-1264 in Rats: Final Report. Project 
Number: P030373, QAT/0064. Unpublished study prepared 
by Panapharm Laboratories Co., Ltd. 393 p. 
12-Nov-2004 
46406736 
Deguchi, Y. (2002) Four-Week Repeated Inhalation 
Toxicity Study of S-1264 in Rats: Final Report. Project 
Number: 3704, QAT/0031, P02027. Unpublished study 
12-Nov-2004 
MRID Citation Receipt Date 
prepared by Sumitomo Chemical Co. Ltd., Envr. Health. 
413 p. 
46406742 
Kitamoto, S. (2002) Reverse Mutation Test of S-1264 in 
Bacterial Systems: Final Report. Project Number: 3673, 
QAT/0026. Unpublished study prepared by Sumitomo 
Chemical Co. Ltd., Envr. Health. 18 p. 
12-Nov-2004 
46406744 
Odawara, K. (2002) In Vitro Chromosomal Aberration Test 
on S-1264 in Chinese Hamster Lung Cells (CHL/IU): Final 
Report. Project Number: 3633, QAT/0022. Unpublished 
study prepared by Sumitomo Chemical Co. Ltd., Envr. 
Health. 27 p. 
12-Nov-2004 
46406745 
Odawara, K. (2002) Micronucleus Test on S-1264 in Mice: 
Final Report. Project Number: 3685, QAT/0032. 
Unpublished study prepared by Sumitomo Chemical Co. 
Ltd., Envr. Health. 20 p. 
12-Nov-2004 
46406746 
Sugimoto, K. (2002) The Disposition and Metabolism of 
[Carbonyl-(Carbon-14)]S-1264RTZ in Rats. Project 
Number: PK0141, QAM0001, PPLK/PK0141. Unpublished 
study prepared by Sumitomo Chemical Co. Ltd., Envr. 
Health. 1043 p. 
12-Nov-2004 
46406747 
Sugimoto, K. (2002) The Disposition and Metabolism of 
Metoxymethylbenzyl-(alpha)-(Carbon 14)S-1264TRZ in 
Rats. Project Number: QAM/0003, PK0142, X0081. 
Unpublished study prepared by Panapharm Laboratories 
Co., Ltd. 871 p. 
12-Nov-2004 
46406748 
Sugimoto, K. (2004) The Disposition and Metabolism of 
[carbonyl-(Carbon 14)]S-1264RTE in Rats. Project 
Number: QAM/0002, PK0143, RIA01028. Unpublished 
study prepared by Panapharm Laboratories Co., Ltd. 777 p. 
12-Nov-2004 
46406749 
Tomigahara, Y. (2004) Percutaneous Absorption of S-1264 
in Rats. Project Number: X0088, QAM/0022. Unpublished 
study prepared by Sumitomo Chemical Co. Ltd., Envr. 
Health. 8 p. 
12-Nov-2004 
46406750 
Ponte, M. (2004) Hydrolysis of [Carbon-14]S-1264 at pH 4, 
7 and 9. Project Number: 1192W, 1192W/001. Unpublished 
study prepared by PTRL West, Inc. 187 p. 
12-Nov-2004 
46406751 
Kodaka, R.; Sugano, T.; Yoshimura, J.; et. al. (2003) 
Aerobic Soil Metabolism Study of [Carbon-14]S-1264. 
Project Number: SOI2002B, EF/2003/003, QAM/0014. 
12-Nov-2004 
MRID Citation Receipt Date 
Unpublished study prepared by Sumitomo Chemical Co. 67 
p. 
46406752 
Curry, K.; Brookman, D. (2004) Metofluthrin Aerobic Soil 
Metabolism: Supplemental Information. Unpublished study 
prepared by Technology Sciences Group, Inc. 29 p. 
12-Nov-2004 
46406753 
Ponte, M. (2004) Soil Adsorption/Desorption of [Carbon-
14]S-1264 by the Batch Equilibrium Method. Project 
Number: 1191W, 1191W/1, QAM/0018. Unpublished study 
prepared by PTRL West, Inc. 291 p. 
12-Nov-2004 
46406754 
Ponte, M. (2004) Aqueous Photolysis of (Carbon 14)S-
1264 in pH 4 Buffer by Artificial Light. Project Number: 
QAM/0019, 1238W. Unpublished study prepared by PTRL 
West, Inc. 251 p. 
12-Nov-2004 
46406755 
Curry, K.; Brookman, D. (2004) Request for a Waiver of 
the Requirement for Data on Metofluthrin Terrestrial Field 
Dissipation. Unpublished study prepared by Technology 
Sciences Group, Inc. 19 p. 
12-Nov-2004 
46406756 
Todd, R. (2004) Waiver Rationale for Honey Bee Acute 
Contact Toxicity Study on SumiOne (Metoflurin). Project 
Number: 110804/BEE. Unpublished study prepared by 
Insect Control And Research Inc. 5 p. 
12-Nov-2004 
46406757 
Gallagher, S.; Grimes, J.; Beavers, J. (2003) An Acute Oral 
Toxicity Study with the Northern Bobwhite. Project 
Number: QAW/0005, 166/172. Unpublished study prepared 
by Wildlife International, Ltd. 50 p. 
12-Nov-2004 
46406758 
Gallagher, S.; Grimes, J.; Martin, K.; et. al. (2003) A 
Dietary LC 50 Study With the Northern Bobwhite. Project 
Number: QAW/0003, 166/170. Unpublished study prepared 
by Wildlife International, Ltd. 63 p. 
12-Nov-2004 
46406759 
Gallagher, S.; Grimes, J.; Martin, K.; et. al.; (2003) S-1264: 
A Dietary LC50 Study With the Mallard. Project Number: 
QAW/0004, 166/171. Unpublished study prepared by 
Wildlife International, Ltd. 64 p. 
12-Nov-2004 
46406760 
Takimoto, Y. (2002) [Methoxymethylbenzyl-alpha-(Carbon 
14)]S-1264: Acute Toxicity Test with Common Carp 
(Cyprinus carpio) Under Flow-Through Conditions. Project 
Number: QAW/0002, 1043/010/174. Unpublished study 
prepared by Springborn Laboratories (Europe) Ag. 89 p. 
12-Nov-2004 
46406761 Lima, W. (2004) S-1264 - Acute Toxicity to Rainbow Trout 12-Nov-2004 
MRID Citation Receipt Date 
(Oncorhynchus mykiss) Under Flow-Through Conditions. 
Project Number: 13048/6398, QAW/0007. Unpublished 
study prepared by Springborn Smithers Laboratories. 51 p. 
46406762 
Putt, A. (2004) S-1264 - Acute Toxicity to Water Fleas 
(Daphnia magna) Under Flow-Through Conditions. Project 
Number: 13048/6397, QAW/0006. Unpublished study 
prepared by Springborn Smithers Laboratories. 53 p. 
12-Nov-2004 
46406764 
Todd, R.; Burin, G.; Brookman, D.; et. al. (2004) Reduced 
Risk Document for Metofluthrin-Based Mosquito Repellent 
Devices. 75 p. 
12-Nov-2004 
46414001 
Sweetapple, G.; Lentz, N. (2003) Determination of 
UV/Visible Absorption and Boiling Point of S-1264. 
Project Number: QAP/0022, 015681/1, 015681/0. 
Unpublished study prepared by Ricerca Biosciences, LLC. 
36 p. 
30-Nov-2004 
46414002 
Sugimoto, K. (2004) The Disposition and Metabolism of 
[Carbonyl-(Carbon 14)] S-1264RTZ (1R-trans-Z) After 
Repeated Administration to Rats. Project Number: 
P020096, QAM/0004. Unpublished study prepared by 
Panapharm Laboratories Co., Ltd. 113 p. 
30-Nov-2004 
46414003 
Sugimoto, K. (2004) The Disposition and Metabolism of 
[methoxymethylbenzyl-(alpha)-(Carbon 14)] S-1264RTZ 
(1R-trans-Z) After Repeated Administration to Rats. Project 
Number: QAM/0005, P020095. Unpublished study 
prepared by Panapharm Laboratories Co., Ltd. 118 p. 
30-Nov-2004 
46454101 
DiFrancesco, D.; Lentz, N. (2004) Determination of Vapor 
Pressure - S-1264. Project Number: 015632/1, QAP/0028. 
Unpublished study prepared by Ricerca Biosciences, LLC. 
82 p. 
26-Jan-2005 
46454102 
Nishiyama, M.; Katagi, T.; Takimoto, Y. (2004) Stability in 
Air of MFFO. Project Number: STA2004B, EF/2004/033, 
QAP/0031. Unpublished study prepared by Sumitomo 
Chemical Co. 8 p. 
26-Jan-2005 
46454103 
Nishyama, M.; Katagi, Takimoto, Y. (2004) Stability in Air 
of S-1264. Project Number: STA2004A, EF/2004/032, 
QAP/0032. Unpublished study prepared by Sumitomo 
Chemical Co. 9 p. 
26-Jan-2005 
46454104 Ose, K. (2004) Acute Oral Toxicity Study of MFFO in Rats. Project Number: 3910. Unpublished study prepared 26-Jan-2005 
MRID Citation Receipt Date 
by Sumitomo Chemical Co. Ltd., Envr. Health. 30 p. 
46454105 
Ose, K. (2004) Acute Dermal Toxicity Study of MFFO in 
Rats. Project Number: 3911, QAT/0069. Unpublished study 
prepared by Sumitomo Chemical Co. Ltd., Envr. Health. 28 
p. 
26-Jan-2005 
46454106 
Nakamura, Y. (2004) Primary Skin Irritation Test of MFFO 
in Rabbits. Project Number: 3909, QAT/0071. Unpublished 
study prepared by Sumitomo Chemical Co. Ltd., Envr. 
Health. 16 p. 
26-Jan-2005 
46454107 
Nakamura, Y. (2004) Skin Sensitization Test of MFFO in 
Guinea Pigs (Buehler Method). Project Number: 3908. 
Unpublished study prepared by Sumitomo Chemical Co. 
Ltd., Envr. Health. 25 p. 
26-Jan-2005 
46454108 
Sommer, E.; Knuppe, C.; Gretener, P.; et. al. (2004) S-
1264: 13-Week Repeated Dose Oral Toxicity (Feeding) 
Study in the CD-1 Mouse: Final Report. Project Number: 
841949, 41620/WEK, QAT/0072. Unpublished study 
prepared by RCC Umweltchemie Ag. 592 p. 
26-Jan-2005 
46454109 
Sommer, E.; Knuppe, C.; Gretener, P.; et. al. (2003) S-
1264: 13-Week Repeated Dose Oral Toxicity (Feeding) 
Study in the Wistar Rat: Final Report. Project Number: 
QAT/0051, 841950. Unpublished study prepared by RCC 
Ltd. 658 p. 
26-Jan-2005 
46454110 
Uchida, H. (2004) 12-Month Repeated Dose Oral Toxicity 
Study of S-1264 in Dogs: Final Report. Project Number: 
P020637, QAT/0061. Unpublished study prepared by 
Panapharm Laboratories Co., Ltd. 353 p. 
26-Jan-2005 
46454111 
Hara, H.; Suyami, S.; Ushimaru, T. et. al. (2002) Study for 
Effects on Embryo-Fetal Developmental of S-1264 
Administered Orally to Rats. Project Number: QAT/0003, 
ST01085. Unpublished study prepared by Ina Research Inc. 
106 p. 
26-Jan-2005 
46454112 
Hara, H.; Suyami, S.; Ushimaru, T.; et. al. (2002) Study of 
Fertility and Early Embryonic Development to Implantation 
of S-1264 Administered Orally to Rats. Project Number: 
QAT/0011, ST01083. Unpublished study prepared by Ina 
Research Inc. 173 p. 
26-Jan-2005 
46454113 Hara, H.; Suyama, S.; Ushimaru, T.; et. al. (2002) Study for Effects on Pre - and Postnatal Development, Including 26-Jan-2005 
MRID Citation Receipt Date 
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Project Number: ST01084, QAT/0020. Unpublished study 
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Develpment of S-1264 Administered Orally to Rabbits: 
Final Report. Project Number: QAT/0019, 3644. 
Unpublished study prepared by Sumitomo Chemical Co. 
Ltd., Envr. Health. 241 p. 
26-Jan-2005 
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Kitamoto, S. (2004) Reverse Mutation Test of MFFO in 
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Number: 3907, QAT/0070. Unpublished study prepared by 
Sumitomo Chemical Co. Ltd., Envr. Health. 23 p. 
26-Jan-2005 
46454116 
Todd, R. (2004) Summary of Physical/Chemical Properties: 
(Sumione Technical Grade). Project Number: 8570/36. 
Unpublished study prepared by Insect Control and 
Research, Inc. 5 p. 
26-Jan-2005 
46556101 
Bando, K. (2004) The Dose Finding Study for Abmsence of 
Clinical Signs by Single Dermal Administration of S-1264 
in Rats: Final Report. Project Number: 3888, QAT/0056. 
Unpublished study prepared by Sumitomo Chemical Co. 
Ltd., Envr. Health. 28 p. 
27-May-2005 
46567701 
Todd, R. (2005) Product Identity and Disclosure of 
Ingredients of S-1264 Technical Grade: Amended Report to 
Replace MRID # 464067-01. Project Number: 
QAP/0034/A. Unpublished study prepared by Insect 
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Research, Inc. 9 p. 
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Deguchi, Y. (2005) Study for Mode of Action of S-1264 for 
Liver Tumor Promotion in Rats. Project Number: 
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41708/WEK. Unpublished study prepared by RCC 
02-Aug-2005 
MRID Citation Receipt Date 
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SIGMA-ALDRICH sigma-aldrich.com 
SAFETY DATA SHEET 
according to Regulation (EC) No. 1907/2006 
Version 4.0  Revision Date 13.03.2010 
Print Date 28.11.2010 
 
 
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 
Product name : Transfluthrin 
 
Product Number : 46114 
Brand : Fluka 
 
Company : Sigma-Aldrich Company Ltd. 
The Old Brickyard 
NEW ROAD, GILLINGHAM 
Dorset 
SP8 4XT 
UNITED KINGDOM 
Telephone : +441747833000 
Fax : +441747833313 
Emergency Phone # : +44 (0)1747 833100 
E-mail address : eurtechserv@sial.com 
 
2. HAZARDS IDENTIFICATION 
Classification of the substance or mixture 
According to Regulation (EC) No1272/2008 
Skin irritation (Category 2) 
Acute aquatic toxicity (Category 1) 
Chronic aquatic toxicity (Category 1) 
According to European Directive 67/548/EEC as amended. 
Irritating to skin. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic 
environment.  
Label elements 
Pictogram 
  
Signal word Warning 
 
Hazard statement(s) 
H315 Causes skin irritation. 
H410 Very toxic to aquatic life with long lasting effects. 
 
Precautionary statement(s) 
P273 Avoid release to the environment. 
P501 Dispose of contents/container to an approved waste disposal plant. 
 
Hazard symbol(s) 
Xi Irritant 
N Dangerous for the environment 
 
R-phrase(s) 
R38 Irritating to skin. 
R50/53 Very toxic to aquatic organisms, may cause long-term adverse effects in 
the aquatic environment. 
 
S-phrase(s) 
S36/37 Wear suitable protective clothing and gloves. 
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S60 This material and its container must be disposed of as hazardous waste. 
S61 Avoid release to the environment. Refer to special instructions/ Safety data 
sheets. 
Other hazards - none 
 
3. COMPOSITION/INFORMATION ON INGREDIENTS 
Formula : C15H12Cl2F4O2  
Molecular Weight : 371.2 g/mol 
 
CAS-No. EC-No. Index-No. Classification Concentration 
2,3,5,6-Tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate 
118712-89-3 405-060-5 607-223-00-8 Skin Irrit. 2; Aquatic Acute 1; 
Aquatic Chronic 1; H315, 
H410 
Xi, N, R38 - R50/53 
 -  
For the full text of the H-Statements mentioned in this Section, see Section 16. 
 
4. FIRST AID MEASURES 
General advice 
Consult a physician. Show this safety data sheet to the doctor in attendance. 
If inhaled 
If breathed in, move person into fresh air. If not breathing give artificial respiration Consult a physician. 
In case of skin contact 
Wash off with soap and plenty of water. Consult a physician. 
In case of eye contact 
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. 
If swallowed 
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 
 
5. FIRE-FIGHTING MEASURES 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
Special protective equipment for fire-fighters 
Wear self contained breathing apparatus for fire fighting if necessary. 
 
6. ACCIDENTAL RELEASE MEASURES 
Personal precautions 
Use personal protective equipment. Avoid dust formation. Avoid breathing dust. Ensure adequate ventilation. 
Environmental precautions 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the 
environment must be avoided. 
Methods and materials for containment and cleaning up 
Pick up and arrange disposal without creating dust. Keep in suitable, closed containers for disposal. 
 
7. HANDLING AND STORAGE 
Precautions for safe handling 
Avoid contact with skin and eyes. Avoid formation of dust and aerosols. 
Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire 
protection.  
Conditions for safe storage 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.  
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Store under inert gas. Sensitive to carbon dioxide  
 
8. EXPOSURE CONTROLS/PERSONAL PROTECTION 
Contains no substances with occupational exposure limit values. 
Personal protective equipment 
Respiratory protection 
Where risk assessment shows air-purifying respirators are appropriate use a dust mask type N95 (US) or 
type P1 (EN 143) respirator. Use respirators and components tested and approved under appropriate 
government standards such as NIOSH (US) or CEN (EU). 
Hand protection 
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the 
standard EN 374 derived from it. 
 
Handle with gloves. 
 
Eye protection 
Face shield and safety glasses 
Skin and body protection 
Choose body protection according to the amount and concentration of the dangerous substance at the 
work place. 
Hygiene measures 
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at 
the end of workday. 
 
9. PHYSICAL AND CHEMICAL PROPERTIES 
Appearance 
Form crystalline 
Safety data 
pH no data available 
 
Melting point no data available 
 
Boiling point 135 °C at 0.09 hPa 
 
Flash point > 35.00 °C 
 
Ignition temperature no data available 
 
Lower explosion limit no data available 
 
Upper explosion limit no data available 
 
Density 1.507 g/cm3 at 23 °C 
 
Water solubility insoluble 
 
Partition coefficient: 
n-octanol/water 
log Pow: 5.46 at 20 °C 
 
 
10. STABILITY AND REACTIVITY 
Chemical stability 
Stable under recommended storage conditions.  
Conditions to avoid 
no data available 
Materials to avoid 
Strong oxidizing agents 
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Hazardous decomposition products 
Hazardous decomposition products formed under fire conditions. - Carbon oxides, Hydrogen chloride gas, 
Hydrogen fluoride 
 
11. TOXICOLOGICAL INFORMATION 
Acute toxicity 
LD50 Oral - rat - > 5,000 mg/kg 
LC50 Inhalation - rat - 4 h - > 513 mg/m3 
LD50 Dermal - rat - > 5,000 mg/kg 
Skin corrosion/irritation 
no data available 
Serious eye damage/eye irritation 
no data available 
Respiratory or skin sensitization 
no data available 
Germ cell mutagenicity 
no data available 
Carcinogenicity 
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by IARC. 
Reproductive toxicity 
no data available 
Specific target organ toxicity - single exposure 
no data available 
Specific target organ toxicity - repeated exposure 
no data available 
Aspiration hazard 
no data available 
Potential health effects 
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.  
Ingestion May be harmful if swallowed.  
Skin May be harmful if absorbed through skin. Causes skin irritation.  
Eyes May cause eye irritation.  
Additional Information 
RTECS: no data available 
 
12. ECOLOGICAL INFORMATION 
Toxicity 
 
no data available 
Persistence and degradability 
no data available 
Bioaccumulative potential 
no data available 
Mobility in soil 
no data available 
PBT and vPvB assessment 
no data available 
 Fluka - 46114  Page 5  of  5 
 
 
Other adverse effects 
Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. 
 
13. DISPOSAL CONSIDERATIONS 
Product 
Observe all federal, state, and local environmental regulations. Contact a licensed professional waste 
disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn 
in a chemical incinerator equipped with an afterburner and scrubber.  
Contaminated packaging 
Dispose of as unused product.  
 
14. TRANSPORT INFORMATION 
ADR/RID 
UN-Number: 3077 Class: 9 Packing group: III 
Proper shipping name: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (2,3,5,6-
Tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate) 
 
IMDG 
UN-Number: 3077  Class: 9 Packing group: III EMS-No: F-A, S-F 
Proper shipping name: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (2,3,5,6-
Tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate) 
Marine pollutant: No 
 
IATA 
UN-Number: 3077 Class: 9 Packing group: III 
Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (2,3,5,6-Tetrafluorobenzyl trans-2-
(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate) 
 
15. REGULATORY INFORMATION 
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. 
 
16. OTHER INFORMATION 
Text of H-code(s) and R-phrase(s) mentioned in Section 3 
Aquatic Acute Acute aquatic toxicity 
Aquatic Chronic Chronic aquatic toxicity 
H315 Causes skin irritation.  
H410 Very toxic to aquatic life with long lasting effects. 
Skin Irrit. Skin irritation 
N Dangerous for the environment  
Xi Irritant  
R38 Irritating to skin.  
R50/53 Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic 
environment.  
Further information 
Copyright 2010 Sigma-Aldrich Co. License granted to make unlimited paper copies for internal use only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be used 
only as a guide. The information in this document is based on the present state of our knowledge and is 
applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee 
of the properties of the product. Sigma-Aldrich Co., shall not be held liable for any damage resulting from 
handling or from contact with the above product. See reverse side of invoice or packing slip for additional 
terms and conditions of sale. 
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Disclaimer1 
 
 
WHO specifications are developed with the basic objective of promoting, as far as 
practicable, the manufacture, distribution and use of pesticides that meet basic 
quality requirements. 
Compliance with the specifications does not constitute an endorsement or warranty 
of the fitness of a particular pesticide for a particular purpose, including its suitability 
for the control of any given pest, or its suitability for use in a particular area.  Owing 
to the complexity of the problems involved, the suitability of pesticides for a particular 
purpose and the content of the labelling instructions must be decided at the national 
or provincial level. 
Furthermore, pesticides which are manufactured to comply with these specifications 
are not exempted from any safety regulation or other legal or administrative provision 
applicable to their manufacture, sale, transportation, storage, handling, preparation 
and/or use. 
WHO disclaims any and all liability for any injury, death, loss, damage or other 
prejudice of any kind that may be arise as a result of, or in connection with, the 
manufacture, sale, transportation, storage, handling, preparation and/or use of 
pesticides which are found, or are claimed, to have been manufactured to comply 
with these specifications. 
Additionally, WHO wishes to alert users to the fact that improper storage, handling, 
preparation and/or use of pesticides can result in either a lowering or complete loss 
of safety and/or efficacy. 
WHO is not responsible, and does not accept any liability, for the testing of 
pesticides for compliance with the specifications, nor for any methods recommended 
and/or used for testing compliance.  As a result, WHO does not in any way warrant 
or represent that any pesticide claimed to comply with a WHO specification actually 
does so. 
____________________________________ 
 
                                             
1  This disclaimer applies to all specifications published by WHO. 
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INTRODUCTION 
 
 
WHO establishes and publishes specifications* for technical material and related 
formulations of public health pesticides with the objective that these specifications 
may be used to provide an international point of reference against which products 
can be judged either for regulatory purposes or in commercial dealings. 
 
From 2002, the development of WHO specifications follows the New Procedure, 
described in the 1st edition of Manual for Development and Use of FAO and WHO 
Specifications for Pesticides (2002).  This New Procedure follows a formal and 
transparent evaluation process.  It describes the minimum data package, the 
procedure and evaluation applied by WHO and the experts of the “FAO/WHO Joint 
Meeting on Pesticide Specifications” (JMPS). 
 
WHO Specifications now only apply to products for which the technical materials 
have been evaluated.  Consequently, from the year 2002 onwards the publication of 
WHO specifications under the New Procedure has changed.  Every specification 
consists now of two parts, namely the specifications and the evaluation report(s): 
 
Part One: The Specification of the technical material and the related formulations of 
the pesticide in accordance with chapters 4 to 9 of the 1st edition of the 
“FAO/WHO Manual on Pesticide Specifications.” 
 
Part Two: The Evaluation Report(s) of the pesticide, reflecting the evaluation of the 
data package carried out by WHO and the JMPS.  The data are provided 
by the manufacturer(s) according to the requirements of chapter 3 of the 
“FAO/WHO Manual on Pesticide Specifications” and supported by other 
information sources.  The Evaluation Report includes the name(s) of the 
manufacturer(s) whose technical material has been evaluated.  Evaluation 
reports on specifications developed subsequently to the original set of 
specifications are added in a chronological order to this report. 
 
WHO specifications under the New Procedure do not necessarily apply to nominally 
similar products of other manufacturer(s), nor to those where the active ingredient is 
produced by other routes of manufacture.  WHO has the possibility to extend the 
scope of the specifications to similar products but only when the JMPS has been 
satisfied that the additional products are equivalent to that which formed the basis of 
the reference specification. 
 
Specifications bear the date (month and year) of publication of the current 
version.  Dates of publication of the earlier versions, if any, are identified in a 
footnote.  Evaluations bear the date (year) of the meeting at which the 
recommendations were made by the JMPS. 
 
* Footnote: The publications are available on the Internet under 
(http://www.who.int/whopes/quality/en/). 
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WHO SPECIFICATIONS FOR PUBLIC HEALTH PESTICIDES 
 
TRANSFLUTHRIN 
 
INFORMATION 
 
ISO common name 
 transfluthrin 
Synonyms 
 benfluthrin 
Chemical names 
IUPAC: 2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropanecarboxylate 
CA: (1R-trans)-(2,3,5,6-tetrafluorophenyl)methyl 3-(2,2-dichloroethenyl)-2,2-
dimethylcyclopropanecarboxylate 
Structural formula 
O
Cl
Cl O
F
F
F
F  
Empirical formula 
 C15H12Cl2F4O2 
Relative molecular mass 
 371.16 
CAS Registry number 
 118712-89-3 
CIPAC number 
 741 
Identity tests 
GC retention time and IR spectrum (CIPAC Handbook K, p. 121, 
2003); Enantioselective GC (CIPAC Handbook L, p. 128, 2006). 
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WHO SPECIFICATIONS FOR PUBLIC HEALTH PESTICIDES 
 
TRANSFLUTHRIN TECHNICAL MATERIAL 
WHO specification 741/TC (November 2006∗) 
 
This specification, which is PART ONE of this publication, is based on an 
evaluation of data submitted by the manufacturer whose name is listed in 
evaluation reports (741/2002 and 741/2006).  It should be applicable to TC 
produced by this manufacturer but it is not an endorsement of it, nor a 
guarantee that it complies with the specification.  The specification may not 
be appropriate for TC produced by other manufacturers. The evaluation 
reports 741/2002 and 741/2006, as PART TWO, form an integral part of this 
publication. 
 
1 Description 
The material shall consist of transfluthrin, together with related manufacturing 
impurities, and shall be a white to cream coloured crystalline powder, free 
from visible extraneous matter and added modifying agents. 
2 Active ingredient 
2.1 Identity tests (741/TC/(M)/2, CIPAC Handbook K, p.121, 2003; CIPAC 
Handbook L, p.128, 2005) 
The active ingredient shall comply with an identity test and, where the identity 
remains in doubt, shall comply with at least one additional test. 
2.2 Transfluthrin content (741/TC/(M/)3, CIPAC Handbook K, p.121, 2003) 
The transfluthrin content shall be declared (not less than 965 g/kg) and, when 
determined, the average measured content shall not be lower than the 
declared minimum content. 
                                             
∗ Specifications may be revised and/or additional evaluations may be undertaken.  Ensure the use of 
current versions by checking at: http://www.who.int/whopes/quality/en/. 
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PART TWO 
 
EVALUATION REPORTS 
 
 
 
 
TRANSFLUTHRIN 
 
 Page 
 
2006 Evaluation report based on submission of data from Bayer 
CropScience (TC) 9 
 
2002 Evaluation report based on submission of data from Bayer AG 
(TC) 11 
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WHO SPECIFICATIONS AND EVALUATIONS FOR PUBLIC HEALTH PESTICIDES 
 
TRANSFLUTHRIN 
EVALUATION REPORT 741/2006 
 
Recommendation 
The Meeting recommended that the specification for transfluthrin, proposed by Bayer 
CropScience∗, should be adopted by WHO. 
 
Appraisal 
Data in support of a specification for transfluthrin TC were evaluated by the JMPS in 
2002 (evaluation report 741/2002) but, at the request of the manufacturer, the 
specification was not published.  In 2004, following submissions of additional 
information, the manufacturer stated that new 5-batch analytical data would be 
generated to support production of the TC at a new site and requested 
reconsideration of the data and proposed specification by the JMPS.  The new data 
and a revised proposed specification for transfluthrin TC were submitted in 2005-6. 
The Meeting was provided with commercially confidential information on: 
(i) the comparability of data with those submitted for registration in Australia; 
(ii) the manufacturing process at the new site; 
(iii) the names, structures and methods of analysis of impurities; 
(iv) data from analysis of 5 batches and the manufacturing specification at the 
new site. 
The Australian Pesticides and Veterinary Medicines Authority (APVMA) confirmed 
that: 
(i) the new site manufacturing process described is essentially identical to that 
described in the data submitted for registration in Australia; 
(ii) the new site manufacturing specification for transfluthrin TC is identical to the 
declaration of composition provided for registration in Australia; 
(iii) the new site 5 batch analysis data provided to WHO comply with the 
declaration of composition provided for registration in Australia. 
Material accountability in the 5-batch data from the new site was high (99.4-100.1%).  
One impurity had a reported limit of quantification (0.08 g/kg) above the stated 
manufacturing QC limit (0.02 g/kg).  The impurity was non-relevant and the 
manufacturing specification for it was below the 1 g/kg threshold, therefore it was 
disregarded in considering whether or not the new manufacturing specification was 
within the earlier one.  Nonetheless, the manufacturer explained that the impurity is 
monitored indirectly by determining the level of its precursor and, if the precursor is 
<0.02 g/kg, then the impurity is taken to be within the same limit. 
                                             
∗ The manufacturer informed WHO that, in 2002, all Bayer AG assets related to crop protection and 
environmental science business, including the supporting data, were transferred to Bayer 
CropScience, which currently has the ownership. 
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The manufacturing process at the new site was identical to that at the previous site 
and the 5-batch data and manufacturing specification from the new site were all 
within the previous manufacturing specification.  Thus a formal determination of 
equivalence by the Meeting was unnecessary. 
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WHO SPECIFICATIONS AND EVALUATIONS FOR PUBLIC HEALTH PESTICIDES 
 
TRANSFLUTHRIN 
 
EVALUATION REPORT 741/20021 
 
Explanation 
The data for transfluthrin were evaluated in support of a new WHO specification.  
Transfluthrin is/was under patent in Barbados until 2002; Poland, Czech Republic, 
Slovakia, South Korea, Libya, Syria, Lebanon, Kuwait, Sri Lanka, China, Dominican 
Republic and Brazil until 2003; Jordan, Pakistan and Taiwan until 2004; Colombia 
until 2005; Panama until 2007; Denmark, Norway, Finland, Hungary, Pakistan, 
Malaysia, South Africa, Nigeria, Turkey, Israel, Ireland, Thailand, South Korea, 
Japan, USA, Mexico, El Salvador, Argentina, Australia and New Zealand until 2008; 
Canada until 2010.  
Transfluthrin has not been evaluated by the FAO/WHO JMPR and WHO/IPCS. 
The WHO hazard classification of transfluthrin is “unlikely to present acute hazard in 
normal use.” 
The draft specification and the supporting data were provided by Bayer AG, 
Leverkusen2, in 2001.  
Uses 
Transfluthrin is a fast acting insecticide.  It is used in household and hygiene 
products, mainly against flying insects, such as mosquitoes and flies, but also 
against material pests, such as moths (Pflanzenschutz Nachrichten Bayer, Special 
edition, 1995, Bayer AG, Leverkusen). 
Identity 
Common name 
transfluthrin: E-ISO (published) 
Synonyms 
benfluthrin (Bayer), NAK 44553 
Chemical names 
IUPAC: 2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropanecarboxylate 
CA: (1R-trans)-(2,3,5,6-tetrafluorophenyl)methyl 3-(2,2-dichloroethenyl)-
2,2-dimethylcyclopropanecarboxylate 
                                             
1 2006 footnote: minor editorial corrections were introduced in 2006, mainly to clarify the CIPAC 
status of the analytical method for determination of transfluthrin. 
2 2006 footnote: the manufacturer informed WHO that, in 2002, all Bayer AG assets related to crop 
protection and environmental science business, including the supporting data, were transferred to 
Bayer CropScience, which currently has the ownership. 
3 The development code, NAK 4455, is included because it appears in various references provided 
by the proposer. 
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Structural formula 
O
Cl
Cl O
F
F
F
F  
 
Molecular formula 
C15H12Cl2F4O2 
Relative molecular mass 
371.2 
CAS Registry number 
118712-89-3 
CIPAC code number 
741 
Identity tests 
(GC retention time and IR spectrum (CIPAC Handbook K, p. 121, 2003); 
Enantioselective GC (CIPAC Handbook L, p. 128, 2006)) 
 
Physico-chemical properties 
Table 1. Physico-chemical properties of pure transfluthrin  
Parameter Value(s) and conditions Purity % Method 
Vapour pressure 9 x 10-4 Pa at 20°C 97.8 OECD 104 
Melting point, boiling 
point and/or 
temperature of 
decomposition 
melting point: 32°C 
boiling point: 242°C 
decomposition temperature: sublimes at 
≥204°C 
98 differential scanning 
calorimetry, OECD 103 
Solubility in water 0.057 mg/l at 20°C 97.8 OECD 105 
Octanol/water 
partition coefficient 
log KOW = 5.46 at 20°C 97.8 OECD 107 
Hydrolysis 
characteristics 
half-life = >1 year at 25°C at pH 5 and pH 7
half-life = 14 days at 25°C at pH 9 
min. 94 according to EPA 
Guideline, Subdivision 
N, § 161–1 (1982) 
Photolysis 
characteristics 
hardly affected by direct photo-degradation 
but accessible to natural photochemical 
degradation, through radical-induced 
oxidation 
97.8 not stated 
Dissociation 
characteristics 
does not show basic or acidic properties in 
water 
98.4 OECD 112, titration 
method 
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Table 2. Chemical composition and properties of transfluthrin technical material (TC) 
Manufacturing process, maximum limits for 
impurities ≥ 1 g/kg, 5 batch analysis data 
Confidential information supplied and held on file by 
WHO.  Mass balances were 99.2 to 99.8%. 
Declared minimum [a.i.] content 950 g/kg  
Relevant impurities ≥ 1 g/kg and maximum 
limits for them 
none 
Relevant impurities < 1 g/kg and maximum 
limits for them: 
none 
Stabilisers or other additives and maximum 
limits for them: 
none 
Melting or boiling temperature range 32°C melting point, 242°C boiling point 
 
Toxicological summaries 
Notes. 
(i)  The proposer confirmed that the toxicological and ecotoxicological data included in the summary 
below were derived from transfluthrin having impurity profiles to those referred to in the table above. 
(ii)  The conclusions expressed in the summary below are those of the proposer, unless otherwise 
specified. 
(iii)   A summary and references were provided by the proposer.  Original reports were not submitted. 
(iv)  The UK evaluation of transfluthrin (ACP 1997) was considered as part of this evaluation. 
 
Table 3. Toxicology profile of transfluthrin technical material, based on acute 
toxicity, irritation and sensitization. 
Species Test Duration and conditions or 
guideline adopted 
Result Reference 
Rat m/f Oral Acute, OECD 401  LD50 > 5000 mg/kg bw 17160 
Mouse m/f Oral Acute, OECD 401 LD50 = 583-688 mg/kg bw 17156 
Rat m/f Dermal Acute, OECD 402 LD50 >5000 mg/kg bw 17155 
Mouse m/f Dermal Acute, OECD 402 LD50 >= 4000 mg/kg bw 28471 
Rat m/f Inhalation Acute, OECD 403 LC50 >513 mg/m3 17216 
Rabbit  Skin irritation 4 hours, occlusive, OECD 404 Not irritating 15804 
Rabbit Eye irritation 24 hours, OECD 405 Not irritating 15804 
Guinea pig Skin 
sensitization 
Semi-occlusive, OECD 406 
(Buehler Test) 
Not sensitizing 17920 
Guinea pig Skin 
sensitization 
Semi-occlusive, OECD 406 
(M&K) 
Not sensitizing 17964 
 
Transfluthrin is of low acute toxicity in the rat, with an LD50 of >5000 mg/kg bw via 
each route of administration and with an acute and dermal NOEL of 100 mg/kg bw/d.  
The 4 h LC50 was >513 mg/m3 air for male and female rats.  The only sign noted 
during the 14 d observation period was a slight tremor in females for 5 minutes after 
dosing.  Transfluthrin is not a skin or eye irritant, nor a skin sensitizer. 
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Table 4. Toxicology profile of transfluthrin technical material based on repeated 
administration (sub-acute to chronic). 
Species Test Duration and conditions 
or guideline adopted 
Result Reference
Rat m/f Sub-acute oral Sub-acute, 28 days, 
OECD 407 
0-10-50-250 mg/kg 
NOEL = 50 mg/kg bw/d 19187 
Rabbit m/f Sub-acute dermal Sub-acute, 15 days, 
OECD 410 
0-20-200-2000 mg/kg 
NOEL = 1000 mg/kg bw/d 19236 
Rat m/f Sub-acute 
inhalation 
Sub-acute, 4 weeks, 
OECD 412 
0-1.6-6.6-36.6-168.1 
mg/m3 air (6 h/d; 5 d/wk) 
NOEL = 36.6 mg/m³  
(≡ 13 mg/kg bw/d) 
17588 
Dog m/f Sub-chronic oral 
diet 
Sub-chronic, 13 weeks, 
OECD 409 
0-50-350-2500 ppm 
NOEL = 50 ppm  
(≡ 1.9 mg/kg bw/d) 
R4723 
Rat m/f Sub-chronic oral 
diet 
Sub-chronic, 13-18 
weeks 
0-10-50-500-5000 ppm 
NOEL = 50 ppm  
(≡ 3.5 mg/kg bw/d) 
19756 
Rat m/f Sub-chronic 
inhalation 
Sub-chronic, 90 days 
0-4.9-46.7-220.2 mg/m3 
air (6 h/d; 5 d/wk) 
LOEL = 46.7 mg/m3 
(≡ 17 mg/kg bw/d) 
18417 
Dog m/f Chronic oral diet Chronic, 52 weeks, 
OECD 452 
0-30-300-3,000 ppm 
NOEL < 30ppm 
(≡ 0.75 mg/kg bw/d) 
22638 
Dog m/f Chronic oral diet Chronic, 53 weeks, 
OECD 452. 0-10 ppm 
NOEL = 10ppm  
(≡ 0.25 mg/kg bw/d) 
22678 
Rat m/f Carcinogenicity 
and Chronic 
toxicity diet 
Chronic, 2 years, OECD 
453 
0-20-200-2,000 ppm 
NOEL = 20 ppm  
(≡ 1,0 mg/kg) 
NOEL for carcinogenicity = 
200 ppm  
(≡ 9.9 mg/kg bw/d) 
22375 
Mouse 
m/f 
Carcinogenicity 
and chronic 
toxicity diet  
Oral feed, 2 years, OECD 
451. 10, 100, and 
1000 ppm diet, i.e. 2, 20, 
and 200 mg/kg bw/d for 
males, 3, 33 and 
280 mg/kg bw/d for 
females 
Males: NOAEL = 100 ppm 
(≡ 20mg/kg bw/d) 
Females: NOEL could not be 
determined as clinical changes 
were observed at the lowest 
dose level.  Liver adenomas 
were observed in females at 
1000 ppm dose level 
22744 
Rat m/f Multi-generation 
study oral diet 
Oral diet, 84 days, OECD 
416 
0-20-200-1000ppm 
NOAEL = 220ppm 
Parental NOAEL = 200ppm (= 9 
to 38 mg/kg) 
Neonatal NOAEL = 1,000ppm (= 
50 mg/kg calculated) 
Reproductive NOAEL = 1,000 
ppm (= 45 to 191 mg/kg) 
R5352 
Rat f Developmental 
toxicity, gavage 
10 days 
0-25-55-125 mg/kg/d 
Maternal NOAEL = 
25mg/kg bw/d 
Developmental NOAEL = 
125mg/kg bw/d 
MTD0058
Rabbit f Developmental 
toxicity, oral feed 
[gavage] 
13 days 
0-15-50-150 mg/kg/d 
Maternal NOAEL = 
15mg/kg bw/d 
Developmental NOAEL =  
150 mg/kg bw/d 
18069 
Page 15 of 20 
In the rat, mortalities and body tremors were seen at 250 mg/kg/d following gavage 
dosing.  There were no mortalities following dietary administration of up 5000 ppm 
(approximately 40 mg/kg bw/d). 
A low incidence of urinary bladder papillomas/carcinomas was observed in rats at a 
dietary level of 2000 ppm of transfluthrin1. In female mice, an increased incidence of 
liver adenomas, but not of carcinomas, was observed at 1000 ppm, the highest dose 
level tested.  In 2-stage studies on promoting effects in rat liver cells with 
diethylnitrosamine as the initiator, transfluthrin had no initiating activity but was a 
weak promotor (22888).  Transfluthrin did not induce hepatocyte proliferation or 
increase mitoses in the liver in vivo (R5555). 
Developmental studies in both the rat and rabbit provided no evidence of 
teratogenicity when transfluthrin was administered at doses up to 125 and 
150 mg/kg bw/d, respectively.  NOELs of 25 and 15 mg/kg bw/d were established for 
maternal toxicity in the rat and rabbit respectively. 
In a dietary multi-generation reproductive toxicity study in the rat, there was no 
evidence of teratogenicity, foetoxicity or reproductive toxicity in rats administered 
transfluthrin at doses up to 191 mg/kg bw/d.  NOELs of 45 to 191 and 9 to 38 mg/kg 
bw/d were established for reproductive and parental toxicity, respectively. 
Table 5. Mutagenicity profile of the transfluthrin technical material based on in vitro 
and in vivo tests. 
Test system Test object Concentration Purity Results Reference
In vitro, Point mutation assays 
Salmonella 
microsome test 
S. typhimurium (TA 
98, TA 100, TA 1535, 
TA 1537) 
20 to 12500 µg/plate, with 
and without S9 activation 
96.0% negative 15144 
Salmonella 
microsome test 
S. typhimurium (TA 
98, TA 100, TA 1535, 
TA 1537) 
20 to 12500 µg/plate, with 
and without S9 activation 
94.5% negative 16084 
HPRT-test Chinese hamster 
ovary (CHO) cells 
25 to 100 µg/ml, with and 
without S9 activation 
94.8% negative 18148 
mitotic 
recombination 
assay 
Saccharomyces 
cerevisiae D7 
625 to 10000 µg/ml, with 
and without S9 activation 
94.5% negative 16083 
In vitro, DNA damage assays 
unscheduled DNA 
synthesis 
primary rat 
hepatocytes 
1 to 500 µg/ml 94.9% negative 21313 
sister chromatid 
exchange 
Chinese hamster 
ovary (CHO) cells 
0.0667 to 2000 µg/ml with 
and without S9 activation 
94.8% negative R4718 
In vivo, DNA damage assays 
unscheduled DNA 
synthesis 
mouse BOR:CFW1 
hepatocytes 
780 and 5580 mg/kg body 
weight 
95.0% negative R3658 
In vitro, Chromosomal damage/aberration assays 
cytogenetic study human lymphocytes 50 to 200 µg/ml, with and 
without S9 activation 
94.8%, 
95.0% 
negative 18742 
In vivo, Chromosomal damage/aberration assays 
                                             
1 The proposer noted that the effect was most likely attributable to a non-genotoxic mechanism of 
chronic urothelial irritation and regeneration, induced by transfluthrin or one of its metabolites 
(Cohen & Ellwein 1990; Bayer 1999). 
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Test system Test object Concentration Purity Results Reference
micronucleus test male and female 
NMRI-mouse bone 
marrow cells 
375 mg/kg body weight 95.0% negative 16912 
32P-post-labelling 
assay for detection 
of adduct formation 
male and female 
Wistar-rat 
hepatocytes and 
urinary bladder cells 
7 x 100 and 7 x 250 mg/kg 
body weight 
94.7% negative R6335 
Transfluthrin was not mutagenic in vitro in bacteria, yeast or mammalian cells with or 
without metabolic activation, neither was the any evidence of mutagenicity from in 
vivo tests on rats and mice. 
 
Table 6. Ecotoxicology profile of transfluthrin technical material. 
Species Test Duration and 
conditions 
Result Reference 
Colinus virginianus 
(bobwhite quail)  
Acute toxicity 14 days,  
OECD 401 
LD50 > 2000 mg/kg 
NOEL = 2000 mg/kg 
VB-003 
Serinus canarius (Canary 
bird) 
Acute toxicity 14 days, 
OECD 401 
LD50 > 2000 mg/kg 
NOEL = 2000 mg/kg 
VK315 
Salmo gairdneri (rainbow 
trout) 
Acute (flow through 
conditions) 
96 hours,  
OECD 203 
LC50 = 0.7 µg/l 
NOEC = 0.5 µg/l * 
FF-220 
Leuciscus idus melanotus 
(golden orfe) 
Acute (flow through 
conditions) 
96 hours,  
OECD 203 
LC50 = 1.25 µg/l 
NOEC = 0.89 µg/l 
F0-1108 
Daphnia magna (water 
flea) 
Acute toxicity 48 hours,  
OECD 202 
EC50 = 1.2 µg/l 
NOEC = 0.33 µg/l 
1091 A/01 
D 
Scenedesmus 
subspicatus (green alga) 
Growth inhibition 72 hours,  
OECD 201 
EC50 > 0.044mg/l 
NOEC = 0.017 mg/l 
1091 A/01 
AI 
Eisenia foetida 
(earthworm) 
Acute toxicity 14 days, 
OECD 207 
LC50 = 194 mg/kg 
NOEC = 32 mg/kg 
HBF/RG15
2 
Activated sludge Microbial respiration 
rate inhibition 
3 hours, 
OECD 209 
EC50 = 10 000 mg/l 1091 A/01 
B 
* It was unclear why the difference between LC50 and NOEC values was so small. 
 
Environmental fate and behaviour 
Tests of hydrolysis for transfluthrin at 25oC for 36 d gave a half-life of 14 d at pH 9 
and >1 year at pH 7 and 5.  Under the test conditions transfluthrin did not readily 
hydrolyse and, considering the very low water solubility and strong adsorption 
characteristics of the compound, hydrolysis is expected to play a minor role in the 
degradation of transfluthrin in the environment. 
Transfluthrin underwent photolysis when irradiated with light of wavelengths 
> 290 nm with an extrapolated half-life of 17 h1.  A calculation to determine the rate 
of degradation of transfluthrin in air estimated the half-life to be 4.1 d. 
                                             
1 The UV absorption spectrum of transfluthrin indicates that direct photodegradation should not 
occur.  Indirect photodegradation, by radicals generated coincidentally in the surrounding medium, 
was responsible for an extrapolated half-life of 17 h.  In a more recent study, the half-life of indirect 
photodegradation was determined as 26 h (3467). 
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Hazard summary 
Environmental toxicity tests showed that transfluthrin is of low toxicity to algae, 
earthworms and birds but is highly toxic to fish and daphnia.  If classified using the 
criteria laid out in the Globally Harmonized System for classification and labelling of 
chemicals (UN, 2003), transfluthrin would be classified in the category Acute I, in its 
lower band. 
Transfluthrin has not been evaluated by the WHO IPCS but the IPCS hazard 
classification based on acute toxicity of transfluthrin is "unlikely to present acute 
hazard in normal use" (WHO, 2002). 
The FAO/WHO JMPR has not evaluated transfluthrin but the UK evaluation of the 
compound (ACP, 1997) was considered as part of this evaluation.  The Australian 
Therapeutic Goods Administration of the Commonwealth Department of Health and 
Ageing has set an ADI of 0 to 0.003 mg/kg/d, based on the NOEL of 0.25 mg/kg 
bw/d for chronic dietary intake by dogs (TGA 2001).  
Formulations  
The main formulation types available are mosquito coils (MC) and liquid vaporizers 
(LV), which are registered and sold in many countries throughout the world. 
Methods of analysis and testing  
The analytical methods for determination of transfluthrin (including identity tests) in 
the TC. SL and LV are full CIPAC methods (CIPAC 2003, CIPAC 2006).  
Transfluthrin is determined by capillary gas chromatography with internal 
standardization (dipentylphthalate) and flame ionization detection. 
Test methods for determination of the physical-chemical properties of technical 
active ingredient were mainly OECD. 
Physical properties  
The limits proposed for physical properties (acidity and alkalinity) of the technical 
material and the methods for testing them comply with the requirements of the 
FAO/WHO Manual (FAO/WHO, 2002).   
Containers and packaging 
The technical active may be stored in glass containers, plastic containers or steel 
drums with appropriate plastic bags. 
Expression of the active ingredient  
The active ingredient content is expressed as transfluthrin in g/kg.  
Appraisal 
There is currently no WHO specification for transfluthrin and this was a new 
application by Bayer AG, Leverkusen.  
Transfluthrin is a synthetic pyrethroid insecticide used in household and hygiene 
products, mainly for the control of flying insects such as mosquitoes and flies.  It has 
been approved for use in about 50 countries worldwide.  The main formulation types 
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available are mosquito coils and aerosols.  Evaluation of specifications for public 
health use was restricted to the TC.  
Transfluthrin is of low acute and dermal toxicity and is classified as unlikely to 
present acute toxicity in normal use by the IPCS.  It is not a skin or eye irritant, nor a 
skin sensitizer. 
In a dietary multi-generation reproductive toxicity study in the rat, there was no 
evidence of teratogenicity, foetoxicity or reproductive toxicity in rats administered 
transfluthrin at doses up to 191 mg/kg bw/d. 
Transfluthrin induced a low frequency of urinary bladder adenomas/carcinomas in 
rats at high doses – the NOEL for non-cancer endpoints was 20 ppm, for cancer, 
200 ppm, and the urinary tumours were observed at a level of 2000 ppm diet.  It also 
induced adenomas in female mice at a high dose level.  Transfluthrin had no 
initiating activity, but was a weak promotor of carcinogenicity.  Transfluthrin was 
consistently negative in mutagenicity studies in vitro and in vivo; it is concluded that 
the tumours induced at high dose in rats and female mice are probably not produced 
by a genotoxic mechanism.  Field and laboratory tests showed that transfluthrin is of 
low toxicity to algae, birds and earthworms but it is highly toxic to fish and aquatic 
invertebrates such as daphnia. 
If classified according to the Globally Harmonized System for classification and 
labelling of chemicals, transfluthrin would be classified in category Acute I, lower 
band. 
The FAO/WHO JMPR has not evaluated transfluthrin.  However, the Australian 
authorities have set an ADI of 0 to 0.003 mg/kg bw/d (TGA 2001).  
The meeting considered the issue of relevant impurities.  WHO/PCS noted that the 
toxicity studies were all performed using transfluthrin with "similar" impurity profiles 
and the results showed not only a generally low toxicity but also the absence of 
unexpected effects.  Information provided by the proposer indicated that, at the 
levels found in the 5 batch analysis, none of the impurities is likely to be associated 
with important toxic effects.  WHO/PCS therefore concluded that none of the 
impurities was relevant and the meeting concurred with this view. 
There were some minor differences in the declared composition of the technical 
material submitted for registration in the UK and that submitted to the WHO, in that 
the batch analysis data and manufacturing limits submitted to WHO indicated 
somewhat lower concentrations of certain impurities.  The proposer explained that 
these were due to improvements in the quality of raw materials used and 
manufacturing improvements, made as part of the transition from pilot-scale to large-
scale production. 
CIPAC has adopted the analytical method for determination of the active ingredient 
in the technical material (including identity tests based on diastereoisomer ratio and 
stereoisomer ratios and infra-red spectroscopy) and in SL and LV formulations, 
which renders it acceptable for support of the specification for the TC.  Transfluthrin 
is determined by capillary gas chromatography with internal standardization.  The 
proposer has verified that the analytical method is capable of separation of the 
diastereoisomers of transfluthrin, i.e. that the corresponding cis-isomers would be 
separated and detected if present and would not be included in the measurement of 
transfluthrin (CIPAC, 2003). 
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Recommendations 
The meeting recommended that the proposed specification for the technical material 
should be adopted by WHO1. 
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